Processing 00000000.tx.1: High-penetrance mouse model of acute promyelocytic leukemia with very low levels of PML-RAR expression Peter Westervelt, Andrew A. 

Phrase: "High-penetrance mouse model of acute promyelocytic leukemia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C2986594:Mouse Model [Experimental Model of Disease]
   744   C3161035:Model [Intellectual Product]

Phrase: "with very low levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   734   C0442811:Very low [Finding]

Phrase: "of PML-RAR expression Peter Westervelt,"

Phrase: "Andrew A."
Processing 00000000.tx.2: Lane, Jessica L. 

Phrase: "Lane,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708639:Lane [Spatial Concept]

Phrase: "Jessica L."
Processing 00000000.tx.3: Pollock, Kristie Oldfather, Matthew S. 

Phrase: "Pollock,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0328442:Pollock [Fish]
  1000   C0453004:Pollack [Food]

Phrase: "Kristie Oldfather,"

Phrase: "Matthew S."
Processing 00000000.tx.4: Holt, Drazen B. 

Phrase: "Holt,"

Phrase: "Drazen B."
Processing 00000000.tx.5: Zimonjic, Nicholas C. 

Phrase: "Zimonjic,"

Phrase: "Nicholas C."
Processing 00000000.tx.6: Popescu, John F. 

Phrase: "Popescu,"

Phrase: "John F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.7: DiPersio, and Timothy J. 

Phrase: "DiPersio,"

Phrase: "and"

Phrase: "Timothy J."
Processing 00000000.tx.8: Ley From the Division of Oncology, Departments of Medicine and Genetics, Siteman Cancer Center, Washington University School of Medicine, St Louis, MO; 

Phrase: "Ley From the Division of Oncology,"

Phrase: "Departments of Medicine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Genetics,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017398:Genetics [Biomedical Occupation or Discipline]
  1000   C0017399:genetics [Biologic Function]

Phrase: "Siteman Cancer Center,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3642270:Siteman Cancer Center [Health Care Related Organization]
   901   C1513817:Cancer Center [Health Care Related Organization]
   827   C0205099:Center [Spatial Concept]

Phrase: "Washington University School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0036375:School [Manufactured Object,Organization]

Phrase: "St Louis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3272372:ST [Intellectual Product]

Phrase: "MO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.9: and Molecular Cytogenetics Section, Laboratory of Experimental Carcinogenesis, National Cancer Institute, Bethesda, MD.  

Phrase: "and"

Phrase: "Molecular Cytogenetics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1513387:Molecular Cytogenetics [Biomedical Occupation or Discipline]
   861   C0010802:Cytogenetics [Biomedical Occupation or Discipline]

Phrase: "Section"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0205155:Section [Spatial Concept]
  1000   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
  1000   C1522472:Section [Substance]
  1000   C1552923:Section [Quantitative Concept]
  1000   C1705191:Section [Physical Object]

Phrase: ","

Phrase: "Laboratory of Experimental Carcinogenesis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0022877:Laboratory [Manufactured Object,Organization]
   770   C3244292:laboratory [Functional Concept]

Phrase: "National Cancer Institute,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1513882:National Cancer Institute [Health Care Related Organization]
   827   C0006826:Cancer [Neoplastic Process]
   827   C0021622:institute [Organization]
   827   C0998265:Cancer [Eukaryote]
   827   C1272753:Institute [Idea or Concept]
   827   C1306459:Cancer [Finding]
   827   C3245503:national [Intellectual Product]

Phrase: "Bethesda,"

Phrase: "MD."
Processing 00000000.tx.10: Abstract Top Abstract Introduction Materials and methods Results Discussion References  Transgenic mice expressing PML-RAR in early myeloid cells under control of human cathepsin G regulatory sequences all develop a myeloproliferative syndrome, but only 15% to 20% develop acute promyelocytic leukemia (APL) after a latent period of 6 to 14 months. 

Phrase: "Abstract Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "expressing"

Phrase: "PML-RAR in early myeloid cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C3538821:RAR [Gene or Genome]

Phrase: "under control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "of human cathepsin G regulatory sequences"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   806   C0314642:Regulatory sequence [Nucleotide Sequence]
   804   C0162326:Sequences [Nucleotide Sequence]
   804   C0220905:regulatory [Regulation or Law]
   804   C1704735:Regulatory [Conceptual Entity]
   771 E C0004793:Sequence [Nucleotide Sequence]
   771 E C0162327:Sequence [Nucleotide Sequence]
   771 E C1519249:Sequence [Functional Concept]
   721 E C1548958:Sequential [Idea or Concept]
   721 E C1705294:Sequential [Qualitative Concept]

Phrase: "all"

Phrase: "develop"

Phrase: "a myeloproliferative syndrome,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039082:Syndrome [Disease or Syndrome]

Phrase: "but"

Phrase: "only 15% to 20%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C1631070:20/15 [Finding]
   770   C0205171:Only [Quantitative Concept]
   770   C1720467:Only [Intellectual Product]

Phrase: "develop"

Phrase: "acute promyelocytic leukemia (APL) after a latent period of 6"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0023487:Acute Promyelocytic Leukemia [Neoplastic Process]
           Promyelocytic Leukemia
   764   C1366903:promyelocytic leukemia [Gene or Genome]
   764   C2745900:Promyelocytic leukemia [Neoplastic Process]
   762   C0085669:Acute leukaemia [Neoplastic Process]
   762   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   742   C0023418:Leukaemia [Neoplastic Process]
   742   C0205178:acute [Temporal Concept]

Phrase: "to 14 months."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]
Processing 00000000.tx.11: However, this transgene is expressed at very low levels in the bone marrow cells of transgenic mice. 

Phrase: "However,"

Phrase: "this transgene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282641:Transgene [Gene or Genome]

Phrase: "is"

Phrase: "expressed at very low levels"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   806   C0442811:Very low [Finding]
   760   C0205251:low [Qualitative Concept]
   760   C0441889:Levels [Qualitative Concept]
   760   C0442824:Very [Qualitative Concept]
   760   C1299352:Low [Qualitative Concept]
   760   C1550472:low [Idea or Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the bone marrow cells"
Meta Candidates (Total=21; Excluded=9; Pruned=0; Remaining=12)
  1000   C0005955:Bone Marrow Cells [Cell]
   913   C0222677:Bone cells [Cell]
   901   C0005953:Bone Marrow [Tissue]
   896 E C0029432:Bone cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0086590:Marrow [Food]
   827   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   827   C0376152:Marrow [Body Part, Organ, or Organ Component]
   827   C0391978:Bone [Tissue]
   827   C1266908:Bone [Body Part, Organ, or Organ Component]
   827   C1266909:Bone [Body System]
   827   C1546708:Marrow [Intellectual Product]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   771 E C0001629:Medullary [Body Part, Organ, or Organ Component]
   771 E C0025148:Medullary [Body Part, Organ, or Organ Component]
   771 E C1550278:Medullary [Body Part, Organ, or Organ Component]
   755 E C0443157:Bony [Functional Concept]
   743 E C0330477:Marrows [Plant]

Phrase: "of transgenic mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
Processing 00000000.tx.12: Because the transgene includes only 6 kb of regulatory sequences from the human cathepsin G locus, we hypothesized that sequences required for high-level expression of the transgene might be located elsewhere in the cathepsin G locus and that a knock-in model might yield much higher expression levels and higher penetrance of disease. 

Phrase: "Because"

Phrase: "the transgene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282641:Transgene [Gene or Genome]

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "only 6 kb of regulatory sequences"

Phrase: "from the human cathepsin G locus,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1708726:Locus [Gene or Genome]

Phrase: "we"

Phrase: "hypothesized"

Phrase: "that sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0162326:Sequences [Nucleotide Sequence]
   966 E C0004793:Sequence [Nucleotide Sequence]
   966 E C0162327:Sequence [Nucleotide Sequence]
   966 E C1519249:Sequence [Functional Concept]
   916 E C1548958:Sequential [Idea or Concept]
   916 E C1705294:Sequential [Qualitative Concept]

Phrase: "required for high-level expression of the transgene"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   767   C3244092:expression level [Idea or Concept]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0205250:High [Qualitative Concept]
   744   C0282641:Transgene [Gene or Genome]
   744   C0441889:Level [Qualitative Concept]
   744   C0456079:Level [Classification]
   744   C1299351:High [Qualitative Concept]
   744   C1514873:Required [Functional Concept]
   744   C1547707:Level [Geographic Area]
   744   C2700149:HIGH [Intellectual Product]
   744   C2946261:Level [Pharmacologic Substance]

Phrase: "might"

Phrase: "be"

Phrase: "located"

Phrase: "elsewhere in the cathepsin G locus"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0054868:Cathepsin G [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1413814:CATHEPSIN G [Gene or Genome]
   753   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0439267:g% [Quantitative Concept]
   753   C1708726:Locus [Gene or Genome]

Phrase: "and"

Phrase: "that"

Phrase: "a knock-in model"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C3161035:Model [Intellectual Product]
   734   C1517676:Knock-in [Research Activity]

Phrase: "might"

Phrase: "yield"

Phrase: "much higher expression levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C3244092:expression level [Idea or Concept]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "higher penetrance of disease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0524899:Penetrance [Quantitative Concept]
Processing 00000000.tx.13: We, therefore, targeted a human PML-RAR cDNA to the 5' untranslated region of the murine cathepsin G gene, using homologous recombination in embryonic stem cells. 

Phrase: "We,"

Phrase: "therefore,"

Phrase: "targeted"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521840:Targeted [Functional Concept]
   966 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "a human PML-RAR cDNA to the 5' untranslated region"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "of the murine cathepsin G gene,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   923   C1413814:Cathepsin G Gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "homologous recombination in embryonic stem cells."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0599773:Homologous Recombination [Genetic Function]
   790   C2984295:Homologous recombination [Functional Concept]
   753   C0034865:Recombination [Genetic Function]
   753   C1334043:Homologous [Gene or Genome]
Processing 00000000.tx.14: This model produced a high-penetrance APL phenotype, with more than 90% of knock-in mice developing APL between 6 and 16 months of age. 

Phrase: "This model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "produced"

Phrase: "a high-penetrance APL phenotype,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0031437:Phenotype [Organism Attribute]
   799   C1285572:Phenotype [Laboratory Procedure]

Phrase: "with more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "than 90%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "of knock-in mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1517676:Knock-in [Research Activity]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "developing"

Phrase: "APL between 6"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0023487:Acute Promyelocytic Leukemia [Neoplastic Process]
           Promyelocytic Leukemia
   806   C1366903:promyelocytic leukemia [Gene or Genome]
   806   C2745900:Promyelocytic leukemia [Neoplastic Process]
   797   C0085669:Acute leukaemia [Neoplastic Process]
   797   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   760   C0023418:Leukaemia [Neoplastic Process]
   760   C0205178:acute [Temporal Concept]

Phrase: "and"

Phrase: "16 months of age."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   819   C1510828:Age-Months [Organism Attribute]
   770   C0439231:months [Temporal Concept]
   737 E C0439507:/month [Temporal Concept]
Processing 00000000.tx.15: The latent period and phenotype of APL (including a low frequency of an interstitial deletion of chromosome 2) was similar to that of the previous transgenic model. 

Phrase: "The latent period"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   964   C0023103:Latency Period [Temporal Concept]
   861   C0205275:Latent [Qualitative Concept]
   861   C0439531:/period [Temporal Concept]
   861   C1948053:Period [Temporal Concept]
   789 E C0332182:Periodic [Temporal Concept]
   789 E C1706381:PERIODIC [Intellectual Product]
   761 E C0031084:Periodicities [Temporal Concept]

Phrase: "and"

Phrase: "phenotype of APL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031437:Phenotype [Organism Attribute]
   760   C1285572:Phenotype [Laboratory Procedure]

Phrase: "("

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "a low frequency of an interstitial deletion of chromosome 2"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0205213:Low frequency [Temporal Concept]
   739   C0205251:low [Qualitative Concept]
   739   C0376249:frequency [Quantitative Concept]
   739   C0439603:Frequency [Temporal Concept]
   739   C0871396:Frequency [Quantitative Concept]
   739   C1299352:Low [Qualitative Concept]
   739   C1550472:low [Idea or Concept]
   739   C1561548:Frequency [Qualitative Concept]
   739   C1705502:Frequency [Quantitative Concept]

Phrase: ")"

Phrase: "was"

Phrase: "similar to that of the previous transgenic model."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.16: Remarkably, however, the expression level of PML-RAR in bone marrow cells or APL cells was less than 3% of that measured in the low-penetrance transgenic model. 

Phrase: "Remarkably,"

Phrase: "however,"

Phrase: "the expression level of PML-RAR"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C3244092:expression level [Idea or Concept]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]

Phrase: "in bone marrow cells"
Meta Candidates (Total=21; Excluded=9; Pruned=0; Remaining=12)
  1000   C0005955:Bone Marrow Cells [Cell]
   913   C0222677:Bone cells [Cell]
   901   C0005953:Bone Marrow [Tissue]
   896 E C0029432:Bone cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0086590:Marrow [Food]
   827   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   827   C0376152:Marrow [Body Part, Organ, or Organ Component]
   827   C0391978:Bone [Tissue]
   827   C1266908:Bone [Body Part, Organ, or Organ Component]
   827   C1266909:Bone [Body System]
   827   C1546708:Marrow [Intellectual Product]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   771 E C0001629:Medullary [Body Part, Organ, or Organ Component]
   771 E C0025148:Medullary [Body Part, Organ, or Organ Component]
   771 E C1550278:Medullary [Body Part, Organ, or Organ Component]
   755 E C0443157:Bony [Functional Concept]
   743 E C0330477:Marrows [Plant]

Phrase: "or"

Phrase: "APL cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   808   C1517806:Leukemic Cell [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756   C0023487:Acute Promyelocytic Leukemia [Neoplastic Process]
   708   C0085669:Acute leukaemia [Neoplastic Process]
   708   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]

Phrase: "was"

Phrase: "less than 3% of that"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0439092:Less Than [Intellectual Product]
           less
   760   C0547044:Less [Qualitative Concept]

Phrase: "measured in the low-penetrance transgenic model."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   778   C1519606:Transgenic Model [Experimental Model of Disease]
   748   C0003069:Transgenic [Animal]
   748   C0205251:low [Qualitative Concept]
   748   C0444706:Measured [Qualitative Concept]
   748   C0524899:Penetrance [Quantitative Concept]
   748   C1299352:Low [Qualitative Concept]
   748   C1550472:low [Idea or Concept]
   748   C3161035:Model [Intellectual Product]
   748   C3541902:MEASURED [Diagnostic Procedure]
   714 E C0079809:Measure [Quantitative Concept]
   714 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.17: Although the explanation for this result is not yet clear, one hypothesis suggests that very low levels of PML-RAR expression in early myeloid cells may be optimal for the development of APL in mice.  

Phrase: "Although"

Phrase: "the explanation for this result"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0681841:Explanation [Intellectual Product]

Phrase: "is"

Phrase: "not yet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: ","

Phrase: "one hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1512571:Hypothesis [Idea or Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that very low levels of PML-RAR expression"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   745   C3244092:expression level [Idea or Concept]
   742   C0441889:Levels [Qualitative Concept]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "in early myeloid cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   901   C0887899:Myeloid Cells [Cell]
   867 E C0596993:Myeloid cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0439677:Myeloid [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "may"

Phrase: "be"

Phrase: "optimal for the development of APL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2698651:Optimal [Qualitative Concept]

Phrase: "in mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]
Processing 00000000.tx.18: Introduction Top Abstract Introduction Materials and methods Results Discussion References  Several groups, including our own, have modeled acute promyelocytic leukemia (APL) in the mouse.1-5 When a PML-RAR cDNA (PR) derived from a t(15;17) translocation is placed under control of human cathepsin G regulatory sequences, it is expressed in early myeloid cells at low levels.1 Virtually all mice expressing PML-RAR in early myeloid cells develop a myeloproliferative syndrome, and 15% to 20% go on to develop a disease that closely resembles acute promyelocytic leukemia after a latent period of 6 to 14 months.1,2,5 The penetrance of that APL-like disease can be increased nearly 4-fold by coexpressing the reciprocal RAR-PML cDNA(RP) in the same early myeloid compartment, but the long latency persists in these doubly transgenic mice.6 These results have suggested that PML-RAR is the primary determinant of the phenotype of this disease and that it is a bona fide leukemia-initiating protein.7 However, even though this molecule is necessary for the development of APL in the mouse, the previous models suggest that it is not sufficient. 

Phrase: "Introduction Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Several groups,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "our own,"

Phrase: "have"

Phrase: "modeled"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3161035:Model [Intellectual Product]

Phrase: "acute promyelocytic leukemia"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0023487:Acute Promyelocytic Leukemia [Neoplastic Process]
           Promyelocytic Leukemia
   913   C0085669:Acute leukaemia [Neoplastic Process]
   913   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   901   C1366903:promyelocytic leukemia [Gene or Genome]
   901   C2745900:Promyelocytic leukemia [Neoplastic Process]
   827   C0023418:Leukaemia [Neoplastic Process]
   827   C0205178:acute [Temporal Concept]

Phrase: "(APL"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0023487:Acute Promyelocytic Leukemia [Neoplastic Process]
           Promyelocytic Leukemia
   913   C0085669:Acute leukaemia [Neoplastic Process]
   913   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   901   C1366903:promyelocytic leukemia [Gene or Genome]
   901   C2745900:Promyelocytic leukemia [Neoplastic Process]
   827   C0023418:Leukaemia [Neoplastic Process]
   827   C0205178:acute [Temporal Concept]

Phrase: ")"

Phrase: "in the mouse.1-5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mouse [Mammal]
   827   C0025929:mouse [Mammal]
   827   C0026809:Mouse [Mammal]

Phrase: "When"

Phrase: "a PML-RAR cDNA (PR)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "derived from a t(15"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1441547:Derived [Qualitative Concept]
   760   C3245521:derived [Idea or Concept]

Phrase: ";17"

Phrase: ")"

Phrase: "translocation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040715:Translocation [Cell or Molecular Dysfunction]
  1000   C2987521:Translocation [Activity]

Phrase: "is"

Phrase: "placed under control of human cathepsin G regulatory sequences,"
Meta Candidates (Total=21; Excluded=3; Pruned=0; Remaining=18)
   764   C0054868:Cathepsin G [Amino Acid, Peptide, or Protein,Enzyme]
   764   C1413814:CATHEPSIN G [Gene or Genome]
   742   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0086418:Human [Human]
   742   C0162326:Sequences [Nucleotide Sequence]
   742   C0220905:regulatory [Regulation or Law]
   742   C0243148:control [Qualitative Concept]
   742   C0439267:g% [Quantitative Concept]
   742   C1550141:Control [Substance]
   742   C1704735:Regulatory [Conceptual Entity]
   742   C1882979:Control [Conceptual Entity]
   742   C2587213:Control [Functional Concept]
   742   C3274648:Control [Qualitative Concept]
   731   C0314642:Regulatory sequence [Nucleotide Sequence]
   708 E C0004793:Sequence [Nucleotide Sequence]
   708 E C0162327:Sequence [Nucleotide Sequence]
   708   C0442504:Place [Spatial Concept]
   708 E C1519249:Sequence [Functional Concept]
   708   C1704765:Place [Functional Concept]
   708   C1882509:Place [Activity]
   708   C3496241:place [Disease or Syndrome]

Phrase: "it"

Phrase: "is"

Phrase: "expressed in early myeloid cells"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   806   C0887899:Myeloid Cells [Cell]
   773 E C0596993:Myeloid cell [Cell]
   760   C0007634:Cells [Cell]
   760   C0439677:Myeloid [Qualitative Concept]
   760   C1279919:Early [Temporal Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "at low levels.1 Virtually"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   844   C0456947:Level 1 [Intellectual Product]
   812   C0205251:low [Qualitative Concept]
   812   C0441889:Levels [Qualitative Concept]
   812   C1299352:Low [Qualitative Concept]
   812   C1550472:low [Idea or Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "all mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "expressing"

Phrase: "PML-RAR in early myeloid cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C3538821:RAR [Gene or Genome]

Phrase: "develop"

Phrase: "a myeloproliferative syndrome,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039082:Syndrome [Disease or Syndrome]

Phrase: "and"

Phrase: "15% to 20%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   858   C1631070:20/15 [Finding]

Phrase: "go on to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1822658:GO [Gene or Genome]

Phrase: "develop"

Phrase: "a disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "that closely"

Phrase: "resembles"

Phrase: "acute promyelocytic leukemia after a latent period of 6"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0023487:Acute Promyelocytic Leukemia [Neoplastic Process]
           Promyelocytic Leukemia
   764   C1366903:promyelocytic leukemia [Gene or Genome]
   764   C2745900:Promyelocytic leukemia [Neoplastic Process]
   762   C0085669:Acute leukaemia [Neoplastic Process]
   762   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   742   C0023418:Leukaemia [Neoplastic Process]
   742   C0205178:acute [Temporal Concept]

Phrase: "to 14 months.1,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439231:months [Temporal Concept]
   793 E C0439507:/month [Temporal Concept]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "The penetrance of that APL-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0524899:Penetrance [Quantitative Concept]

Phrase: "like disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "can"

Phrase: "be"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "nearly 4-fold by coexpressing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332462:Fold [Spatial Concept]
   760   C1880834:FOLD [Phenomenon or Process]

Phrase: "the reciprocal RAR-PML cDNA("
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "RP) in the same early myeloid compartment,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1538326:RP [Gene or Genome]
   748   C3541325:RP [Idea or Concept]

Phrase: "but"

Phrase: "the long latency"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C0205275:Latent [Qualitative Concept]

Phrase: "persists in these doubly transgenic mice.6"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0025936:Mice, Transgenic [Mammal]
   748   C0003069:Transgenic [Animal]
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "have"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that PML-RAR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C3538821:RAR [Gene or Genome]
   734   C0023487:Promyelocytic Leukemia [Neoplastic Process]
   734   C1366903:promyelocytic leukemia [Gene or Genome]
   734   C2745900:Promyelocytic leukemia [Neoplastic Process]

Phrase: "is"

Phrase: "the primary determinant of the phenotype of this disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1521761:Determinant [Functional Concept]

Phrase: "and"

Phrase: "that"

Phrase: "it"

Phrase: "is"

Phrase: "a bona fide leukemia-initiating protein.7 However,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   795   C0023418:Leukaemia [Neoplastic Process]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C1548602:Initiate [Idea or Concept]
   762   C1704686:Initiate [Functional Concept]

Phrase: "even"

Phrase: "though"

Phrase: "this molecule"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0567416:Molecule [Substance]
   928 E C1521991:Molecular [Qualitative Concept]

Phrase: "is"

Phrase: "necessary for the development of APL"

Phrase: "in the mouse,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "the previous models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Models [Intellectual Product]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "it"

Phrase: "is"

Phrase: "not sufficient."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]
Processing 00000000.tx.19: The long latency and low penetrance suggest that additional genetic events are required for leukemia progression. 

Phrase: "The long latency"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C0205275:Latent [Qualitative Concept]

Phrase: "and"

Phrase: "low penetrance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0524899:Penetrance [Quantitative Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that additional genetic events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0441471:Events [Event]
   827   C3541888:Events [Classification]

Phrase: "are"

Phrase: "required for leukemia progression."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0023418:Leukaemia [Neoplastic Process]
   770   C0242656:progression [Pathologic Function]
   770   C0449258:Progression [Functional Concept]
   770   C1514873:Required [Functional Concept]
Processing 00000000.tx.20: Several events associated with progression have been identified cytogenetically, including an interstitial deletion of chromosome 2, gain of chromosome 15, and loss of a sex chromosome.8,9 In addition, overexpression of bcl-2 in early myeloid cells,10 or the coexpression of an activated FLT3 allele,11 also increases the penetrance of the APL phenotype in transgenic mice expressing PML-RAR. 

Phrase: "Several events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441471:Events [Event]
   861   C3541888:Events [Classification]

Phrase: "associated with progression"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0242656:progression [Pathologic Function]
   790   C0449258:Progression [Functional Concept]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "have"

Phrase: "been"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "cytogenetically,"

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "an interstitial deletion of chromosome 2,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0008628:Deletion of chromosome NOS [Cell or Molecular Dysfunction]
           Chromosome Deletion
   753   C1442161:Deletion [Cell or Molecular Dysfunction]
   753   C1511760:Deletion [Genetic Function]
   753   C1880274:Deletion [Activity]

Phrase: "gain of chromosome 15,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1517389:Gain of Chromosome 15 [Cell or Molecular Dysfunction]
   783   C1516517:Chromosomal Gain [Cell or Molecular Dysfunction]
   770   C1517378:Gain [Quantitative Concept]

Phrase: "and"

Phrase: "loss of a sex chromosome.8,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   858   C1517991:Loss of Chromosome 8 [Cell or Molecular Dysfunction]
   783   C0598174:chromosome loss [Genetic Function]
   753   C1517945:Loss [Quantitative Concept]
   748 E C1516519:Chromosomal Loss [Cell or Molecular Dysfunction]

Phrase: "9 In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1883712:Addition [Functional Concept]
   718 E C1524062:Additional [Functional Concept]

Phrase: "overexpression of bcl-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514559:Overexpression [Genetic Function]

Phrase: "in early myeloid cells,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   901   C0887899:Myeloid Cells [Cell]
   867 E C0596993:Myeloid cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0439677:Myeloid [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "10"

Phrase: "or"

Phrase: "the coexpression of an activated FLT3 allele,"

Phrase: "11 also"

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the penetrance of the APL phenotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0524899:Penetrance [Quantitative Concept]

Phrase: "in transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "expressing"

Phrase: "PML-RAR."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C3538821:RAR [Gene or Genome]
   734   C0023487:Promyelocytic Leukemia [Neoplastic Process]
   734   C1366903:promyelocytic leukemia [Gene or Genome]
   734   C2745900:Promyelocytic leukemia [Neoplastic Process]
Processing 00000000.tx.21: The precise mechanism by which PML-RAR expression facilitates the development of APL is not yet known. 

Phrase: "The precise mechanism by which PML-RAR expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0441712:Mechanism [Functional Concept]
   742   C1706376:Mechanism [Manufactured Object]

Phrase: "facilitates"

Phrase: "the development of APL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0243107:development [Physiologic Function]
   753   C0678723:Development [Organism Function]
   753   C1527148:Development [Functional Concept]

Phrase: "is"

Phrase: "not yet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "known."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]
Processing 00000000.tx.22: This molecule has been proposed to act in a dominant-negative fashion to suppress the normal function of both RAR and PML.12-16 When overexpressed, it interferes with the assembly of RAR-RXR heterodimers, and its ability to be displaced from target sequences by its physiologic ligand is dramatically reduced.17 Furthermore, when human cathepsin G (hCG)PML-RAR transgenic mice are intercrossed with mice that are deficient for PML, the penetrance of APL increases, suggesting that enforcement of a dominant-negative activity against PML may increase the susceptibility of mice to leukemia.18 Because hCGPML-RAR mice express the transgene at very low levels compared with the endogenous cathepsin G allele,1 we hypothesized that the penetrance of APL might be greatly increased in these mice if we could increase levels of PML-RAR expression in early myeloid cells. 

Phrase: "This molecule"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0567416:Molecule [Substance]
   928 E C1521991:Molecular [Qualitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "act in a dominant-negative fashion to"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   748   C0079613:ACT [Therapeutic or Preventive Procedure]
   748   C0205160:Negative [Qualitative Concept]
   748   C1513916:Negative [Finding]
   748   C1527180:Dominant [Functional Concept]
   748   C2825415:Negative [Conceptual Entity]
   748   C2825491:Negative [Qualitative Concept]

Phrase: "suppress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "the normal function of both RAR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]

Phrase: "and"

Phrase: "PML.12-16"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0023487:Promyelocytic Leukemia [Neoplastic Process]
   861   C1366903:promyelocytic leukemia [Gene or Genome]
   861   C2745900:Promyelocytic leukemia [Neoplastic Process]
   812   C0023418:Leukaemia [Neoplastic Process]

Phrase: "When"

Phrase: "overexpressed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: ","

Phrase: "it"

Phrase: "interferes with the assembly of RAR-RXR heterodimers,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0521102:Interferes with [Qualitative Concept]
           Interfere
   744   C0140283:RXR [Amino Acid, Peptide, or Protein,Receptor]
   744   C1148772:RXR [Genetic Function]
   744   C1706853:Assembly [Activity]
   744   C1879748:Assembly [Manufactured Object]
   744   C3538821:RAR [Gene or Genome]

Phrase: "and"

Phrase: "its ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "be"

Phrase: "displaced from target sequences"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0012727:Displaced [Spatial Concept]
   770   C0162326:Sequences [Nucleotide Sequence]
   770   C1521840:Target [Functional Concept]
   770   C2986546:TARGET [Diagnostic Procedure]
   737 E C0004793:Sequence [Nucleotide Sequence]
   737 E C0162327:Sequence [Nucleotide Sequence]
   737 E C1519249:Sequence [Functional Concept]

Phrase: "by its physiologic ligand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023688:Ligand [Chemical]

Phrase: "is"

Phrase: "dramatically"

Phrase: "reduced.17 Furthermore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0392756:Reduced [Qualitative Concept]

Phrase: "when"

Phrase: "human cathepsin G (hCG)PML-RAR transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0025936:Mice, Transgenic [Mammal]
   793   C0003069:Transgenic [Animal]
   793   C0025914:Mice [Mammal]
   793   C0025929:mice [Mammal]
   793   C0026809:Mice [Mammal]

Phrase: "are"

Phrase: "intercrossed with mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]

Phrase: "that"

Phrase: "are"

Phrase: "deficient for PML,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0011155:Deficient [Functional Concept]
   770   C1636779:% deficient [Quantitative Concept]

Phrase: "the penetrance of APL increases,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0524899:Penetrance [Quantitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that enforcement of a dominant-negative activity"

Phrase: "against PML"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0023487:Promyelocytic Leukemia [Neoplastic Process]
  1000   C1366903:promyelocytic leukemia [Gene or Genome]
  1000   C2745900:Promyelocytic leukemia [Neoplastic Process]
   861   C0023418:Leukaemia [Neoplastic Process]

Phrase: "may"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the susceptibility of mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0012655:Susceptibility [Clinical Attribute]
   770   C0220898:Susceptibility [Organism Attribute]
   770   C1264642:Susceptibility [Functional Concept]
   770   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "to leukemia.18"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023418:Leukaemia [Neoplastic Process]

Phrase: "Because"

Phrase: "hCGPML-RAR mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "express"

Phrase: "the transgene at very low levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0282641:Transgene [Gene or Genome]

Phrase: "compared with the endogenous cathepsin G allele,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0054868:Cathepsin G [Amino Acid, Peptide, or Protein,Enzyme]
   778   C1413814:CATHEPSIN G [Gene or Genome]
   748   C0002085:Allele [Gene or Genome]
   748   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0205227:Endogenous [Functional Concept]
   748   C0439267:g% [Quantitative Concept]
   748   C1707455:Compared [Activity]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "we"

Phrase: "hypothesized"

Phrase: "that"

Phrase: "the penetrance of APL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0524899:Penetrance [Quantitative Concept]

Phrase: "might"

Phrase: "be"

Phrase: "greatly"

Phrase: "increased in these mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]

Phrase: "if"

Phrase: "we"

Phrase: "could"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "levels of PML-RAR expression"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   767   C3244092:expression level [Idea or Concept]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "in early myeloid cells."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   901   C0887899:Myeloid Cells [Cell]
   867 E C0596993:Myeloid cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0439677:Myeloid [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.23: To accomplish this end, we targeted the same bcr-1derived PML-RAR cDNA used previously in the hCGPML-RAR transgenic mice to the 5' untranslated region of the endogenous murine cathepsin G locus, using homologous recombination techniques in embryonic stem cells (we decided not to target PML-RAR into the endogenous mouse PML locus because PML expression is ubiquitous; widespread expression of PML-RAR in transgenic mice may be toxic2). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "accomplish"

Phrase: "this end,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "we"

Phrase: "targeted"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521840:Targeted [Functional Concept]
   966 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "the same bcr-1derived PML-RAR cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "previously in the hCGPML-RAR transgenic mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0025936:Mice, Transgenic [Mammal]
   748   C0003069:Transgenic [Animal]
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]
   748   C3538821:RAR [Gene or Genome]

Phrase: "to the 5' untranslated region"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0600493:5' Untranslated Region [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   913   C1883644:5' Region [Nucleotide Sequence]
   901   C0600680:Untranslated Region [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "of the endogenous murine cathepsin G locus,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1708726:Locus [Gene or Genome]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "homologous recombination techniques in embryonic stem cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0025664:techniques [Intellectual Product]
   748   C0449851:Techniques [Functional Concept]

Phrase: "("

Phrase: "we"

Phrase: "decided"

Phrase: "not to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "target"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521840:Target [Functional Concept]
  1000   C2986546:TARGET [Diagnostic Procedure]

Phrase: "PML-RAR into the endogenous mouse PML locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C3538821:RAR [Gene or Genome]

Phrase: "because"

Phrase: "PML expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0023487:Promyelocytic Leukemia [Neoplastic Process]
   734   C1366903:promyelocytic leukemia [Gene or Genome]
   734   C2745900:Promyelocytic leukemia [Neoplastic Process]

Phrase: "is"

Phrase: "ubiquitous"

Phrase: "; widespread expression of PML-RAR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "may"

Phrase: "be"

Phrase: "toxic2"

Phrase: ")."
Processing 00000000.tx.24: We found that the retained PGK-neo cassette in the mutant cathepsin G allele caused transcriptional shutdown of the gene. 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "the retained PGK-neo cassette in the mutant cathepsin G allele"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0450240:Cassette [Medical Device]
   738   C1706210:Cassette [Manufactured Object]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "transcriptional shutdown of the gene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1547200:Shut down [Idea or Concept]
Processing 00000000.tx.25: We, therefore, removed the PGK-neo cassette from the locus in targeted embryonic stem (ES) cells using Lox P-Cremediated recombination. 

Phrase: "We,"

Phrase: "therefore,"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "the PGK-neo cassette from the locus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0450240:Cassette [Medical Device]
   748   C1706210:Cassette [Manufactured Object]

Phrase: "in targeted embryonic stem (ES) cells"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   923   C0596508:Embryonic Stem Cells [Cell]
   886   C0221284:Target cells [Cell]
   886   C3272919:Target Cells [Laboratory Procedure]
   861   C0038250:Stem cells [Cell]
   858   C1947950:Embryonic Cell [Embryonic Structure]
   812   C0007634:Cells [Cell]
   812   C0013935:Embryonic [Embryonic Structure]
   812   C0242767:Stem [Plant]
   812   C1186763:Stem [Body Part, Organ, or Organ Component]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Lox P-Cremediated recombination."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0034865:Recombination [Genetic Function]
Processing 00000000.tx.26: These PGK-neo mice did express PML-RAR, and more than 90% developed APL with a latency similar to that of the original transgenic model. 

Phrase: "These PGK-neo mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "did"

Phrase: "express"

Phrase: "PML-RAR,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C3538821:RAR [Gene or Genome]
   734   C0023487:Promyelocytic Leukemia [Neoplastic Process]
   734   C1366903:promyelocytic leukemia [Gene or Genome]
   734   C2745900:Promyelocytic leukemia [Neoplastic Process]

Phrase: "and"

Phrase: "more than 90% developed APL"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   814   C0023487:Acute Promyelocytic Leukemia [Neoplastic Process]
           Promyelocytic Leukemia
   778   C1366903:promyelocytic leukemia [Gene or Genome]
   778   C2745900:Promyelocytic leukemia [Neoplastic Process]
   774   C0085669:Acute leukaemia [Neoplastic Process]
   774   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   748   C0023418:Leukaemia [Neoplastic Process]
   748   C0205172:More [Functional Concept]
   748   C0205178:acute [Temporal Concept]
   748   C0439083:>90 [Quantitative Concept]
   748   C0439087:<90 [Quantitative Concept]

Phrase: "with a latency"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0205275:Latent [Qualitative Concept]

Phrase: "similar to that of the original transgenic model."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.27: Surprisingly, however, the expression of PML-RAR in the bone marrow and inAPL cells was not higher than that of the transgenic mice; 

Phrase: "Surprisingly,"

Phrase: "however,"

Phrase: "the expression of PML-RAR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in the bone marrow"
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
  1000   C0005953:Bone Marrow [Tissue]
   861   C0086590:Marrow [Food]
   861   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   861   C0376152:Marrow [Body Part, Organ, or Organ Component]
   861   C0391978:Bone [Tissue]
   861   C1266908:Bone [Body Part, Organ, or Organ Component]
   861   C1266909:Bone [Body System]
   861   C1546708:Marrow [Intellectual Product]
   805 E C0001629:Medullary [Body Part, Organ, or Organ Component]
   805 E C0025148:Medullary [Body Part, Organ, or Organ Component]
   805 E C1550278:Medullary [Body Part, Organ, or Organ Component]
   789 E C0443157:Bony [Functional Concept]
   777 E C0330477:Marrows [Plant]

Phrase: "and"

Phrase: "inAPL cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "not higher than that of the transgenic mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   711   C0205250:High [Qualitative Concept]
   711   C1299351:High [Qualitative Concept]
   711   C2700149:HIGH [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.28: in fact, it was less than 3% that of the transgenic model. 

Phrase: "in fact,"

Phrase: "it"

Phrase: "was"

Phrase: "less than 3%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0439092:Less Than [Intellectual Product]
           less
   790   C0547044:Less [Qualitative Concept]

Phrase: "that of the transgenic model."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1519606:Transgenic Model [Experimental Model of Disease]
   760   C0003069:Transgenic [Animal]
   760   C3161035:Model [Intellectual Product]
Processing 00000000.tx.29: These results suggest that this high-penetrance model does not arise because of a simple dominant-negative effect, but rather an optimal, low level of PML-RAR expression that facilitates its gain-of-function effects.  

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "this high-penetrance model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3161035:Model [Intellectual Product]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "arise because of a simple dominant-negative effect,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   744   C0205160:Negative [Qualitative Concept]
   744   C0205352:Simple [Qualitative Concept]
   744   C1280500:Effect [Qualitative Concept]
   744   C1513916:Negative [Finding]
   744   C1527180:Dominant [Functional Concept]
   744   C2348382:Effect [Qualitative Concept]
   744   C2825415:Negative [Conceptual Entity]
   744   C2825491:Negative [Qualitative Concept]

Phrase: "but"

Phrase: "rather"

Phrase: "an optimal, low level of PML-RAR expression"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   762   C3244092:expression level [Idea or Concept]
   742   C0205251:low [Qualitative Concept]
   742   C0441889:Level [Qualitative Concept]
   742   C0456079:Level [Classification]
   742   C1299352:Low [Qualitative Concept]
   742   C1547707:Level [Geographic Area]
   742   C1550472:low [Idea or Concept]
   742   C2946261:Level [Pharmacologic Substance]

Phrase: "that"

Phrase: "facilitates"

Phrase: "its gain-of-function effects."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1280500:effects [Qualitative Concept]
   779 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.30: Materials and methods Top Abstract Introduction Materials and methods Results Discussion References  Generation of knock-in mice A targeting vector for inserting a bcr-1 PML-RAR cDNA1 into the 5' untranslated region of the murine cathepsin G locus (mCG) was generated using the polymerase chain reaction (PCR) to generate 5' and 3' targeting arms flanking the insertion site. 

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Generation of knock-in mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0079411:Generation [Temporal Concept]
   760   C3146294:Generation [Activity]

Phrase: "A targeting vector for inserting"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0442335:Vector [Spatial Concept]
   760   C1705099:Vector [Idea or Concept]

Phrase: "a bcr-1 PML-RAR cDNA1"

Phrase: "into the 5' untranslated region"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0600493:5' Untranslated Region [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   913   C1883644:5' Region [Nucleotide Sequence]
   901   C0600680:Untranslated Region [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "of the murine cathepsin G locus (mCG)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1708726:Locus [Gene or Genome]

Phrase: "was"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the polymerase chain reaction (PCR) to"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   812   C0337112:Chain [Manufactured Object]
   812   C0443286:Reaction [Functional Concept]
   812   C1114821:Reaction [Clinical Attribute]
   812   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1524075:Chain [Idea or Concept]

Phrase: "generate"

Phrase: "5'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "3' targeting arms"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0206655:ARMS [Neoplastic Process]
   827   C0446516:Arm [Body Location or Region]
   827   C1269078:Arm [Body Part, Organ, or Organ Component]
   827   C1269612:Arm [Body Location or Region]
   827   C2681631:ARMS [Gene or Genome]
   771 E C0445456:Brachial [Spatial Concept]

Phrase: "flanking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230171:flanking [Body Location or Region]

Phrase: "the insertion site."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0449682:Insertion site [Spatial Concept]
  1000   C1705686:Insertion Site [Nucleotide Sequence]
   861   C0021107:Insertion [Therapeutic or Preventive Procedure]
   861   C0205145:Site [Spatial Concept]
   861   C0441587:Insertion [Health Care Activity]
   861   C1512796:Insertion [Genetic Function]
   861   C1515974:Site [Body Location or Region]
   861   C1883719:Insertion [Functional Concept]
   861   C2825164:Site [Spatial Concept]
Processing 00000000.tx.31: Oligonucleotide primers were used to generate a 1.9-kb 5' targeting arm flanked by SacI and BamHI sites at its 5' and 3' ends, respectively, and extending to within 1 bp of the translation initiation site within exon 1. 

Phrase: "Oligonucleotide primers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206415:Oligonucleotide Primers [Nucleic Acid, Nucleoside, or Nucleotide]
           Primer

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "generate"

Phrase: "a 1.9-kb 5' targeting arm"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   795   C0446516:Arm [Body Location or Region]
   795   C1269078:Arm [Body Part, Organ, or Organ Component]
   795   C1269612:Arm [Body Location or Region]
   740 E C0445456:Brachial [Spatial Concept]
   712 E C0206655:ARMS [Neoplastic Process]
   712 E C2681631:ARMS [Gene or Genome]

Phrase: "flanked by SacI"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1519179:SACI [Health Care Related Organization]
   790   C1854580:SACI [Gene or Genome]
   756   C0230171:Flank [Body Location or Region]

Phrase: "and"

Phrase: "BamHI sites at its 5'"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0205145:Sites [Spatial Concept]
   726 E C1515974:Site [Body Location or Region]
   726 E C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "3' ends,"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   861   C0444930:ends [Spatial Concept]
   827 E C2746065:End [Temporal Concept]
   789 E C0205088:Terminal [Temporal Concept]
   789 E C1705314:Terminal [Manufactured Object]
   789 E C1705315:Terminal [Spatial Concept]

Phrase: "respectively,"

Phrase: "and"

Phrase: "extending to within 1 bp of the translation initiation site"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   739   C0439792:Extending [Spatial Concept]
   706 E C0231448:Extend [Functional Concept]

Phrase: "within exon 1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.32: Oligonucleotide primers were used to generate a 2.0-kb 3' targeting arm flanked by SalI and HindIII sites at its 5' and 3' ends, respectively, and extending from the translational initiation site in exon 1 to within exon 4 (nucleotides 461-2441).19 The targeting vector was assembled within a pUC19 backbone, together with a 1.6-kb PGK-neo selectable marker cassette flanked by LoxP1 sequences. 

Phrase: "Oligonucleotide primers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206415:Oligonucleotide Primers [Nucleic Acid, Nucleoside, or Nucleotide]
           Primer

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "generate"

Phrase: "a 2.0-kb 3' targeting arm"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   799   C0446516:Arm [Body Location or Region]
   799   C1269078:Arm [Body Part, Organ, or Organ Component]
   799   C1269612:Arm [Body Location or Region]
   743 E C0445456:Brachial [Spatial Concept]
   716 E C0206655:ARMS [Neoplastic Process]
   716 E C2681631:ARMS [Gene or Genome]

Phrase: "flanked by SalI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0230171:Flank [Body Location or Region]

Phrase: "and"

Phrase: "HindIII sites at its 5'"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0205145:Sites [Spatial Concept]
   726 E C1515974:Site [Body Location or Region]
   726 E C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "3' ends,"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   861   C0444930:ends [Spatial Concept]
   827 E C2746065:End [Temporal Concept]
   789 E C0205088:Terminal [Temporal Concept]
   789 E C1705314:Terminal [Manufactured Object]
   789 E C1705315:Terminal [Spatial Concept]

Phrase: "respectively,"

Phrase: "and"

Phrase: "extending from the translational initiation site"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0439792:Extending [Spatial Concept]
   719 E C0231448:Extend [Functional Concept]

Phrase: "in exon 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "to within exon 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(nucleotides 461-2441"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ").19"

Phrase: "The targeting vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]

Phrase: "was"

Phrase: "assembled within a pUC19 backbone,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0037949:Backbone [Body Part, Organ, or Organ Component]
   760   C1267072:Backbone [Body Part, Organ, or Organ Component]
   726   C1706853:Assemble [Activity]

Phrase: "together with a 1.6-kb PGK-neo selectable marker cassette"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0450240:Cassette [Medical Device]
   791   C1706210:Cassette [Manufactured Object]

Phrase: "flanked by LoxP1 sequences."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0162326:Sequences [Nucleotide Sequence]
   737 E C0004793:Sequence [Nucleotide Sequence]
   737 E C0162327:Sequence [Nucleotide Sequence]
   737   C0230171:Flank [Body Location or Region]
   737 E C1519249:Sequence [Functional Concept]
Processing 00000000.tx.33: The RW-4 embryonic stem (ES) cell line20 was transfected with the targeting vector by electroporation, and G418-resistant clones were isolated. 

Phrase: "The RW-4 embryonic stem (ES) cell line20"

Phrase: "was"

Phrase: "transfected with the targeting vector"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0442335:Vector [Spatial Concept]
   760   C1521840:Targeting [Functional Concept]
   760   C1705099:Vector [Idea or Concept]
   726 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "by electroporation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206691:Electroporation [Laboratory Procedure,Research Activity]

Phrase: "and"

Phrase: "G418-resistant clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0009013:Clones [Cell]
   793 E C1522642:Clone [Tissue]
   743 E C1704387:Clonal [Qualitative Concept]
   721 E C0796368:clonality [Diagnostic Procedure]

Phrase: "were"

Phrase: "isolated."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.34: To screen for homologous recombination at the mCG locus, DNA samples isolated from resistant clones were digested with HindIII, Southern blotted, and probed using a PCR-generated 512-bp random primer-labeled DNA probe that spanned exons 3-4 and intron 3 of the mCG locus (nucleotide 2415-292619), located downstream of the 3' targeting arm (Figure 1A). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "screen for homologous recombination"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0599773:Homologous Recombination [Genetic Function]
   833   C2984295:Homologous recombination [Functional Concept]
   770   C0034865:Recombination [Genetic Function]
   770   C0220908:screen [Health Care Activity]
   770   C1305399:screen [Functional Concept]
   770   C1334043:Homologous [Gene or Genome]
   770   C1705053:Screen [Medical Device]

Phrase: "at the mCG locus,"

Phrase: "DNA samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "isolated from resistant clones"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0009013:Clones [Cell]
   770   C0205409:Isolated [Functional Concept]
   770   C0332325:Resistant [Functional Concept]
   770   C1548221:Isolated [Idea or Concept]
   770   C2827757:RESISTANT [Laboratory or Test Result]
   737 E C0370215:Isolate [Substance]
   737 E C1522642:Clone [Tissue]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "were"

Phrase: "digested with HindIII,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0868946:digested [Physiologic Function]

Phrase: "Southern blotted,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0005862:Southern Blot [Molecular Biology Research Technique]
   983   C1148472:Blot, Southern [Laboratory or Test Result]

Phrase: "and"

Phrase: "probed"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0182400:Probe [Medical Device]
   966   C1704681:Probe [Gene or Genome]
   966   C2347609:Probe [Chemical Viewed Functionally]
   966   C3536729:Probe [Manufactured Object]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a PCR-"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0337112:Chain [Manufactured Object]
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]
   827   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1524075:Chain [Idea or Concept]

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "512-bp random primer-labeled DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "probe"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0182400:Probe [Medical Device]
  1000   C1704681:Probe [Gene or Genome]
  1000   C2347609:Probe [Chemical Viewed Functionally]
  1000   C3536729:Probe [Manufactured Object]

Phrase: "that spanned exons 3-4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   779   C1711300:Span [Conceptual Entity]
   779   C2700613:Span [Quantitative Concept]

Phrase: "and"

Phrase: "intron 3 of the mCG locus"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   764   C0054868:Cathepsin G [Amino Acid, Peptide, or Protein,Enzyme]
   764   C1413814:CATHEPSIN G [Gene or Genome]
   742   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0026809:Murine [Mammal]
   742   C0439267:g% [Quantitative Concept]
   742   C0591833:Murine [Organic Chemical,Pharmacologic Substance]
   742   C1708726:Locus [Gene or Genome]

Phrase: "(nucleotide 2415-292619"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: ","

Phrase: "located downstream of the 3' targeting arm (Figure 1A"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   742   C0446516:Arm [Body Location or Region]
   742   C0450344:1A [Intellectual Product]
   742   C0522506:Downstream [Spatial Concept]
   742   C1269078:Arm [Body Part, Organ, or Organ Component]
   742   C1269612:Arm [Body Location or Region]
   742   C1521840:Targeting [Functional Concept]
   742   C1553633:1a [Medical Device]
   708 E C2986546:TARGET [Diagnostic Procedure]

Phrase: ")."
Processing 00000000.tx.35: To remove the PGK-neo selectable marker cassette, a correctly targeted ES cell clone (no. 100) was transfected with the pTurbo-Cre expression cassette and grown in the absence of G418 as described.20 Loss of PGK-neo was determined by Southern blotting of HindIII-digested ES cell DNA, which was hybridized with the 3' CG probe described earlier. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "the PGK-neo selectable marker cassette,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0450240:Cassette [Medical Device]
   804   C1706210:Cassette [Manufactured Object]

Phrase: "a correctly"

Phrase: "targeted"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521840:Targeted [Functional Concept]
   966 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "ES cell clone"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0009013:Cell Clone [Cell]
           Clone
   812   C1522642:Clone [Tissue]
   756   C0596508:Embryonic stem cell [Cell]
   741 E C1704387:Clonal [Qualitative Concept]
   712 E C0796368:clonality [Diagnostic Procedure]
   708   C1947950:Embryonic Cell [Embryonic Structure]

Phrase: "("

Phrase: "no. 100"

Phrase: ")"

Phrase: "was"

Phrase: "transfected with the pTurbo-Cre expression cassette"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0450240:Cassette [Medical Device]
   748   C1511573:CRE [Gene or Genome]
   748   C1706210:Cassette [Manufactured Object]

Phrase: "and"

Phrase: "grown in the absence of G418"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0052009:G418 [Antibiotic,Organic Chemical]
   753   C0332197:absence [Quantitative Concept]
   753   C1689985:Absence [Anatomical Abnormality]

Phrase: "as"

Phrase: "described.20 Loss of PGK-neo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1517945:Loss [Quantitative Concept]

Phrase: "was"

Phrase: "determined by Southern blotting of HindIII-digested ES cell DNA,"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   775   C0596508:Embryonic stem cell [Cell]
   756   C0005862:Blotting, Southern [Molecular Biology Research Technique]
           DNA blotting
   756   C0038250:Stem cell [Cell]
   754   C1947950:Embryonic Cell [Embryonic Structure]
   739 E C1148472:Blot, Southern [Laboratory or Test Result]
   738   C0007634:Cell [Cell]
   738   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0013935:Embryonic [Embryonic Structure]
   738   C0242767:Stem [Plant]
   738   C0868946:digested [Physiologic Function]
   738   C1186763:Stem [Body Part, Organ, or Organ Component]
   738   C1269647:Cell [Cell]
   738   C1704653:Cell [Medical Device]
   738   C1710133:Southern [Spatial Concept]
   738   C1948049:Cell [Spatial Concept]

Phrase: "which"

Phrase: "was"

Phrase: "hybridized with the 3' CG probe"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0182400:Probe [Medical Device]
   753   C1704681:Probe [Gene or Genome]
   753   C2347609:Probe [Chemical Viewed Functionally]
   753   C3536729:Probe [Manufactured Object]
   753   C3540479:CG [Gene or Genome]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "earlier."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1279919:Early [Temporal Concept]
Processing 00000000.tx.36: View larger version (41K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(41K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.37: Targeting PML-RAR to the murine cathepsin G locus by homologous recombination and generation of transgenic mice. 

Phrase: "Targeting"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521840:Targeting [Functional Concept]
   966 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "PML-RAR to the murine cathepsin G locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C3538821:RAR [Gene or Genome]

Phrase: "by homologous recombination"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0599773:Homologous Recombination [Genetic Function]
  1000   C2984295:Homologous recombination [Functional Concept]
   861   C0034865:Recombination [Genetic Function]
   861   C1334043:Homologous [Gene or Genome]

Phrase: "and"

Phrase: "generation of transgenic mice."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0079411:Generation [Temporal Concept]
   770   C3146294:Generation [Activity]
Processing 00000000.tx.38: (A) A targeting vector consisting of a PML-RAR cDNA and PGK-neo selectable marker cassette, flanked by targeting arms from the murine cathepsin G (mCG) locus were transfected into embryonic stem cells. 

Phrase: "(A)"

Phrase: "A targeting vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]

Phrase: "consisting of a PML-RAR cDNA"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0023487:Promyelocytic Leukemia [Neoplastic Process]
   778   C1366903:promyelocytic leukemia [Gene or Genome]
   778   C2745900:Promyelocytic leukemia [Neoplastic Process]
   748   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0023418:Leukaemia [Neoplastic Process]
   748   C3538821:RAR [Gene or Genome]
   714   C0332529:CONSIST [Qualitative Concept]

Phrase: "and"

Phrase: "PGK-neo selectable marker cassette,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0450240:Cassette [Medical Device]
   804   C1706210:Cassette [Manufactured Object]

Phrase: "flanked by targeting arms"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   770   C0206655:ARMS [Neoplastic Process]
   770   C0446516:Arm [Body Location or Region]
   770   C1269078:Arm [Body Part, Organ, or Organ Component]
   770   C1269612:Arm [Body Location or Region]
   770   C1521840:Targeting [Functional Concept]
   770   C2681631:ARMS [Gene or Genome]
   737   C0230171:Flank [Body Location or Region]
   737 E C2986546:TARGET [Diagnostic Procedure]
   715 E C0445456:Brachial [Spatial Concept]

Phrase: "from the murine cathepsin G"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0054868:Cathepsin G [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1413814:CATHEPSIN G [Gene or Genome]
   827   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0439267:g% [Quantitative Concept]

Phrase: "(mCG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1708726:Locus [Gene or Genome]

Phrase: ")"

Phrase: "locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708726:Locus [Gene or Genome]

Phrase: "were"

Phrase: "transfected into embryonic stem cells."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   862   C0596508:Embryonic Stem Cells [Cell]
   806   C0038250:Stem cells [Cell]
   781   C1947950:Embryonic Cell [Embryonic Structure]
   760   C0007634:Cells [Cell]
   760   C0013935:Embryonic [Embryonic Structure]
   760   C0242767:Stem [Plant]
   760   C1186763:Stem [Body Part, Organ, or Organ Component]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.39: Coding exons of the mCG gene are represented as black boxes (not to scale). 

Phrase: "Coding exons of the mCG gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "are"

Phrase: "represented as black boxes"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0005680:Black [Population Group]
   770   C0027567:Black [Population Group]
   770   C0085756:Black [Population Group]
   770   C0179400:boxes [Manufactured Object]
   770   C0439541:Black [Qualitative Concept]
   770   C1638312:Boxes [Quantitative Concept]
   737 E C1533124:Box [Medical Device]
   737   C1882932:Represent [Activity]

Phrase: "("

Phrase: "not to scale"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0175659:Scale [Medical Device]
   790   C0349674:Scale [Intellectual Product]
   790   C1518422:Not [Functional Concept]
   790   C1947916:Scale [Activity]
   790   C3536777:Scale [Manufactured Object]
   718 E C1710017:Scalar [Qualitative Concept]
   706 E C0222045:Scales [Body Part, Organ, or Organ Component]

Phrase: ")."
Processing 00000000.tx.40: The PML-RAR cDNA and PGK-neo selectable marker cassette are represented as open boxes. 

Phrase: "The PML-RAR cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "PGK-neo selectable marker cassette"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0450240:Cassette [Medical Device]
   804   C1706210:Cassette [Manufactured Object]

Phrase: "are"

Phrase: "represented as open boxes."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0175566:Open [Spatial Concept]
   770   C0179400:boxes [Manufactured Object]
   770   C1638312:Boxes [Quantitative Concept]
   737 E C1533124:Box [Medical Device]
   737   C1882932:Represent [Activity]
Processing 00000000.tx.41: Transcriptional start sites for the mCG gene and PGK-neo selectable marker cassette are indicated by arrows. 

Phrase: "Transcriptional start sites for the mCG gene"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   746   C0949639:Transcription Start Sites [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0040649:Transcriptional [Genetic Function]
           Gene Transcription
   739   C0205145:Sites [Spatial Concept]
   739   C0439659:Start [Temporal Concept]
   706 E C1515974:Site [Body Location or Region]
   706 E C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "PGK-neo selectable marker cassette"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0450240:Cassette [Medical Device]
   804   C1706210:Cassette [Manufactured Object]

Phrase: "are"

Phrase: "indicated by arrows."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0336721:arrows [Manufactured Object]
   790   C1444656:Indicated [Finding]
Processing 00000000.tx.42: The mCG 5' untranslated region is represented by a gray box. 

Phrase: "The mCG 5' untranslated region"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   818   C0600680:Untranslated Region [Nucleic Acid, Nucleoside, or Nucleotide]
   795   C0017446:Region [Geographic Area]
   795   C0205147:Region [Spatial Concept]
   724 E C0205276:Regional [Spatial Concept]
   724 E C1947913:Regional [Spatial Concept]

Phrase: "is"

Phrase: "represented by a gray box."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0179400:Box [Manufactured Object]
   760   C0556636:gray [Quantitative Concept]
   760   C1269776:Gray [Qualitative Concept]
   760   C1533124:Box [Medical Device]
   726   C1882932:Represent [Activity]
Processing 00000000.tx.43: LoxP sites used for CRE recombinase-mediated cassette excision are represented as shaded ovals. 

Phrase: "LoxP sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: "used for CRE recombinase-mediated cassette excision"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   778   C1744318:Cre recombinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0015252:excision [Therapeutic or Preventive Procedure]
   748   C0073020:recombinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0086597:mediated [Social Behavior]
   748   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   748   C0450240:Cassette [Medical Device]
   748   C0728940:Excision [Therapeutic or Preventive Procedure]
   748   C1273517:used [Finding]
   748   C1511573:CRE [Gene or Genome]
   748   C1706210:Cassette [Manufactured Object]
   714 E C0042153:use [Functional Concept]
   714 E C0457083:Use [Functional Concept]
   714 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: "represented as shaded ovals."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1709367:Oval [Qualitative Concept]
   737   C1882932:Represent [Activity]
Processing 00000000.tx.44: The position of an external 3'-mCG DNA probe is indicated as a hatched box under mCG exons 3 and 4. 

Phrase: "The position of an external 3'-mCG DNA probe"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C0733755:Position [Spatial Concept]

Phrase: "is"

Phrase: "indicated as a hatched box"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0179400:Box [Manufactured Object]
   760   C1444656:Indicated [Finding]
   760   C1533124:Box [Medical Device]
   726   C0598016:hatch [Organism Function]

Phrase: "under mCG exons 3"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   827   C0054868:Cathepsin G [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1413814:CATHEPSIN G [Gene or Genome]
   799   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0026809:Murine [Mammal]
   799   C0439267:g% [Quantitative Concept]
   799   C0591833:Murine [Organic Chemical,Pharmacologic Substance]
   799   C1708726:Locus [Gene or Genome]

Phrase: "and"

Phrase: "4."
Processing 00000000.tx.45: The PGK-neo cassette was subsequently removed from a homologously recombinant ES cell clone by transient transfection of targeted ES cells with a Cre recombinase expression vector. 

Phrase: "The PGK-neo cassette"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0450240:Cassette [Medical Device]
   827   C1706210:Cassette [Manufactured Object]

Phrase: "was"

Phrase: "subsequently"

Phrase: "removed from a homologously recombinant ES cell clone"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   790   C0596508:Embryonic stem cell [Cell]
   764   C0009013:Cell Clone [Cell]
           Clone
   764   C0038250:Stem cell [Cell]
   762   C1947950:Embryonic Cell [Embryonic Structure]
   742   C0007634:Cell [Cell]
   742   C0013935:Embryonic [Embryonic Structure]
   742   C0242767:Stem [Plant]
   742   C0849355:Removed [Qualitative Concept]
   742   C1186763:Stem [Body Part, Organ, or Organ Component]
   742   C1269647:Cell [Cell]
   742   C1514798:recombinant [Organism]
   742   C1522642:Clone [Tissue]
   742   C1704653:Cell [Medical Device]
   742   C1948049:Cell [Spatial Concept]
   708 E C1883720:Remove [Activity]
   708 E C3244314:remove [Functional Concept]

Phrase: "by transient transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "of targeted ES cells"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   923   C0596508:Embryonic Stem Cells [Cell]
   886   C0221284:Target cells [Cell]
   886   C3272919:Target Cells [Laboratory Procedure]
   861   C0038250:Stem cells [Cell]
   858   C1947950:Embryonic Cell [Embryonic Structure]
   812   C0007634:Cells [Cell]
   812   C0013935:Embryonic [Embryonic Structure]
   812   C0242767:Stem [Plant]
   812   C1186763:Stem [Body Part, Organ, or Organ Component]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "with a Cre recombinase expression vector."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0442335:Vector [Spatial Concept]
   812   C1705099:Vector [Idea or Concept]
Processing 00000000.tx.46: (B) The targeted mCG locus was identified in ES cells by a size shift from 3.2 kb (wild type [WT]) to 7.9 kb (targeted, +PGK-neo) following HindIII digestion of genomic DNA. 

Phrase: "(B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "The targeted mCG locus"

Phrase: "was"

Phrase: "identified in ES cells"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   862   C0596508:Embryonic Stem Cells [Cell]
   806   C0038250:Stem cells [Cell]
   797   C0805527:Cells identified [Laboratory or Test Result]
   781   C1947950:Embryonic Cell [Embryonic Structure]
   760   C0007634:Cells [Cell]
   760   C0013935:Embryonic [Embryonic Structure]
   760   C0205396:Identified [Qualitative Concept]
   760   C0242767:Stem [Plant]
   760   C1186763:Stem [Body Part, Organ, or Organ Component]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "by a size shift"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333051:Shift [Functional Concept]
   861   C2347509:Shift [Phenomenon or Process]

Phrase: "from 3.2 kb ("

Phrase: "wild type [WT]"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: ")"

Phrase: "to 7.9 kb ("

Phrase: "targeted"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521840:Targeted [Functional Concept]
   966 E C2986546:TARGET [Diagnostic Procedure]

Phrase: ","

Phrase: "+PGK-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1150521:PGK [Molecular Function]
  1000   C1418929:PGK [Gene or Genome]

Phrase: "neo)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1366752:NEO [Gene or Genome]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "HindIII digestion of genomic DNA."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0012238:Digestion [Organism Function]
   760   C2349986:Digestion [Research Activity]
   704 E C0443277:Peptic [Functional Concept]
Processing 00000000.tx.47: Removal of the PGK-neo cassette by Cre recombinase resulted in a shift in the size of the recombinant band to 6.4 kb (a loading artifact caused the slight apparent differences in the sizes of the WT mCG bands at 3.2 kb). 

Phrase: "Removal of the PGK-neo cassette"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0015252:Removal [Therapeutic or Preventive Procedure]
   753   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "by Cre recombinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1744318:Cre recombinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0073020:recombinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "resulted in a shift"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0333051:Shift [Functional Concept]
   770   C2347509:Shift [Phenomenon or Process]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "in the size"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456389:size [Spatial Concept]

Phrase: "of the recombinant band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0175723:Band [Medical Device]
   861   C0439645:Band [Spatial Concept]
   861   C1521913:band [Cell Component]

Phrase: "to 6.4 kb ("
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0442748:6/4 [Finding]

Phrase: "a loading artifact"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085089:Artefact [Human-caused Phenomenon or Process]
   861   C1879740:ARTIFACT [Phenomenon or Process]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "the slight apparent differences in the sizes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   782   C1268722:Difference in size [Finding]
           differences size
   714   C1705241:*Difference [Quantitative Concept]
   714   C1705242:Difference [Qualitative Concept]

Phrase: "of the WT mCG bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   795   C0175723:Bands [Medical Device]
   762 E C0439645:Band [Spatial Concept]
   762 E C1521913:band [Cell Component]

Phrase: "at 3.2 kb"

Phrase: ")."
Processing 00000000.tx.48: (C) Tail DNA from the offspring a heterozygous CGPR/+ intercross was screened by Southern blotting to identify wild-type (CG+/+), heterozygous (CG+/PR), and homozygous (CGPR/PR) animals. 

Phrase: "(C) Tail DNA from the offspring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "a heterozygous CGPR/+ intercross"

Phrase: "was"

Phrase: "screened by Southern blotting to"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0005862:Blotting, Southern [Molecular Biology Research Technique]
   790 E C1148472:Blot, Southern [Laboratory or Test Result]
   760   C1710133:Southern [Spatial Concept]
   726   C0220908:screen [Health Care Activity]
   726   C1305399:screen [Functional Concept]
   726   C1705053:Screen [Medical Device]

Phrase: "identify"

Phrase: "wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "(CG+/+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C3540479:CG [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "heterozygous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019425:Heterozygous [Organism Attribute]

Phrase: "(CG+/PR),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3540479:CG [Gene or Genome]

Phrase: "and"

Phrase: "homozygous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019904:Homozygous [Organism Attribute]

Phrase: "(CGPR/PR) animals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003062:Animals [Animal]
Processing 00000000.tx.49: (D) Tail DNA from the offspring of CGPR/PR x CG+/ animals was screened by Southern blotting to identify animals that carried one PML-RAR allele together with either an intact CG gene (CG+/PR) or a CG null mutation (CG/PR) at the other allele.  

Phrase: "("

Phrase: "D)"

Phrase: "Tail DNA from the offspring of CGPR/PR x CG+/ animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "screened by Southern blotting to"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0005862:Blotting, Southern [Molecular Biology Research Technique]
   790 E C1148472:Blot, Southern [Laboratory or Test Result]
   760   C1710133:Southern [Spatial Concept]
   726   C0220908:screen [Health Care Activity]
   726   C1305399:screen [Functional Concept]
   726   C1705053:Screen [Medical Device]

Phrase: "identify"

Phrase: "animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "that carried one PML-RAR allele together with either"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0002085:Allele [Gene or Genome]

Phrase: "an intact CG gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Gene [Gene or Genome]

Phrase: "(CG+/PR)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3540479:CG [Gene or Genome]

Phrase: "or"

Phrase: "a CG null mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0026882:Mutation [Genetic Function]
   827   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(CG/PR) at the"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   770   C3540479:CG [Gene or Genome]

Phrase: "other allele."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.50: Mutant mice were generated by injection of C57Bl/6 blastocysts with correctly targeted ES cells that were implanted into pseudopregnant Swiss Webster females. 

Phrase: "Mutant mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "generated by injection of C57Bl/6 blastocysts"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   778   C1521751:C57BL/6 [Mammal]
   748   C0021485:injection [Therapeutic or Preventive Procedure]
   748   C0025921:C57BL [Mammal]
   748   C1272883:Injection [Biomedical or Dental Material]
   748   C1281743:Blastocysts [Embryonic Structure]
   748   C1533685:Injection [Therapeutic or Preventive Procedure]
   748   C1828121:Injection [Functional Concept]
   748   C3146294:Generated [Activity]
   714 E C0005705:Blastocyst [Embryonic Structure]
   714 E C1281786:Blastocyst [Embryonic Structure]

Phrase: "with correctly"

Phrase: "targeted"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521840:Targeted [Functional Concept]
   966 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "ES cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0596508:Embryonic Stem Cells [Cell]
   901   C0038250:Stem cells [Cell]
   896   C1947950:Embryonic Cell [Embryonic Structure]
   827   C0007634:Cells [Cell]
   827   C0013935:Embryonic [Embryonic Structure]
   827   C0242767:Stem [Plant]
   827   C1186763:Stem [Body Part, Organ, or Organ Component]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "were"

Phrase: "implanted into pseudopregnant Swiss Webster females."
Meta Candidates (Total=10; Excluded=6; Pruned=0; Remaining=4)
   753   C0015780:Females [Finding]
   753   C0021102:Implanted [Medical Device]
   753   C0086287:Females [Population Group]
   753   C0241315:Swiss [Population Group]
   719 E C0021107:implant [Therapeutic or Preventive Procedure]
   719 E C0043210:female [Population Group]
   719 E C0332837:Implant [Injury or Poisoning]
   719 E C1705497:Female [Qualitative Concept]
   719 E C1705498:Female [Qualitative Concept]
   719 E C1711357:Implant [Functional Concept]
Processing 00000000.tx.51: Chimeric male offspring were identified on the basis of coat color and bred to C57Bl/6 female mice. 

Phrase: "Chimeric male offspring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0680063:Offspring [Family Group]

Phrase: "were"

Phrase: "identified on the basis of coat color"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   748   C0009393:Color [Natural Phenomenon or Process]
   748   C0205396:Identified [Qualitative Concept]
   748   C0453946:Coat [Manufactured Object]
   748   C1522408:Coat [Qualitative Concept]
   748   C1527178:Basis [Functional Concept]
   748   C1550043:Identified [Finding]
   748   C1550604:color [Indicator, Reagent, or Diagnostic Aid]
   748   C1551388:Identified [Functional Concept]
   748   C1705245:Color [Pharmacologic Substance]
   748   C1874451:Basis [Pharmacologic Substance]
   748   C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "bred to C57Bl/6 female mice."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   809   C1521751:C57BL/6 Mouse [Mammal]
           C57BL/6
   783   C0025921:Mice, C57BL [Mammal]
           C57BL
   753   C0015780:Female [Finding]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0043210:female [Population Group]
   753   C0086287:female [Population Group]
   753   C1705497:Female [Qualitative Concept]
   753   C1705498:Female [Qualitative Concept]
   719   C0006159:breed [Organism Function]
   719   C1704650:Breed [Classification]
Processing 00000000.tx.52: Germ line transmission of the mutant CG locus was assessed by Southern blotting of HindIII-digested tail DNA as described earlier. 

Phrase: "Germ line transmission of the mutant CG locus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C1707722:Transmission Line [Manufactured Object]
   744   C0040722:transmission [Idea or Concept]
   744   C0242781:Transmission [Pathologic Function]
   744   C1521797:Transmission [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "assessed by Southern blotting of HindIII-digested tail DNA"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   764   C0005862:Blotting, Southern [Molecular Biology Research Technique]
           DNA blotting
   748 E C1148472:Blot, Southern [Laboratory or Test Result]
   742   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0039259:Tail [Body Part, Organ, or Organ Component]
   742   C0868946:digested [Physiologic Function]
   742   C1516048:Assessed [Activity]
   742   C1710133:Southern [Spatial Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "earlier."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1279919:Early [Temporal Concept]
Processing 00000000.tx.53: To generate animals homozygous for the targeted mutation, heterozygous animals were intercrossed, and homozygous male offspring were subsequently bred with heterozygous females to generate a colony of PML-RAR heterozygous and homozygous littermates. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "generate"

Phrase: "animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "homozygous for the targeted mutation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0019904:Homozygous [Organism Attribute]

Phrase: "heterozygous animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "intercrossed"

Phrase: ","

Phrase: "and"

Phrase: "homozygous male offspring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0680063:Offspring [Family Group]

Phrase: "were"

Phrase: "subsequently"

Phrase: "bred with heterozygous females to"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0015780:Females [Finding]
   760   C0019425:Heterozygous [Organism Attribute]
   760   C0086287:Females [Population Group]
   726   C0006159:breed [Organism Function]
   726 E C0043210:female [Population Group]
   726   C1704650:Breed [Classification]
   726 E C1705497:Female [Qualitative Concept]
   726 E C1705498:Female [Qualitative Concept]

Phrase: "generate"

Phrase: "a colony of PML-RAR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439158:colony [Quantitative Concept]
   753   C1947989:Colony [Cell]

Phrase: "heterozygous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019425:Heterozygous [Organism Attribute]

Phrase: "and"

Phrase: "homozygous littermates."
Processing 00000000.tx.54: To generate knock-in heterozygotes with or without a functional CG gene on the residual allele, mCGPR/PR homozygotes were bred with mCG+/ mice.21 Leukemia development To determine the incidence of leukemia among PML-RAR animals, cohorts of each genotype were generated and followed over time. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "generate"

Phrase: "knock-in heterozygotes with"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0019425:Heterozygotes [Organism Attribute]

Phrase: "or without a functional CG gene"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0017337:Gene [Gene or Genome]
   753   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0205245:Functional [Functional Concept]
   753   C0542341:Functional [Functional Concept]
   753   C2700217:Functional [Conceptual Entity]
   753   C3540479:CG [Gene or Genome]

Phrase: "on the residual allele,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "mCGPR/PR homozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019904:Homozygotes [Organism Attribute]

Phrase: "were"

Phrase: "bred with mCG+/ mice.21 Leukemia development To"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   756   C0054868:Cathepsin G [Amino Acid, Peptide, or Protein,Enzyme]
   756   C1413814:CATHEPSIN G [Gene or Genome]
   738   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0023418:Leukaemia [Neoplastic Process]
   738   C0025914:Mice [Mammal]
   738   C0025929:mice [Mammal]
   738   C0026809:Mice [Mammal]
           Murine
   738   C0243107:development [Physiologic Function]
   738   C0439267:g% [Quantitative Concept]
   738   C0591833:Murine [Organic Chemical,Pharmacologic Substance]
   738   C0678723:Development [Organism Function]
   738   C1527148:Development [Functional Concept]
   738   C1708726:Locus [Gene or Genome]
   737   C0596978:Mouse Leukemia [Neoplastic Process]
   704   C0006159:breed [Organism Function]
   704   C1704650:Breed [Classification]

Phrase: "determine"

Phrase: "the incidence of leukemia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021149:Incidence [Quantitative Concept]
   770   C0220856:incidence [Functional Concept]

Phrase: "among PML-RAR animals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003062:Animals [Animal]

Phrase: "cohorts of each genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0599755:cohorts [Population Group]

Phrase: "were"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "and"

Phrase: "followed over time."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   790   C0040223:Time [Temporal Concept]
   790   C0332283:followed [Temporal Concept]
   790   C3541383:Time [Temporal Concept]
   756 E C1719822:Follow [Intellectual Product]
   734 E C0442043:Temporal [Spatial Concept]
   734 E C2362314:Temporal [Temporal Concept]
   706 E C1632851:Times [Quantitative Concept]
Processing 00000000.tx.55: To screen for leukemia development, peripheral blood was obtained for automated complete blood count analysis by retro-orbital plexus bleeding at 1- to 2-month intervals. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "screen for leukemia development,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0023418:Leukaemia [Neoplastic Process]
   770   C0220908:screen [Health Care Activity]
   770   C0243107:development [Physiologic Function]
   770   C0678723:Development [Organism Function]
   770   C1305399:screen [Functional Concept]
   770   C1527148:Development [Functional Concept]
   770   C1705053:Screen [Medical Device]

Phrase: "peripheral blood"
Meta Candidates (Total=13; Excluded=8; Pruned=0; Remaining=5)
  1000   C0229664:peripheral blood [Body Substance]
           Blood
   958 E C0150936:Peripheral Blood Vessel [Body Part, Organ, or Organ Component]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0205100:Peripheral [Spatial Concept]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "was"

Phrase: "obtained for automated complete blood count analysis"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   814   C0009555:Complete Blood Count [Laboratory Procedure]
   774   C1441489:Automated count [Laboratory Procedure]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0005767:Blood [Tissue]
   748   C0005768:blood [Body Substance]
   748   C0205197:Complete [Qualitative Concept]
   748   C0205554:Automated [Functional Concept]
   748   C0229664:Blood [Body Substance]
   748   C0725685:COMPLEAT [Food]
   748   C0750480:Count [Activity]
   748   C0936012:Analysis [Research Activity]
   748   C1301820:Obtained [Functional Concept]
   748   C1524024:analysis [Functional Concept]
   748   C1705566:Count [Quantitative Concept]
   714 E C1706701:Obtain [Activity]

Phrase: "by retro-orbital plexus bleeding at 1-"

Phrase: "to 2-month intervals."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1272706:intervals [Temporal Concept]
   793 E C1552654:Interval [Idea or Concept]
   793 E C1552713:Interval [Intellectual Product]
Processing 00000000.tx.56: Animals that became moribund were killed, and blood and spleen samples were analyzed for evidence of acute leukemia, using Coulter analysis, morphology, flow cytometry, and histopathologic analysis. 

Phrase: "Animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "that"

Phrase: "became"

Phrase: "moribund"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0424547:Moribund [Finding]
  1000   C1547299:Moribund [Intellectual Product]

Phrase: "were"

Phrase: "killed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0162388:killed [Social Behavior]
   966 E C0681205:Kill [Idea or Concept]
   966 E C1550555:kill [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "blood"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]

Phrase: "and"

Phrase: "spleen samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "analyzed for evidence of acute leukemia,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0085669:Acute leukaemia [Neoplastic Process]
   790   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   790   C0332120:Evidence of [Functional Concept]
           Evidence
   753   C0023418:Leukaemia [Neoplastic Process]
   753   C0205178:acute [Temporal Concept]
   753   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Coulter analysis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "morphology,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0332437:Morphology [Qualitative Concept]
  1000   C0543482:morphology [Spatial Concept]
  1000   C0700329:Morphology, NOS [Finding]
  1000   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "flow cytometry,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016263:Flow Cytometry [Laboratory Procedure]
   861   C0806140:Flow [Natural Phenomenon or Process]
   861   C0814048:Cytometry [Laboratory Procedure]

Phrase: "and"

Phrase: "histopathologic analysis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.57: Cryopreservation of tumor cells Splenocytes from killed leukemic animals were harvested under sterile conditions and cryopreserved in 10% dimethyl sulfoxide (DMSO) media in liquid nitrogen as previously described.6 Flow cytometry Cryopreserved tumor samples were thawed and washed with phosphate-buffered saline, and samples were prepared for flow cytometric analysis by red cell lysis and incubation with antibodies to Gr-1, Mac-1, Sca-1, CD34, Ter119, B220, CD3, CD34, or isotype controls (Becton Dickinson, San Jose, CA). 

Phrase: "Cryopreservation of tumor cells Splenocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0010405:Cryopreservation [Laboratory Procedure]

Phrase: "from killed leukemic animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "harvested under sterile conditions"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0232920:Sterile [Qualitative Concept]
   770   C0678108:Sterile [Pathologic Function]
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1512335:Harvest [Health Care Activity]
   737   C1705253:Condition [Conceptual Entity]

Phrase: "and"

Phrase: "cryopreserved in 10% dimethyl sulfoxide (DMSO) media"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   790   C0012403:Dimethyl Sulfoxide [Organic Chemical,Pharmacologic Substance]
   753   C0009458:Media [Intellectual Product]
   753   C0010405:Cryopreserved [Laboratory Procedure]
   753   C0038770:sulfoxide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0038771:sulfoxide [Organic Chemical]
   753   C0162867:Media [Tissue]
   753   C0851343:Sulfoxide [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   753   C1254021:Media [Tissue]
   719 E C0439536:Medium [Quantitative Concept]
   719 E C1705217:Medium [Substance]
   719 E C3244283:medium [Intellectual Product]

Phrase: "in liquid nitrogen"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0260055:Liquid nitrogen [Element, Ion, or Isotope]
  1000   C1550121:Liquid nitrogen [Intellectual Product]
   861   C0028158:Nitrogen [Element, Ion, or Isotope]
   861   C0302908:Liquid [Substance]
   861   C1304698:Liquid [Finding]
   861   C1546699:Liquid NOS [Intellectual Product]
   861   C1550581:nitrogen [Human-caused Phenomenon or Process]
   861   C1561501:Liquid NOS [Substance]

Phrase: "as"

Phrase: "previously"

Phrase: "described.6 Flow cytometry"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016263:Flow Cytometry [Laboratory Procedure]
   812   C0806140:Flow [Natural Phenomenon or Process]
   812   C0814048:Cytometry [Laboratory Procedure]

Phrase: "Cryopreserved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010405:Cryopreserved [Laboratory Procedure]

Phrase: "tumor samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0475358:Tumor Sample [Tissue]
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "thawed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710378:Thaw [Laboratory Procedure]

Phrase: "and"

Phrase: "washed with phosphate-buffered saline,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   797   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0036082:Saline [Substance]
   760   C1548982:Washed [Idea or Concept]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   726 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "prepared for flow cytometric analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0016263:Flow Cytometries [Laboratory Procedure]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0806140:Flow [Natural Phenomenon or Process]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   726   C1521827:Prepare [Functional Concept]

Phrase: "by red cell lysis"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0024348:Lysis [Pathologic Function]
   827   C1536403:lysis [Cell Function]
   755 E C0439680:Lytic [Qualitative Concept]
   734   C0014792:Red Cell [Cell]

Phrase: "and"

Phrase: "incubation with antibodies"

Phrase: "to Gr-1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552950:[gr] [Quantitative Concept]

Phrase: "Mac-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079785:Mac 1 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   861   C3538559:MAC [Cell Component]

Phrase: "Sca-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0291573:SCA-1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0752120:SCA1 [Disease or Syndrome]
   861   C0149575:SCA [Body Part, Organ, or Organ Component]

Phrase: "CD34,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538723:CD34 [Laboratory Procedure]

Phrase: "Ter119,"

Phrase: "B220,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1335285:B220 [Gene or Genome]
  1000   C1706240:B220 [Gene or Genome]

Phrase: "CD3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3542405:CD3 [Laboratory Procedure]

Phrase: "CD34,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538723:CD34 [Laboratory Procedure]

Phrase: "or"

Phrase: "isotype controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "(Becton Dickinson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331782:Becton Dickinson [Health Care Related Organization]

Phrase: "San Jose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA)."
Processing 00000000.tx.58: Flow cytometry was performed using a BD FACscan, and data were analyzed using CellQuest software (Becton Dickinson). 

Phrase: "Flow cytometry"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016263:Flow Cytometry [Laboratory Procedure]
   861   C0806140:Flow [Natural Phenomenon or Process]
   861   C0814048:Cytometry [Laboratory Procedure]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a BD FACscan,"

Phrase: "and"

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "CellQuest software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "(Becton Dickinson"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331782:Becton Dickinson [Health Care Related Organization]

Phrase: ")."
Processing 00000000.tx.59: Real time quantitative RT-PCR Bone marrow was collected from the tibias and femurs of 3- to 6-month old C57Bl/6 wild-type, mCG+/PR (+PGK-neo), mCG+/PR (PGK-neo), and transgenic hCGPML-RAR nonleukemic animals. 

Phrase: "Real time quantitative RT-PCR Bone marrow"
Meta Candidates (Total=16; Excluded=5; Pruned=0; Remaining=11)
   841   C0039484:Temporal Bone [Body Part, Organ, or Organ Component]
   841   C1279054:Temporal bone [Body Part, Organ, or Organ Component]
   804   C0005953:Bone Marrow [Tissue]
   790   C0086590:Marrow [Food]
   790   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   790   C0376152:Marrow [Body Part, Organ, or Organ Component]
   790   C0391978:Bone [Tissue]
   790   C1266908:Bone [Body Part, Organ, or Organ Component]
   790   C1266909:Bone [Body System]
   790   C1546708:Marrow [Intellectual Product]
   734 E C0001629:Medullary [Body Part, Organ, or Organ Component]
   734 E C0025148:Medullary [Body Part, Organ, or Organ Component]
   734 E C1550278:Medullary [Body Part, Organ, or Organ Component]
   718 E C0443157:Bony [Functional Concept]
   714   C1709846:Real-Time Polymerase Chain Reaction [Molecular Biology Research Technique]
   706 E C0330477:Marrows [Plant]

Phrase: "was"

Phrase: "collected from the tibias"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0040184:Tibias [Body Part, Organ, or Organ Component]
   770   C1516695:Collected [Idea or Concept]
   770   C1516698:Collected [Functional Concept]
   737 E C1279118:Tibia [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "femurs of 3-"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0015811:Femurs [Body Part, Organ, or Organ Component]
   756 E C1279112:Femur [Body Part, Organ, or Organ Component]

Phrase: "to 6-month old C57Bl/6 wild-type, mCG+/PR (+PGK-neo), mCG+/PR (PGK-"

Phrase: "neo),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1366752:NEO [Gene or Genome]

Phrase: "and"

Phrase: "transgenic hCGPML-RAR nonleukemic animals."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   897   C0003069:Animals, Transgenic [Animal]
   804   C0003062:Animals [Animal]
Processing 00000000.tx.60: Whole marrow was washed in phosphate-buffered saline (PBS), and red cells were removed by incubation in red cell lysis buffer (150 mM NH4Cl, 10 mM KHCO3, 0.1 mM EDTA (ethylenediaminetetraacetic acid)). 

Phrase: "Whole marrow"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0086590:Marrow [Food]
   861   C0376152:Marrow [Body Part, Organ, or Organ Component]
   861   C1546708:Marrow [Intellectual Product]
   805 E C0001629:Medullary [Body Part, Organ, or Organ Component]
   805 E C0025148:Medullary [Body Part, Organ, or Organ Component]
   805 E C1550278:Medullary [Body Part, Organ, or Organ Component]
   777 E C0330477:Marrows [Plant]

Phrase: "was"

Phrase: "washed in phosphate-buffered saline (PBS),"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   797   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0036082:Saline [Substance]
   760   C1548982:Washed [Idea or Concept]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   726 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "red cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0014792:Red cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0332575:Red [Finding]
   861   C1260956:Red [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "removed by incubation"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0849355:Removed [Qualitative Concept]
   756 E C1883720:Remove [Activity]
   756 E C3244314:remove [Functional Concept]

Phrase: "in red cell lysis buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(150 mM NH4Cl,"

Phrase: "10 mM KHCO3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0071751:KHCO3 [Organic Chemical,Pharmacologic Substance]

Phrase: "0.1 mM EDTA (ethylenediaminetetraacetic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0013618:Ethylenediaminetetraacetic Acid [Organic Chemical,Pharmacologic Substance]
   799   C0001128:Acid [Chemical]
   799   C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: ")."
Processing 00000000.tx.61: Cryopreserved splenic tumor cells obtained from overtly leukemic mCG+/PR (PGK-neo) and transgenic hCGPML-RAR animals were thawed, and RNA was purified from 5 x 106 cells using an RNEasy kit (Qiagen, Valencia, CA) with on-column DNAseI treatment, per the manufacturer's protocols. 

Phrase: "Cryopreserved splenic tumor cells"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   886   C1511548:Cryopreserved Cell [Cell]
   861   C0431085:Tumor cells [Cell]
   827 E C0597032:Tumor Cell [Cell]
   812   C0007634:Cells [Cell]
   812   C0027651:Tumor [Neoplastic Process]
   812   C1578706:Tumor [Intellectual Product]
   812   C3273930:Tumor [Finding]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "obtained from overtly leukemic mCG+/PR (PGK-"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   760   C0054868:Cathepsin G [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1413814:CATHEPSIN G [Gene or Genome]
   739   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0026809:Murine [Mammal]
   739   C0279759:PR+ [Laboratory or Test Result]
   739   C0279766:PR- [Laboratory or Test Result]
   739   C0439267:g% [Quantitative Concept]
   739   C0591833:Murine [Organic Chemical,Pharmacologic Substance]
   739   C1150521:PGK [Molecular Function]
   739   C1301820:Obtained [Functional Concept]
   739   C1418864:PR@ [Gene or Genome]
   739   C1418929:PGK [Gene or Genome]
   739   C1708726:Locus [Gene or Genome]
   739   C3538934:PR [Intellectual Product]
   739   C3538935:PR [Idea or Concept]
   706 E C1706701:Obtain [Activity]

Phrase: "neo)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1366752:NEO [Gene or Genome]

Phrase: "and"

Phrase: "transgenic hCGPML-RAR animals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   902   C0003069:Animals, Transgenic [Animal]
   812   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "thawed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710378:Thaw [Laboratory Procedure]

Phrase: ","

Phrase: "and"

Phrase: "RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "purified from 5 x 106 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   753   C0007634:Cells [Cell]
   753   C1998793:Purified [Functional Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an RNEasy kit (Qiagen,"

Phrase: "Valencia,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1217267:Valencia [Fish]
   928 E C1553365:Valencian [Population Group]

Phrase: "CA) with on-column DNAseI treatment,"

Phrase: "per the manufacturer's protocols."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0442711:Protocols [Intellectual Product]
   827 E C1507394:Protocol [Intellectual Product]
   827 E C1522729:Protocol [Intellectual Product]
   827 E C2348563:Protocol [Intellectual Product]
Processing 00000000.tx.62: RNA was subjected to real-time quantitative one-step reverse transpcription (RT)PCR. 

Phrase: "RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "subjected"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "to real-time quantitative one-step reverse transpcription (RT)PCR."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   903   C1709846:Real-Time Polymerase Chain Reaction [Molecular Biology Research Technique]
   880   C0034746:time reaction [Temporal Concept]
   821   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0337112:Chain [Manufactured Object]
   790   C0443286:Reaction [Functional Concept]
   790   C1114821:Reaction [Clinical Attribute]
   790   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1524075:Chain [Idea or Concept]
Processing 00000000.tx.63: Briefly, PCR assays were performed using 500 ng total RNA per reaction in TaqMan One-Step RT-PCR Master Mix (Applied Biosystems, Foster City, CA), 400 nM each oligonucleotide primer, and 250 nM TaqMan probe (Applied Biosystems), with or without 1.25 U/L MultiScribe reverse transcriptase. 

Phrase: "Briefly,"

Phrase: "PCR assays"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   812   C0337112:Chain [Manufactured Object]
   812   C0443286:Reaction [Functional Concept]
   812   C1114821:Reaction [Clinical Attribute]
   812   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1524075:Chain [Idea or Concept]
   779   C0005507:Assay [Laboratory Procedure]
   779   C0243073:assay [Qualitative Concept]
   779   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "500 ng total RNA per reaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "in TaqMan One-Step RT-PCR Master Mix"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205430:Mix [Functional Concept]
   790   C1421951:MIX [Gene or Genome]
   790   C1720722:Mix [Qualitative Concept]

Phrase: "(Applied Biosystems,"

Phrase: "Foster City,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0008848:City [Geographic Area]
   861   C0242298:foster [Daily or Recreational Activity]
   861   C0344349:foster [Family Group]
   861   C3262831:City [Clinical Attribute]

Phrase: "CA),"

Phrase: "400 nM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "each oligonucleotide primer,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206415:Oligonucleotide Primer [Nucleic Acid, Nucleoside, or Nucleotide]
           Primer

Phrase: "and"

Phrase: "250 nM TaqMan probe"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0182400:Probe [Medical Device]
   812   C1704681:Probe [Gene or Genome]
   812   C2347609:Probe [Chemical Viewed Functionally]
   812   C3536729:Probe [Manufactured Object]

Phrase: "(Applied Biosystems"

Phrase: ")"

Phrase: ","

Phrase: "with"

Phrase: "or without 1.25 U/L MultiScribe reverse transcriptase."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C0035379:Reverse Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   764   C0439339:U/L [Quantitative Concept]
   742   C0040646:Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C1555029:Reverse [Idea or Concept]
   742   C2257077:transcriptase [Genetic Function]
Processing 00000000.tx.64: Primers for human PML-RAR were forward (5'-CCCAGGAGCCCCGTCATAGG-3') and reverse (5'-CTTGTAGATGCGGGGTAGAGG-3'). 

Phrase: "Primers for human PML-RAR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "forward"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439780:Forward [Spatial Concept]

Phrase: "(5'-CCCAGGAGCCCCGTCATAGG-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "reverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: "(5'-CTTGTAGATGCGGGGTAGAGG-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.65: Primers for mouse neutrophil elastase were forward (5'-CCTTCTCTGTCAGCGGATCTTC-3') and reverse (5'-ACATGGAGTTCTGTCACCCAC-3'). 

Phrase: "Primers for mouse neutrophil elastase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "forward"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439780:Forward [Spatial Concept]

Phrase: "(5'-CCTTCTCTGTCAGCGGATCTTC-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "reverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: "(5'-ACATGGAGTTCTGTCACCCAC-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.66: Primers for mouse MMP9 were forward (5'-CAGGGAGATGCCCATTTCG-3') and reverse (5'-GGGCACCATTTGGAGTTTCCA-3'). 

Phrase: "Primers for mouse MMP9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "forward"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439780:Forward [Spatial Concept]

Phrase: "(5'-CAGGGAGATGCCCATTTCG-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "reverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: "(5'-GGGCACCATTTGGAGTTTCCA-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.67: Fluorescent probes were synthesized by Applied Biosystems for human PML-RAR (5'-VIC-TCCTGCCCAACAGCAACCACGT-TAMRA-3'), for mouse neutrophil elastase (5'-VICCCAACGTGCAGGTGGCCCAG-TAMRA-3'), and for mouse MMP9 (5'-VIC-TCGCTGGGCAAAGGCGTCG-TAMRA-3'). 

Phrase: "Fluorescent probes"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0016321:Fluorescent Probes [Indicator, Reagent, or Diagnostic Aid]
   861   C0182400:Probes [Medical Device]
   861   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: "were"

Phrase: "synthesized by Applied Biosystems"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0185125:Applied [Health Care Activity]
   770   C1883254:Synthesized [Activity]

Phrase: "for human PML-RAR (5'-VIC-TCCTGCCCAACAGCAACCACGT-TAMRA-3'"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   807   C0023487:Promyelocytic Leukemia [Neoplastic Process]
   807   C1366903:promyelocytic leukemia [Gene or Genome]
   807   C2745900:Promyelocytic leukemia [Neoplastic Process]
   791   C0023418:Leukaemia [Neoplastic Process]
   791   C0086418:Human [Human]
   791   C0278911:VIC [Therapeutic or Preventive Procedure]
   791   C3538821:RAR [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "for mouse neutrophil elastase"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0064833:Neutrophil Elastase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1414369:ELASTASE, NEUTROPHIL [Gene or Genome]
   901   C1524102:Mouse Neutrophil [Cell]
   827   C0027950:Neutrophile [Cell]
   827   C0030306:Elastase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0699918:Elastase [Amino Acid, Peptide, or Protein,Enzyme]
   755 E C0746885:neutrophilic [Cell Function]
   727 E C0151683:Neutrophilia [Finding]

Phrase: "(5'-VICCCAACGTGCAGGTGGCCCAG-TAMRA-3'"

Phrase: ")"

Phrase: ","

Phrase: "and for mouse MMP9"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0025914:Mouse [Mammal]
   770   C0025929:mouse [Mammal]
   770   C0026809:Mouse [Mammal]
   770   C0165519:MMP-9 [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1334523:MMP9 [Gene or Genome]
   770   C1515981:And [Idea or Concept]
   770   C2698028:MMP9 [Laboratory Procedure]

Phrase: "(5'-VIC-TCGCTGGGCAAAGGCGTCG-TAMRA-3'"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0278911:VIC [Therapeutic or Preventive Procedure]
   804   C0439084:>5 [Quantitative Concept]
   804   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.68: Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) amplification was performed on the same cDNA using the ABI protocol and ABI reagents. 

Phrase: "Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) amplification"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   804   C1517480:Amplification [Molecular Biology Research Technique]
   804   C1521871:Amplification [Phenomenon or Process]
   804   C1705759:Amplification [Cell or Molecular Dysfunction]
   771   C1414968:GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE [Gene or Genome]
   771   C3536868:Glyceraldehyde-3-phosphate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   722   C2260086:dehydrogenase, glyceraldehyde phosphate [Molecular Function]
   717   C0017855:Glyceraldehyde 3-Phosphate [Biologically Active Substance,Carbohydrate]

Phrase: "was"

Phrase: "performed on the same cDNA"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0445247:Same [Qualitative Concept]
   760   C0884358:Performed [Functional Concept]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the ABI protocol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442711:Protocol [Intellectual Product]
   861   C1507394:Protocol [Intellectual Product]
   861   C1522729:Protocol [Intellectual Product]
   861   C2348563:Protocol [Intellectual Product]

Phrase: "and"

Phrase: "ABI reagents."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.69: RT-PCR was performed on a GeneAmp 5700 (Applied Biosystems) as follows: 25C for 10 minutes, 48C for 30 minutes, 95C for 5 minutes, then 40 cycles of 95C for 15 seconds and 62C for 1 minute. 

Phrase: "RT-PCR"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   804   C0337112:Chain [Manufactured Object]
   804   C0443286:Reaction [Functional Concept]
   804   C1114821:Reaction [Clinical Attribute]
   804   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1524075:Chain [Idea or Concept]

Phrase: "was"

Phrase: "performed on a GeneAmp 5700"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0884358:Performed [Functional Concept]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(Applied Biosystems"

Phrase: ")"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "25C for 10 minutes,"

Phrase: "48C for 30 minutes,"

Phrase: "95C for 5 minutes,"

Phrase: "then 40 cycles of 95C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1511572:Cycle [Temporal Concept]

Phrase: "for 15 seconds"
Meta Candidates (Total=7; Excluded=6; Pruned=0; Remaining=1)
   861   C0457385:seconds [Temporal Concept]
   827 E C0205436:Second [Quantitative Concept]
   827 E C0565930:/second [Quantitative Concept]
   827 E C1561503:second [Idea or Concept]
   827 E C1705190:Second [Qualitative Concept]
   777 E C0027627:secondary [Neoplastic Process]
   777 E C0175668:Secondary [Temporal Concept]

Phrase: "and"

Phrase: "62C for 1 minute."
Processing 00000000.tx.70: Fluorescence CT values were used to calculate mRNA levels of PML-RAR relative to neutrophil elastase, or of MMP9 relative to GAPDH. 

Phrase: "Fluorescence CT values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0042295:Values [Qualitative Concept]
   793 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "calculate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441506:Calculate [Activity]

Phrase: "mRNA levels of PML-RAR"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   753   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "relative to neutrophil elastase,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0080103:Relative [Family Group]
   770   C0205345:Relative [Qualitative Concept]
   770   C1547039:*Relative [Quantitative Concept]

Phrase: "or of MMP9"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0165519:MMP-9 [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1334523:MMP9 [Gene or Genome]
   790   C2698028:MMP9 [Laboratory Procedure]

Phrase: "relative to GAPDH."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0080103:Relative [Family Group]
   753   C0205345:Relative [Qualitative Concept]
   753   C1547039:*Relative [Quantitative Concept]
   716   C1414968:GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE [Gene or Genome]
   716   C3536868:Glyceraldehyde-3-phosphate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.71: Data represent samples obtained from 3 animals or 1 tumor; 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "obtained from 3 animals"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0003062:Animals [Animal]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "or"

Phrase: "1 tumor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0027651:Tumor [Neoplastic Process]
   861   C1578706:Tumor [Intellectual Product]
   861   C3273930:Tumor [Finding]

Phrase: ";"
Processing 00000000.tx.72: each was assayed in duplicate in 3 independent experiments. 

Phrase: "each"

Phrase: "was"

Phrase: "assayed in duplicate"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0205173:Duplicate [Functional Concept]
   790   C3539942:Duplicate [Intellectual Product]
   756   C0005507:Assay [Laboratory Procedure]
   756   C0243073:assay [Qualitative Concept]
   756   C1510438:Assay [Laboratory Procedure]

Phrase: "in 3 independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.73: Western blotting Bone marrow and splenic tumor cells were washed with PBS and subjected to red cell lysis. 

Phrase: "Western blotting Bone marrow"
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
   861   C0005953:Bone Marrow [Tissue]
   812   C0086590:Marrow [Food]
   812   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   812   C0376152:Marrow [Body Part, Organ, or Organ Component]
   812   C0391978:Bone [Tissue]
   812   C1266908:Bone [Body Part, Organ, or Organ Component]
   812   C1266909:Bone [Body System]
   812   C1546708:Marrow [Intellectual Product]
   756 E C0001629:Medullary [Body Part, Organ, or Organ Component]
   756 E C0025148:Medullary [Body Part, Organ, or Organ Component]
   756 E C1550278:Medullary [Body Part, Organ, or Organ Component]
   741 E C0443157:Bony [Functional Concept]
   729 E C0330477:Marrows [Plant]

Phrase: "and"

Phrase: "splenic tumor cells"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   901   C0431085:Tumor cells [Cell]
   867 E C0597032:Tumor Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0027651:Tumor [Neoplastic Process]
   827   C1578706:Tumor [Intellectual Product]
   827   C3273930:Tumor [Finding]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed with PBS"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   797   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0036082:Saline [Substance]
   760   C1548982:Washed [Idea or Concept]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   726 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "subjected to red cell lysis."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   806   C0014792:Red Cell [Cell]
   760   C0007634:Cell [Cell]
   760   C0024348:Lysis [Pathologic Function]
   760   C0332575:Red [Finding]
   760   C1260956:Red [Qualitative Concept]
   760   C1269647:Cell [Cell]
   760   C1536403:lysis [Cell Function]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]
Processing 00000000.tx.74: Cells (2 x 106) were dissolved in 100 L RIPA (radioimmunoprecipitation assay) buffer, protein was quantitated by a BCA (bicinchoninic acid) assay (Pierce, Rockford, IL), and 50 g total protein was electrophoresed on 8% SDS-PAGE (sodium dodecyl sulfatepolyacrylamide gel electrophoresis) and transferred to PVDF (polyvinylidene difluoride) according to standard protocols. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "(2 x 106"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0740116:+2 [Quantitative Concept]
   827   C2827735:2+ [Quantitative Concept]
   827   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "were"

Phrase: "dissolved in 100 L RIPA (radioimmunoprecipitation assay"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0034584:Radioimmunoprecipitation Assay [Laboratory Procedure]
           RIPA
           radioimmunoprecipitation
   748   C0005507:Assay [Laboratory Procedure]
   748   C0243073:assay [Qualitative Concept]
   748   C1510438:Assay [Laboratory Procedure]
   714   C1549535:Dissolve [Functional Concept]

Phrase: ")"

Phrase: "buffer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "quantitated by a BCA (bicinchoninic acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0053554:bicinchoninic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0001128:Acid [Chemical]
   753   C0202406:Acid [Laboratory Procedure]
   753   C1332420:bca [Gene or Genome]

Phrase: ")"

Phrase: "assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "(Pierce,"

Phrase: "Rockford,"

Phrase: "IL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020898:IL [Geographic Area]
  1000   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0022271:IL [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "50 g total protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   875   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0555903:Total protein [Laboratory Procedure]
   861   C1261360:total protein [Laboratory or Test Result]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0439175:% total [Quantitative Concept]
   812   C0439810:Total [Qualitative Concept]

Phrase: "was"

Phrase: "electrophoresed on 8% SDS-PAGE (sodium dodecyl sulfatepolyacrylamide gel electrophoresis"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   833   C0600209:Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis [Laboratory Procedure,Research Activity]
           SDS-PAGE
   760   C0596607:Gel Electrophoresis [Laboratory Procedure]
   757 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   739   C0013855:Electrophoresis [Laboratory Procedure]
           electrophorese
   739   C0017243:Gel [Biomedical or Dental Material]
   739   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   739   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   739   C1382104:Gel [Substance]
   739   C1704732:Page [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "transferred to PVDF"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0071710:PVDF [Organic Chemical]
   790   C0348011:transferred [Functional Concept]
   756 E C0040671:Transfer [Mental Process]
   756 E C1705822:Transfer [Activity]

Phrase: "(polyvinylidene difluoride"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0071710:polyvinylidene difluoride [Organic Chemical]

Phrase: ")"

Phrase: "according to standard protocols."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0442711:Protocols [Intellectual Product]
   827 E C1507394:Protocol [Intellectual Product]
   827 E C1522729:Protocol [Intellectual Product]
   827 E C2348563:Protocol [Intellectual Product]
Processing 00000000.tx.75: Blotting was performed using polyclonal rabbit antisera against human PML, 2 monoclonal antimouse PML antibodies (a generous gift from Scott Lowe Cold Spring Harbor Laboratory, Cold Spring Harbor, NY), a rabbit polyclonal antibody against RAR (C-20; Santa Cruz Biotechnology, Santa Cruz, CA), or a goat anti-actin polyclonal antibody (C-11; Santa Cruz Biotechnology). 

Phrase: "Blotting"

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "polyclonal rabbit antisera against human PML,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0020960:Antisera [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "2 monoclonal antimouse PML antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   876   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   766 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "("

Phrase: "a generous gift from Scott Lowe Cold Spring Harbor Laboratory,"

Phrase: "Cold Spring Harbor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0475311:Harbor [Manufactured Object]

Phrase: "NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "a rabbit polyclonal antibody against RAR (C-20"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C0368582:A Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C0368815:antibody c [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "; Santa Cruz Biotechnology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: "Santa Cruz,"

Phrase: "CA),"

Phrase: "or"

Phrase: "a goat anti-actin polyclonal antibody"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   888   C0369998:Anti-actin antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   853   C1718641:Actin Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   840   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(C-11"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "; Santa Cruz Biotechnology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: ")."
Processing 00000000.tx.76: After staining with the appropriate secondary horseradish peroxidase (HRP)conjugated antibodies (Amersham, Arlington Heights, IL) diluted 1:10 000 in TBST (Tris (tris(hydroxymethyl)aminomethane)buffered saline Tween-20 (polyoxyethylene sorbitane monolaureate)), protein was visualized using Maximum Sensitivity Fempto electrogenerated chemiluminescence (ECL; Pierce). 

Phrase: "After staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]

Phrase: "with the appropriate secondary horseradish peroxidase (HRP)conjugated antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   766 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Amersham,"

Phrase: "Arlington Heights,"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   861   C0489786:heights [Organism Attribute]
   777 E C0205250:High [Qualitative Concept]
   777 E C1299351:High [Qualitative Concept]
   777 E C1522410:Highest [Qualitative Concept]
   777 E C2700149:HIGH [Intellectual Product]

Phrase: "IL)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020898:IL [Geographic Area]
  1000   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0022271:IL [Geographic Area]

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "10 000 in TBST"

Phrase: "(Tris"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
  1000   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
  1000   C0814229:TRI [Intellectual Product]

Phrase: "(tris"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
  1000   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
  1000   C0814229:TRI [Intellectual Product]

Phrase: "(hydroxymethyl"

Phrase: ")"

Phrase: "aminomethane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0066318:aminomethane [Organic Chemical]

Phrase: ")"

Phrase: "buffered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "saline Tween-20"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C0041415:Tween 20 [Organic Chemical,Pharmacologic Substance]
   873 E C0032600:Polysorbate 20 [Organic Chemical,Pharmacologic Substance]
   827   C0036082:Saline [Substance]
   827   C0041420:tween [Organic Chemical,Pharmacologic Substance]
   771 E C0032602:Polysorbate [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: "(polyoxyethylene sorbitane monolaureate"

Phrase: ")"

Phrase: ")"

Phrase: ","

Phrase: "protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "visualized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234621:Visualized [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Maximum Sensitivity Fempto electrogenerated chemiluminescence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0162524:Chemiluminescence [Natural Phenomenon or Process]
   804   C1450278:Chemiluminescence [Natural Phenomenon or Process]

Phrase: "(ECL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1332684:ECL [Gene or Genome]

Phrase: "; Pierce"

Phrase: ")."
Processing 00000000.tx.77: In vitro ATRA differentiation Spleen cells from banked APL tumors were incubated in vitro (1 x 106 cells per mL) with 1 M ATRA (all-trans retinoic acid) dissolved in ethanol (EtOH) or with EtOH alone (total 0.1% EtOH by volume) for 72 hours at 37C in RPM1-1640 with 10% fetal calf serum (FCS). 

Phrase: "In vitro ATRA differentiation Spleen cells from banked APL tumors"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   751   C0007589:cells differentiation [Cell Function]
   751   C0037999:spleen tumors [Neoplastic Process]
   736   C0007634:Cells [Cell]
   736   C0037993:Spleen [Body Part, Organ, or Organ Component]
   736   C0771377:SPLEEN [Tissue]
   736   C1278932:Spleen [Body Part, Organ, or Organ Component]
   736   C3282337:Cells [Cell]
   734   C0431085:Tumor cells [Cell]
   718 E C0597032:Tumor Cell [Cell]
   718   C0920429:Cell Bank [Intellectual Product,Manufactured Object]
   703 E C1269647:Cell [Cell]
   703 E C1704653:Cell [Medical Device]
   703 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(1 x 106 cells per mL)"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   783   C2699156:Cells/mL [Quantitative Concept]
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "with 1 M ATRA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0040845:ATRA [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "(all-trans retinoic acid"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0040845:all-trans-Retinoic Acid [Organic Chemical,Pharmacologic Substance,Vitamin]
           trans-Retinoic Acid
           Retinoic Acid
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]
   812   C0444868:All [Quantitative Concept]
   812   C2826298:TRANS [Idea or Concept]
   812   C3539085:All [Idea or Concept]

Phrase: ")"

Phrase: "dissolved in ethanol (EtOH)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0001962:Ethanol [Organic Chemical]
   756   C1549535:Dissolve [Functional Concept]

Phrase: "or with EtOH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0001962:Ethanol [Organic Chemical]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "(total 0.1% EtOH by volume"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0001962:Ethanol [Organic Chemical]

Phrase: ")"

Phrase: "for 72 hours"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1292423:72 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "at 37C"

Phrase: "in RPM1-1640"

Phrase: "with 10% fetal calf serum (FCS)."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0230445:Calf [Body Location or Region]
   812   C0521457:Fetal [Functional Concept]
   812   C1305418:Calf [Body Part, Organ, or Organ Component]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   756 E C0626053:sural [Pharmacologic Substance]
Processing 00000000.tx.78: Total RNA was then prepared and subjected to real time quantitative RT-PCR analysis as described in "Real time quantitative RT-PCR." 

Phrase: "Total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "and"

Phrase: "subjected to real time quantitative RT-PCR analysis"
Meta Candidates (Total=25; Excluded=0; Pruned=0; Remaining=25)
   825   C3179034:Quantitative Real-Time Polymerase Chain Reaction [Molecular Biology Research Technique]
   809   C1709846:Real-Time Polymerase Chain Reaction [Molecular Biology Research Technique]
   797   C0200931:Polymerase chain reaction analysis [Laboratory Procedure]
   775   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   756   C1550177:Real Time [Idea or Concept]
   754   C0034746:Reaction Time [Temporal Concept]
   738   C0002778:Analysis [Laboratory Procedure]
   738   C0040223:Time [Temporal Concept]
   738   C0237400:Real [Qualitative Concept]
   738   C0337112:Chain [Manufactured Object]
   738   C0392762:Quantitative [Quantitative Concept]
   738   C0443286:Reaction [Functional Concept]
   738   C0936012:Analysis [Research Activity]
   738   C1114821:Reaction [Clinical Attribute]
   738   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   738   C1524024:analysis [Functional Concept]
   738   C1524075:Chain [Idea or Concept]
   738   C1555029:Reverse [Idea or Concept]
   738   C3272377:REAL [Intellectual Product]
   738   C3541383:Time [Temporal Concept]
   704   C0681850:Subject [Group]
   704   C1550501:{Subject} [Idea or Concept]
   704   C1706203:Subject [Idea or Concept]
   704   C2349001:Subject [Human]
   704   C2697811:Subject [Functional Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "in ""Real time quantitative RT-PCR."""
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   894   C1709846:Real-Time Polymerase Chain Reaction [Molecular Biology Research Technique]
   866   C0034746:time reaction [Temporal Concept]
   827   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   791   C0337112:Chain [Manufactured Object]
   791   C0443286:Reaction [Functional Concept]
   791   C1114821:Reaction [Clinical Attribute]
   791   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   791   C1524075:Chain [Idea or Concept]
Processing 00000000.tx.79: Molecular cytogenetics Chromosomes were prepared from APL spleen cells as previously described.9 Chromosome preparations prepared from cells cultured for 4 to 5 days were stained with Giemsa for chromosome counting or were used for fluorescence in situ hybridization (FISH) with a painting probe for mouse chromosome 2. 

Phrase: "Molecular cytogenetics Chromosomes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0008633:Chromosomes [Cell Component]
   734   C1513387:Molecular Cytogenetics [Biomedical Occupation or Discipline]

Phrase: "were"

Phrase: "prepared from APL spleen cells"
Meta Candidates (Total=18; Excluded=3; Pruned=0; Remaining=15)
   814   C0023487:Acute Promyelocytic Leukemia [Neoplastic Process]
           Promyelocytic Leukemia
   778   C1366903:promyelocytic leukemia [Gene or Genome]
   778   C2745900:Promyelocytic leukemia [Neoplastic Process]
   774   C0085669:Acute leukaemia [Neoplastic Process]
   774   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   748   C0007634:Cells [Cell]
   748   C0023418:Leukaemia [Neoplastic Process]
   748   C0037993:Spleen [Body Part, Organ, or Organ Component]
   748   C0205178:acute [Temporal Concept]
   748   C0771377:SPLEEN [Tissue]
   748   C1278932:Spleen [Body Part, Organ, or Organ Component]
   748   C3282337:Cells [Cell]
   721   C1517806:Leukemic Cell [Cell]
   714 E C1269647:Cell [Cell]
   714   C1521827:Prepare [Functional Concept]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "as"

Phrase: "previously"

Phrase: "described.9 Chromosome preparations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0455052:Preparation [Health Care Activity]
   779   C1521827:Preparation [Functional Concept]

Phrase: "prepared from cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756   C1521827:Prepare [Functional Concept]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "cultured for 4"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C0010453:Culture [Idea or Concept]
   756   C0220814:culture [Functional Concept]
   756   C0430400:Culture [Laboratory Procedure]
   756   C2242979:Culture [Laboratory Procedure]

Phrase: "to 5 days"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1442466:5 Days [Temporal Concept]
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "were"

Phrase: "stained with Giemsa"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   858   C0017542:giemsa stained [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Giemsa
   858   C0523205:giemsa stained [Laboratory Procedure]
   790   C2986582:Stained [Qualitative Concept]
   756 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "for chromosome counting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0750480:Count [Activity]
   827   C1705566:Count [Quantitative Concept]

Phrase: "or"

Phrase: "were"

Phrase: "used for fluorescence in situ hybridization (FISH)"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   882   C0162789:Fluorescence in situ hybridisation [Molecular Biology Research Technique]
           fluorescence hybridization situ
   833   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   790   C0444498:In situ [Spatial Concept]
   753   C0016315:Fluorescence [Natural Phenomenon or Process]
   753   C0020202:Hybridisation [Genetic Function]
   753   C1273517:used [Finding]
   753   C1300517:Hybridization [Laboratory Procedure]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]

Phrase: "with a painting probe"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0182400:Probe [Medical Device]
   861   C1704681:Probe [Gene or Genome]
   861   C2347609:Probe [Chemical Viewed Functionally]
   861   C3536729:Probe [Manufactured Object]

Phrase: "for mouse chromosome 2."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0008662:Chromosome 2 [Cell Component]
   827   C0008633:Chromosome [Cell Component]
   827   C0025914:Mouse [Mammal]
   827   C0025929:mouse [Mammal]
   827   C0026809:Mouse [Mammal]
Processing 00000000.tx.80: The conditions of hybridization, the detection of hybridization signals, and digital-image acquisition and processing were performed as previously described.22  Results Top Abstract Introduction Materials and methods Results Discussion References  Generation of mCG+/PR knock-in mice by homologous recombination To generate a transgenic mouse line in which a single copy of PML-RAR cDNA was inserted into the murine cathepsin G locus, ES cells were transfected with the targeting vector shown in Figure 1. 

Phrase: "The conditions of hybridization,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]

Phrase: "the detection of hybridization signals,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C0206100:Signal Detection [Mental Process]
   760   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "digital-image acquisition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1708464:Image Acquisition [Machine Activity]
   827   C1706701:Acquisition [Activity]

Phrase: "and"

Phrase: "processing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709694:Processing [Activity]

Phrase: "were"

Phrase: "performed as previously"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "described.22  Results Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Generation of mCG+/PR knock-in mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0079411:Generation [Temporal Concept]
   739   C3146294:Generation [Activity]

Phrase: "by homologous recombination To"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0599773:Homologous Recombination [Genetic Function]
   901   C2984295:Homologous recombination [Functional Concept]
   827   C0034865:Recombination [Genetic Function]
   827   C1334043:Homologous [Gene or Genome]

Phrase: "generate"

Phrase: "a transgenic mouse line in which"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0025936:Mouse, Transgenic [Mammal]
   783   C1522424:A Mouse [Mammal]
   753   C0003069:Transgenic [Animal]
   753   C0025914:Mouse [Mammal]
   753   C0025929:mouse [Mammal]
   753   C0026809:Mouse [Mammal]
   753   C0205132:Line [Spatial Concept]
   753   C1550648:Line [Substance]
   753   C1552960:Line [Quantitative Concept]

Phrase: "a single copy of PML-RAR cDNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0037179:Single [Population Group]
   744   C0087136:single [Finding]
   744   C0205171:Single [Quantitative Concept]
   744   C1948062:Copy [Manufactured Object]

Phrase: "was"

Phrase: "inserted into the murine cathepsin G locus,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   778   C0054868:Cathepsin G [Amino Acid, Peptide, or Protein,Enzyme]
   778   C1413814:CATHEPSIN G [Gene or Genome]
   748   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0026809:Murine [Mammal]
   748   C0439267:g% [Quantitative Concept]
   748   C0441587:Inserted [Health Care Activity]
   748   C0591833:Murine [Organic Chemical,Pharmacologic Substance]
   748   C1708726:Locus [Gene or Genome]
   714 E C1743766:Insert [Medical Device]
   714 E C1883719:Insert [Functional Concept]

Phrase: "ES cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0596508:Embryonic Stem Cells [Cell]
   901   C0038250:Stem cells [Cell]
   896   C1947950:Embryonic Cell [Embryonic Structure]
   827   C0007634:Cells [Cell]
   827   C0013935:Embryonic [Embryonic Structure]
   827   C0242767:Stem [Plant]
   827   C1186763:Stem [Body Part, Organ, or Organ Component]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected with the targeting vector"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0442335:Vector [Spatial Concept]
   760   C1521840:Targeting [Functional Concept]
   760   C1705099:Vector [Idea or Concept]
   726 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "shown in Figure 1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.81: The PML-RAR cDNA (the same bcr-1 fusion cDNA used in our previous studies),1,6 in tandem with a PGK-neo selection cassette, was inserted by homologous recombination into the 5' untranslated region of the murine cathepsin G locus. 

Phrase: "The PML-RAR cDNA ("
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "the same bcr-1 fusion cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "used in our previous studies"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   781   C0869040:Use studies [Research Activity]
   760   C0205156:Previous [Temporal Concept]
   760   C0947630:studies [Laboratory Procedure]
   760   C1273517:used [Finding]
   760   C1552607:previous [Temporal Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C0557651:Study [Manufactured Object]
   726 E C1947944:Use [Intellectual Product]
   726 E C2603343:Study [Research Activity]

Phrase: ")"

Phrase: ","

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "6 in tandem with a PGK-neo selection cassette,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   742   C0036576:selection [Genetic Function]
   742   C0075804:TANDEM [Organic Chemical,Pharmacologic Substance]
   742   C0450240:Cassette [Medical Device]
   742   C1150521:PGK [Molecular Function]
   742   C1366752:NEO [Gene or Genome]
   742   C1418929:PGK [Gene or Genome]
   742   C1706210:Cassette [Manufactured Object]

Phrase: "was"

Phrase: "inserted by homologous recombination"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0599773:Homologous Recombination [Genetic Function]
   833   C2984295:Homologous recombination [Functional Concept]
   770   C0034865:Recombination [Genetic Function]
   770   C0441587:Inserted [Health Care Activity]
   770   C1334043:Homologous [Gene or Genome]
   737 E C1743766:Insert [Medical Device]
   737 E C1883719:Insert [Functional Concept]

Phrase: "into the 5' untranslated region"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0600493:5' Untranslated Region [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   913   C1883644:5' Region [Nucleotide Sequence]
   901   C0600680:Untranslated Region [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "of the murine cathepsin G locus."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1708726:Locus [Gene or Genome]
Processing 00000000.tx.82: On the basis of evidence that a transcriptionally active selectable marker cassette might alter the expression of nearby genes,20 we designed the targeting vector with loxP sites flanking the PGK-neo cassette to facilitate its subsequent removal, which was achieved via transient expression of CRE recombinase in the targeted ES clone (Figure 1A). 

Phrase: "On the basis of evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that"

Phrase: "a transcriptionally active selectable marker cassette"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0450240:Cassette [Medical Device]
   804   C1706210:Cassette [Manufactured Object]

Phrase: "might"

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the expression of nearby genes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C0017262:Gene Expression [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "20"

Phrase: "we"

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "the targeting vector with loxP sites"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0442335:Vector [Spatial Concept]
   753   C1705099:Vector [Idea or Concept]

Phrase: "flanking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230171:flanking [Body Location or Region]

Phrase: "the PGK-neo cassette to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0450240:Cassette [Medical Device]
   812   C1706210:Cassette [Manufactured Object]

Phrase: "facilitate"

Phrase: "its subsequent removal,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0015252:Removal [Therapeutic or Preventive Procedure]
   861   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "which"

Phrase: "was"

Phrase: "achieved via transient expression of CRE recombinase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C1744318:Cre recombinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0040704:Transient [Population Group]
   748   C0073020:recombinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0205374:Transient [Temporal Concept]
   748   C1511573:CRE [Gene or Genome]

Phrase: "in the targeted ES clone"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0009013:Clone [Cell]
   812   C1522642:Clone [Tissue]
   741 E C1704387:Clonal [Qualitative Concept]
   712 E C0796368:clonality [Diagnostic Procedure]

Phrase: "(Figure 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.83: After CRE transfection, a subclone was identified that retained the PML-RAR cDNA in the 5' untranslated region of the mCG locus, but from which the PGK-neo cassette was excised, leaving only a single loxP site in its place (Figure 1B). 

Phrase: "After CRE transfection,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "a subclone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883178:Subclone [Cell]

Phrase: "was"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "that"

Phrase: "retained"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retained [Functional Concept]

Phrase: "the PML-RAR cDNA in the 5' untranslated region"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "of the mCG locus,"

Phrase: "but from which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0233535:but [Mental or Behavioral Dysfunction]

Phrase: "the PGK-neo cassette"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0450240:Cassette [Medical Device]
   827   C1706210:Cassette [Manufactured Object]

Phrase: "was"

Phrase: "excised"

Phrase: ","

Phrase: "leaving"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a single loxP site in its place"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0205145:Site [Spatial Concept]
   748   C1515974:Site [Body Location or Region]
   748   C2825164:Site [Spatial Concept]

Phrase: "(Figure 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.84: Blastocyst injection of both unmanipulated (+PGK-neo) and pTurboCRE-transfected (PGK-neo) clones was performed to generate chimeric male founder animals, and germ line transmission of the targeted loci was observed with predicted Mendelian frequency in both +PGK-neo and PGK-neo lines. 

Phrase: "Blastocyst injection of both unmanipulated"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021485:injection [Therapeutic or Preventive Procedure]
   760   C1272883:Injection [Biomedical or Dental Material]
   760   C1533685:Injection [Therapeutic or Preventive Procedure]
   760   C1828121:Injection [Functional Concept]

Phrase: "(+PGK-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1150521:PGK [Molecular Function]
  1000   C1418929:PGK [Gene or Genome]

Phrase: "neo)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1366752:NEO [Gene or Genome]

Phrase: "and"

Phrase: "pTurboCRE-transfected"

Phrase: "(PGK-neo) clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0009013:Clones [Cell]
   793 E C1522642:Clone [Tissue]
   743 E C1704387:Clonal [Qualitative Concept]
   721 E C0796368:clonality [Diagnostic Procedure]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "generate"

Phrase: "chimeric male founder animals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003062:Animals [Animal]

Phrase: "and"

Phrase: "germ line transmission of the targeted loci"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C1707722:Transmission Line [Manufactured Object]
   748   C0040722:transmission [Idea or Concept]
   748   C0242781:Transmission [Pathologic Function]
   748   C1521797:Transmission [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "observed with predicted Mendelian frequency"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0376249:frequency [Quantitative Concept]
   760   C0439603:Frequency [Temporal Concept]
   760   C0681842:Predicted [Idea or Concept]
   760   C0871396:Frequency [Quantitative Concept]
   760   C1441672:Observed [Functional Concept]
   760   C1561548:Frequency [Qualitative Concept]
   760   C1705502:Frequency [Quantitative Concept]
   760   C1882327:%{Predicted} [Quantitative Concept]

Phrase: "in both +PGK-neo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1366752:NEO [Gene or Genome]

Phrase: "and"

Phrase: "PGK-neo lines."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205132:lines [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]
Processing 00000000.tx.85: Southern blot analysis of genomic DNA from mCG+/PR animals revealed that the pTurboCRE plasmid had stably integrated into the genome of the ES cell at the time of transfection. 

Phrase: "Southern blot analysis of genomic DNA"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0005862:Southern blot analysis [Molecular Biology Research Technique]
           Southern Blot
   833   C1148472:southern blot analysis [Laboratory or Test Result]
           Blot, Southern
   783   C0200898:DNA analysis [Laboratory Procedure]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]
   753   C1710133:Southern [Spatial Concept]

Phrase: "from mCG+/PR animals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   841   C2348877:g/animal [Quantitative Concept]
   799   C0003062:Animals [Animal]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "the pTurboCRE plasmid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "had"

Phrase: "stably"

Phrase: "integrated into the genome of the ES cell"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   790   C0596508:Embryonic stem cell [Cell]
   764   C0038250:Stem cell [Cell]
   762   C1947950:Embryonic Cell [Embryonic Structure]
   742   C0007634:Cell [Cell]
   742   C0013935:Embryonic [Embryonic Structure]
   742   C0017428:Genome [Gene or Genome]
   742   C0242767:Stem [Plant]
   742   C1186763:Stem [Body Part, Organ, or Organ Component]
   742   C1269647:Cell [Cell]
   742   C1704653:Cell [Medical Device]
   742   C1948049:Cell [Spatial Concept]
   742   C2338314:Genome [Conceptual Entity]

Phrase: "at the time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "of transfection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
Processing 00000000.tx.86: The integrated CRE gene was inherited independently from the mCG+/PR locus, and its presence was not associated with development of APL (data not shown). 

Phrase: "The integrated CRE gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Gene [Gene or Genome]

Phrase: "was"

Phrase: "inherited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439660:Inherited [Functional Concept]

Phrase: "independently from the mCG+/PR locus,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   764   C0054868:Cathepsin G [Amino Acid, Peptide, or Protein,Enzyme]
   764   C1413814:CATHEPSIN G [Gene or Genome]
   742   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0026809:Murine [Mammal]
   742   C0279759:PR+ [Laboratory or Test Result]
   742   C0279766:PR- [Laboratory or Test Result]
   742   C0439267:g% [Quantitative Concept]
   742   C0591833:Murine [Organic Chemical,Pharmacologic Substance]
   742   C1418864:PR@ [Gene or Genome]
   742   C1708726:Locus [Gene or Genome]
   742   C3538934:PR [Intellectual Product]
   742   C3538935:PR [Idea or Concept]

Phrase: "and"

Phrase: "its presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "associated with development of APL"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   814   C0023487:Acute Promyelocytic Leukemia [Neoplastic Process]
           Promyelocytic Leukemia
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   778   C1366903:promyelocytic leukemia [Gene or Genome]
   778   C2745900:Promyelocytic leukemia [Neoplastic Process]
   774   C0085669:Acute leukaemia [Neoplastic Process]
   774   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   748   C0023418:Leukaemia [Neoplastic Process]
   748   C0205178:acute [Temporal Concept]
   748   C0243107:development [Physiologic Function]
   748   C0678723:Development [Organism Function]
   748   C1527148:Development [Functional Concept]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.87: High-penetrance acute myeloid leukemia in mCG+/PR (PGK-neo) mice Transgenic mCG+/PR (+PGK-neo) animals were phenotypically normal, with peripheral blood and bone marrow counts that were indistinguishable from wild-type littermates (data not shown). 

Phrase: "High-penetrance acute myeloid leukemia"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0023467:Acute myeloid leukaemia [Neoplastic Process]
   884   C2984331:Acute myeloid leukemia [Functional Concept]
   884   C3541370:Acute Myeloid Leukemia [Intellectual Product]
   853   C0085669:Acute leukaemia [Neoplastic Process]
   853   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   840   C0023470:Myeloid Leukemia [Neoplastic Process]
   804   C0023418:Leukaemia [Neoplastic Process]
   804   C0205178:acute [Temporal Concept]
   804   C0439677:Myeloid [Qualitative Concept]

Phrase: "in mCG+/PR (PGK-neo) mice Transgenic mCG+/PR (+PGK-neo) animals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   859   C2348877:g/animal [Quantitative Concept]
   837   C0003069:Animals, Transgenic [Animal]
   784   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "phenotypically normal,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205307:Normal [Qualitative Concept]
   861   C0439166:% normal [Quantitative Concept]
   861   C2347086:% Normal [Quantitative Concept]

Phrase: "with peripheral blood"
Meta Candidates (Total=13; Excluded=8; Pruned=0; Remaining=5)
  1000   C0229664:peripheral blood [Body Substance]
           Blood
   958 E C0150936:Peripheral Blood Vessel [Body Part, Organ, or Organ Component]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0205100:Peripheral [Spatial Concept]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "and"

Phrase: "bone marrow"
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
  1000   C0005953:Bone Marrow [Tissue]
   861   C0086590:Marrow [Food]
   861   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   861   C0376152:Marrow [Body Part, Organ, or Organ Component]
   861   C0391978:Bone [Tissue]
   861   C1266908:Bone [Body Part, Organ, or Organ Component]
   861   C1266909:Bone [Body System]
   861   C1546708:Marrow [Intellectual Product]
   805 E C0001629:Medullary [Body Part, Organ, or Organ Component]
   805 E C0025148:Medullary [Body Part, Organ, or Organ Component]
   805 E C1550278:Medullary [Body Part, Organ, or Organ Component]
   789 E C0443157:Bony [Functional Concept]
   777 E C0330477:Marrows [Plant]

Phrase: "counts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439157:counts [Quantitative Concept]
  1000   C0750480:Count [Activity]
  1000   C1705566:Count [Quantitative Concept]

Phrase: "that"

Phrase: "were"

Phrase: "indistinguishable from wild-type littermates"

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.88: None of these animals developed acute leukemia during observation for up to 2 years (Figure 2A). 

Phrase: "None of these animals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0003062:Animals [Animal]
   770   C0456148:None [Quantitative Concept]
   770   C0549184:None [Quantitative Concept]

Phrase: "developed"

Phrase: "acute leukemia during observation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0085669:Acute leukaemia [Neoplastic Process]
   833   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   770   C0023418:Leukaemia [Neoplastic Process]
   770   C0205178:acute [Temporal Concept]

Phrase: "for"

Phrase: "up to 2 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "(Figure 2A"

Phrase: ")."
Processing 00000000.tx.89: In contrast, all tested mCG+/PR (PGK-neo) animals showed evidence of a myeloid expansion in the bone marrow similar to that described in our previously characterized hCGPML-RAR model, with progressive splenomegaly and extramedullary splenic hematopoiesis. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "all tested mCG+/PR (PGK-neo) animals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   837   C2348877:g/animal [Quantitative Concept]
   791   C0003062:Animals [Animal]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "evidence of a myeloid expansion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "in the bone marrow"
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
  1000   C0005953:Bone Marrow [Tissue]
   861   C0086590:Marrow [Food]
   861   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   861   C0376152:Marrow [Body Part, Organ, or Organ Component]
   861   C0391978:Bone [Tissue]
   861   C1266908:Bone [Body Part, Organ, or Organ Component]
   861   C1266909:Bone [Body System]
   861   C1546708:Marrow [Intellectual Product]
   805 E C0001629:Medullary [Body Part, Organ, or Organ Component]
   805 E C0025148:Medullary [Body Part, Organ, or Organ Component]
   805 E C1550278:Medullary [Body Part, Organ, or Organ Component]
   789 E C0443157:Bony [Functional Concept]
   777 E C0330477:Marrows [Plant]

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "described in our previously characterized hCGPML-RAR model,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C1552738:described [Idea or Concept]
   744   C1880022:Characterized [Activity]
   744   C3161035:Model [Intellectual Product]
   744   C3538821:RAR [Gene or Genome]

Phrase: "with progressive splenomegaly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038002:Splenomegaly [Finding]

Phrase: "and"

Phrase: "extramedullary splenic hematopoiesis."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C0018952:Hematopoiesis, Extramedullary [Organ or Tissue Function]
   913   C2613439:Extramedullary haematopoiesis [Disease or Syndrome]
   827   C0018951:Haematopoiesis [Organ or Tissue Function]
   755 E C0018957:Haematopoietic [Body System]
   755 E C0229601:Hematopoietic [Functional Concept]
Processing 00000000.tx.90: Peripheral blood counts were not significantly different from wild-type littermates during the "preleukemic" phase (Figure 3B; Table 1). 

Phrase: "Peripheral blood counts"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0439157:counts [Quantitative Concept]
   793 E C0750480:Count [Activity]
   793 E C1705566:Count [Quantitative Concept]
   734   C0229664:peripheral blood [Body Substance]

Phrase: "were"

Phrase: "not significantly different from wild-type littermates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1705242:Different [Qualitative Concept]

Phrase: "during the ""preleukemic"" phase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205390:Phase [Temporal Concept]

Phrase: "(Figure 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: "; Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.91: Between 6 and 19 months of age, however, these animals exhibited a high probability of developing an abrupt onset, rapidly fatal acute leukemia, characterized by pronounced leukocytosis with increased myeloblasts and promyelocytes, anemia, thrombocytopenia, and massive hepatosplenomegaly with leukemic cell infiltration (Figure 2A; Table 1). 

Phrase: "Between 6"

Phrase: "and"

Phrase: "19 months of age,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   819   C1510828:Age-Months [Organism Attribute]
   770   C0439231:months [Temporal Concept]
   737 E C0439507:/month [Temporal Concept]

Phrase: "however,"

Phrase: "these animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "a high probability of developing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033204:Probability [Quantitative Concept]

Phrase: "an abrupt onset,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1276802:Abrupt onset [Qualitative Concept]
   861   C0332162:Onset [Qualitative Concept]

Phrase: "rapidly fatal acute leukemia,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0085669:Acute leukaemia [Neoplastic Process]
   861   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   812   C0023418:Leukaemia [Neoplastic Process]
   812   C0205178:acute [Temporal Concept]

Phrase: "characterized by pronounced leukocytosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0023518:Leucocytosis [Pathologic Function]
   770   C0750426:Leukocytosis [Finding]
   770   C1880022:Characterized [Activity]

Phrase: "with increased myeloblasts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0229633:Myeloblasts [Cell]
   861   C0580952:Myeloblasts [Laboratory Procedure]

Phrase: "and"

Phrase: "promyelocytes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033416:Promyelocytes [Cell]
  1000   C0455279:Promyelocytes [Laboratory Procedure]

Phrase: "anemia,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0002871:Anaemia [Disease or Syndrome]
  1000   C1000483:Anemia [Plant]
   928 E C0857322:anaemic [Finding]

Phrase: "thrombocytopenia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040034:Thrombocytopenia [Finding]

Phrase: "and"

Phrase: "massive hepatosplenomegaly with leukemic cell infiltration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0019214:Hepatosplenomegaly [Sign or Symptom]

Phrase: "(Figure 2A"

Phrase: "; Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.92: Leukemic cells from the spleens of moribund animals displayed an APL phenotype that was similar to that of PR transgenic mice, with markedly increased numbers of immature myeloid cells, including promyelocytes (Figure 3A). 

Phrase: "Leukemic cells from the spleens of moribund animals"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   754   C1517806:Leukemic Cell [Cell]
   744   C0007634:Cells [Cell]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "an APL phenotype"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0031437:Phenotype [Organism Attribute]
   812   C1285572:Phenotype [Laboratory Procedure]
   756   C0023487:Acute Promyelocytic Leukemia [Neoplastic Process]
   708   C0085669:Acute leukaemia [Neoplastic Process]
   708   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]

Phrase: "that"

Phrase: "was"

Phrase: "similar to that of PR transgenic mice,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2348205:Similar [Qualitative Concept]

Phrase: "with markedly increased numbers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0237753:*Number [Quantitative Concept]
   827   C0449788:Number [Quantitative Concept]

Phrase: "of immature myeloid cells,"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   913   C2708700:Immature cells [Cell]
   913   C3272950:Immature Cells [Laboratory Procedure]
   901   C0887899:Myeloid Cells [Cell]
   867 E C0596993:Myeloid cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0439677:Myeloid [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "promyelocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033416:Promyelocytes [Cell]
  1000   C0455279:Promyelocytes [Laboratory Procedure]

Phrase: "(Figure 3A"

Phrase: ")."
Processing 00000000.tx.93: The median age of overt leukemia development was 10 months. 

Phrase: "The median age of overt leukemia development"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0001779:Age [Organism Attribute]
   738   C2733260:Developmental age [Organism Attribute]

Phrase: "was"

Phrase: "10 months."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]
Processing 00000000.tx.94: Leukemia was readily transferable to genetically compatible wild-type secondary recipients (C57Bl/6 x 129Sv/J F1), which developed similar, rapidly fatal leukemias within 6 to 8 weeks of tumor inoculation (data not shown). 

Phrase: "Leukemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023418:Leukaemia [Neoplastic Process]

Phrase: "was"

Phrase: "readily transferable to genetically compatible wild-type secondary recipients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   758   C1709854:Recipient [Human]

Phrase: "(C57Bl/6 x 129Sv/J F1"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "developed"

Phrase: "similar, rapidly fatal leukemias within 6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0023418:LEUKEMIAS, NOS [Neoplastic Process]

Phrase: "to 8 weeks"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]

Phrase: "of tumor inoculation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0042196:Inoculation [Therapeutic or Preventive Procedure]
   861   C2987620:Inoculation [Therapeutic or Preventive Procedure]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.95: View larger version (12K): [in this window] [in a new window]  Figure 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(12K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 2."
Processing 00000000.tx.96: Development of acute myeloid leukemia in transgenic and knock-in animals. 

Phrase: "Development of acute myeloid leukemia"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243107:development [Physiologic Function]
   760   C0678723:Development [Organism Function]
   760   C1527148:Development [Functional Concept]

Phrase: "in transgenic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003069:Transgenic [Animal]

Phrase: "and"

Phrase: "knock-in animals."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003062:Animals [Animal]
   734   C1517676:Knock-in [Research Activity]
Processing 00000000.tx.97: (A) Kaplan-Meier probability of leukemia-free survival of wild-type (CG+/+; ), mCG+/PR (+PGK-neo; g), and mCG+/PR (PGK-neo; ) animals is plotted against time and is compared with leukemia-free survival of a simultaneous cohort of hCGPML-RAR animals from line no. 

Phrase: "(A) Kaplan-Meier probability of leukemia-free survival"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0033204:Probability [Quantitative Concept]

Phrase: "of wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "(CG+/+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C3540479:CG [Gene or Genome]

Phrase: ";"

Phrase: ")"

Phrase: ","

Phrase: "mCG+/PR (+PGK-neo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C1366752:NEO [Gene or Genome]

Phrase: "; g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "mCG+/PR (PGK-neo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C1366752:NEO [Gene or Genome]

Phrase: ";"

Phrase: ")"

Phrase: "animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "is"

Phrase: "plotted against time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0040223:Time [Temporal Concept]
   790   C3541383:Time [Temporal Concept]
   734 E C0442043:Temporal [Spatial Concept]
   734 E C2362314:Temporal [Temporal Concept]
   706 E C1632851:Times [Quantitative Concept]

Phrase: "and"

Phrase: "is"

Phrase: "compared with leukemia-free survival of a simultaneous cohort"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   742   C0023418:Leukaemia [Neoplastic Process]
   742   C0038952:Survival [Activity]
   742   C0220921:survival [Functional Concept]
   742   C0332296:free [Functional Concept]
   742   C0521115:Simultaneous [Temporal Concept]
   742   C0599755:Cohort [Population Group]
   742   C1548968:Simultaneous [Idea or Concept]
   742   C1707455:Compared [Activity]
   742   C1880497:Free [Qualitative Concept]
   742   C1996904:Free [Qualitative Concept]

Phrase: "of hCGPML-RAR animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003062:Animals [Animal]

Phrase: "from line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205132:Line [Spatial Concept]
  1000   C1550648:Line [Substance]
  1000   C1552960:Line [Quantitative Concept]

Phrase: "no."
Processing 00000000.tx.98: 134 (the same data were used in Pollock et al6; ). 

Phrase: "134"

Phrase: "("

Phrase: "the same data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "used in Pollock et al6"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0328442:Pollock [Fish]
   760   C0453004:Pollack [Food]
   760   C1273517:used [Finding]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: ";"

Phrase: ")."
Processing 00000000.tx.99: The number of mice in each cohort was as follows: CG+/+ = 25; 

Phrase: "The number of mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "in each cohort"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599755:Cohort [Population Group]

Phrase: "was"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "CG+/+ = 25"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3540479:CG [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.100: mCG+/PR (+PGK-neo) = 26; 

Phrase: "mCG+/PR (+PGK-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1150521:PGK [Molecular Function]
   799   C1418929:PGK [Gene or Genome]

Phrase: "neo)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1366752:NEO [Gene or Genome]

Phrase: "= 26"

Phrase: ";"
Processing 00000000.tx.101: mCG+/PR (PGK-neo) = 118; 

Phrase: "mCG+/PR (PGK-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1150521:PGK [Molecular Function]
   799   C1418929:PGK [Gene or Genome]

Phrase: "neo)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1366752:NEO [Gene or Genome]

Phrase: "= 118"

Phrase: ";"
Processing 00000000.tx.102: hCG-PR = 27. 

Phrase: "hCG-PR = 27."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   840   C0054868:Cathepsin G [Amino Acid, Peptide, or Protein,Enzyme]
   840   C1413814:CATHEPSIN G [Gene or Genome]
   804   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0086418:Human [Human]
   804   C0279759:PR+ [Laboratory or Test Result]
   804   C0279766:PR- [Laboratory or Test Result]
   804   C0439267:g% [Quantitative Concept]
   804   C1418864:PR@ [Gene or Genome]
   804   C3538934:PR [Intellectual Product]
   804   C3538935:PR [Idea or Concept]
Processing 00000000.tx.103: (B) Kaplan-Meier probability of leukemia-free survival of heterozygous mCG+/PR (PGK-neo; ) versus homozygous (mCGPR/PR; ) animals is plotted against time. 

Phrase: "(B) Kaplan-Meier probability of leukemia-free survival"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0033204:Probability [Quantitative Concept]

Phrase: "of heterozygous mCG+/PR (PGK-neo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1366752:NEO [Gene or Genome]

Phrase: ";"

Phrase: ")"

Phrase: "versus"

Phrase: "homozygous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019904:Homozygous [Organism Attribute]

Phrase: "(mCGPR/PR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0279759:PR+ [Laboratory or Test Result]
   861   C0279766:PR- [Laboratory or Test Result]
   861   C1418864:PR@ [Gene or Genome]
   861   C3538934:PR [Intellectual Product]
   861   C3538935:PR [Idea or Concept]

Phrase: ";"

Phrase: ")"

Phrase: "animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "is"

Phrase: "plotted against time."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0040223:Time [Temporal Concept]
   790   C3541383:Time [Temporal Concept]
   734 E C0442043:Temporal [Spatial Concept]
   734 E C2362314:Temporal [Temporal Concept]
   706 E C1632851:Times [Quantitative Concept]
Processing 00000000.tx.104: The difference between the curves is statistically significant (P = .002). 

Phrase: "The difference between the curves"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1705241:*Difference [Quantitative Concept]
   760   C1705242:Difference [Qualitative Concept]

Phrase: "is"

Phrase: "statistically significant"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0237881:statistically significant [Quantitative Concept]
           significant
   928 E C1709380:Statistical Significance [Quantitative Concept]
   861   C0038215:Statistically [Occupation or Discipline]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]

Phrase: "(P = .002"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.105: mCG+/PR (PGK-neo) = 118 mice; 

Phrase: "mCG+/PR (PGK-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1150521:PGK [Molecular Function]
   799   C1418929:PGK [Gene or Genome]

Phrase: "neo)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1366752:NEO [Gene or Genome]

Phrase: "= 118 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: ";"
Processing 00000000.tx.106: mCGPR/PR (PGK-neo) = 99 mice. 

Phrase: "mCGPR/PR (PGK-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1150521:PGK [Molecular Function]
   827   C1418929:PGK [Gene or Genome]

Phrase: "neo)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1366752:NEO [Gene or Genome]

Phrase: "= 99 mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
Processing 00000000.tx.107: (C) Kaplan-Meier probability of leukemia-free survival of animals carrying a single PML-RAR gene copy together with either an intact CG gene (CG+/PR; ) or a null mutation (CG/PR; ) at the other allele is plotted against time. 

Phrase: "(C) Kaplan-Meier probability of leukemia-free survival of animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0033204:Probability [Quantitative Concept]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "a single PML-RAR gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   888   C1366903:Promyelocytic Leukemia Gene [Gene or Genome]
   804   C0017337:Gene [Gene or Genome]

Phrase: "copy together with either"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1883357:Together [Qualitative Concept]
   770   C1948062:Copy [Manufactured Object]

Phrase: "an intact CG gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Gene [Gene or Genome]

Phrase: "(CG+/PR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0279759:PR+ [Laboratory or Test Result]
   861   C0279766:PR- [Laboratory or Test Result]
   861   C1418864:PR@ [Gene or Genome]
   861   C3538934:PR [Intellectual Product]
   861   C3538935:PR [Idea or Concept]

Phrase: ";"

Phrase: ")"

Phrase: "or"

Phrase: "a null mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(CG/PR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0279759:PR+ [Laboratory or Test Result]
   861   C0279766:PR- [Laboratory or Test Result]
   861   C1418864:PR@ [Gene or Genome]
   861   C3538934:PR [Intellectual Product]
   861   C3538935:PR [Idea or Concept]

Phrase: ";"

Phrase: ")"

Phrase: "at the"

Phrase: "other allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002085:Allele [Gene or Genome]

Phrase: "is"

Phrase: "plotted against time."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0040223:Time [Temporal Concept]
   790   C3541383:Time [Temporal Concept]
   734 E C0442043:Temporal [Spatial Concept]
   734 E C2362314:Temporal [Temporal Concept]
   706 E C1632851:Times [Quantitative Concept]
Processing 00000000.tx.108: The differences between the curves are not statistically significant (P = .48). 

Phrase: "The differences between the curves"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "are"

Phrase: "not statistically significant"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   913   C1273937:Not significant [Finding]
   901   C0237881:statistically significant [Quantitative Concept]
           significant
   829 E C1709380:Statistical Significance [Quantitative Concept]
   827   C0038215:Statistically [Occupation or Discipline]
   827   C0750502:Significant [Idea or Concept]
   827   C1546944:Significant [Qualitative Concept]

Phrase: "(P = .48"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.109: mCG+/PR (PGK-neo) = 60 mice; 

Phrase: "mCG+/PR (PGK-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1150521:PGK [Molecular Function]
   799   C1418929:PGK [Gene or Genome]

Phrase: "neo)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1366752:NEO [Gene or Genome]

Phrase: "= 60 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: ";"
Processing 00000000.tx.110: mCG/PR (PGK-neo) = 71 mice.  

Phrase: "mCG/PR (PGK-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1150521:PGK [Molecular Function]
   799   C1418929:PGK [Gene or Genome]

Phrase: "neo)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1366752:NEO [Gene or Genome]

Phrase: "= 71 mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
Processing 00000000.tx.111: View larger version (44K): [in this window] [in a new window]  Figure 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(44K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 3."
Processing 00000000.tx.112: Characterization of APL cells. 

Phrase: "Characterization of APL cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1880022:Characterization [Activity]
Processing 00000000.tx.113: (A) Morphology by May-Grnwald-Giemsa staining and flow cytometric analysis for Gr-1 and CD34 is shown for 2 independent splenic tumors arising in hCG-PML-RAR animals and in 2 mCGPR/PR animals. 

Phrase: "(A) Morphology by May-Grnwald-Giemsa staining"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0332437:Morphology [Qualitative Concept]
   748   C0543482:morphology [Spatial Concept]
   748   C0700329:Morphology, NOS [Finding]
   748   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "flow cytometric analysis for Gr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "CD34"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538723:CD34 [Laboratory Procedure]

Phrase: "is"

Phrase: "shown for 2 independent splenic tumors"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0027651:Tumors [Neoplastic Process]
   753   C0037993:Splenic [Body Part, Organ, or Organ Component]
   753   C0085862:Independent [Idea or Concept]
   753   C1299583:Independent [Finding]
   719   C1547282:Show [Intellectual Product]
   719 E C1578706:Tumor [Intellectual Product]
   719 E C3273930:Tumor [Finding]

Phrase: "arising in hCG-PML-RAR animals"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   764   C0023487:Promyelocytic Leukemia [Neoplastic Process]
   764   C0054868:Cathepsin G [Amino Acid, Peptide, or Protein,Enzyme]
   764   C0332284:Arising in [Qualitative Concept]
           arising
   764   C1366903:promyelocytic leukemia [Gene or Genome]
   764   C1413814:CATHEPSIN G [Gene or Genome]
   764   C2745900:Promyelocytic leukemia [Neoplastic Process]
   745   C2348877:g/animal [Quantitative Concept]
   742   C0003062:Animals [Animal]
   742   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0023418:Leukaemia [Neoplastic Process]
   742   C0086418:Human [Human]
   742   C0439267:g% [Quantitative Concept]
   742   C3538821:RAR [Gene or Genome]

Phrase: "and in 2 mCGPR/PR animals."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0003062:Animals [Animal]
   753   C0279759:PR+ [Laboratory or Test Result]
   753   C0279766:PR- [Laboratory or Test Result]
   753   C1418864:PR@ [Gene or Genome]
   753   C1515981:And [Idea or Concept]
   753   C3538934:PR [Intellectual Product]
   753   C3538935:PR [Idea or Concept]
Processing 00000000.tx.114: Numbers represent the percentage of cells in each quadrant. 

Phrase: "Numbers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237753:*Number [Quantitative Concept]
  1000   C0449788:Number [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the percentage of cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439165:Percentage [Quantitative Concept]
   770   C1549488:Percentage [Idea or Concept]
   770   C1561533:Percentage [Idea or Concept]

Phrase: "in each quadrant."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1631280:Quadrant [Spatial Concept]
Processing 00000000.tx.115: Original magnification, x400. 

Phrase: "Original magnification,"

Phrase: "x400."
Processing 00000000.tx.116: (B) Peripheral white blood cell (WBC; ) counts and absolute neutrophil counts (ANCs; ) determined by automated counting are shown for wild-type littermates, nonleukemic mCG+/PR, and leukemic mCG+/PR and mCGPR/PR animals. 

Phrase: "(B) Peripheral white blood cell (WBC; ) counts"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   867   C0023508:Blood Cell Count, White [Laboratory Procedure]
   867   C0427512:white blood cell count [Laboratory or Test Result]
   861   C0005771:Counts, Blood Cell [Laboratory Procedure]
   827   C0007584:Counts, Cell [Laboratory Procedure]
   827 E C0009555:Blood Cell Count [Laboratory Procedure]
   799   C0439157:counts [Quantitative Concept]
   766 E C0750480:Count [Activity]
   766 E C1705566:Count [Quantitative Concept]
   709   C0004561:B-cell [Cell]
   700   C0005773:Peripheral blood cell [Cell]

Phrase: "and"

Phrase: "absolute neutrophil counts (ANCs; )"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   966   C0948762:Absolute neutrophil count [Laboratory Procedure]
   884   C0200633:Neutrophil count [Laboratory Procedure]
   827   C0027950:Neutrophile [Cell]
   827   C0205344:Absolute [Qualitative Concept]
   827   C0439157:counts [Quantitative Concept]
   793 E C0750480:Count [Activity]
   793 E C1705566:Count [Quantitative Concept]
   755 E C0746885:neutrophilic [Cell Function]
   727 E C0151683:Neutrophilia [Finding]

Phrase: "determined by automated counting"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   816   C1441489:Automated count [Laboratory Procedure]
   770   C0205554:Automated [Functional Concept]
   737   C0750480:Count [Activity]
   737   C1705566:Count [Quantitative Concept]

Phrase: "are"

Phrase: "shown for wild-type littermates,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]
   726   C1547282:Show [Intellectual Product]

Phrase: "nonleukemic mCG+/PR,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0279759:PR+ [Laboratory or Test Result]
   799   C0279766:PR- [Laboratory or Test Result]
   799   C1418864:PR@ [Gene or Genome]
   799   C3538934:PR [Intellectual Product]
   799   C3538935:PR [Idea or Concept]

Phrase: "and"

Phrase: "leukemic mCG+/PR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0279759:PR+ [Laboratory or Test Result]
   799   C0279766:PR- [Laboratory or Test Result]
   799   C1418864:PR@ [Gene or Genome]
   799   C3538934:PR [Intellectual Product]
   799   C3538935:PR [Idea or Concept]

Phrase: "and"

Phrase: "mCGPR/PR animals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003062:Animals [Animal]
Processing 00000000.tx.117: For panels B and C, wild type = 7 mice; 

Phrase: "For panels B"

Phrase: "and"

Phrase: "C,"

Phrase: "wild type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "= 7 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: ";"
Processing 00000000.tx.118: nonleukemic mCG+/PR = 9 mice; 

Phrase: "nonleukemic mCG+/PR = 9 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0025914:Mice [Mammal]
   793   C0025929:mice [Mammal]
   793   C0026809:Mice [Mammal]

Phrase: ";"
Processing 00000000.tx.119: leukemic mCG+/PR = 9 mice; 

Phrase: "leukemic mCG+/PR = 9 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0025914:Mice [Mammal]
   793   C0025929:mice [Mammal]
   793   C0026809:Mice [Mammal]

Phrase: ";"
Processing 00000000.tx.120: leukemic mCGPR/PR = 10 mice. 

Phrase: "leukemic mCGPR/PR = 10 mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]
Processing 00000000.tx.121: (C) The fraction of Gr-1+, CD34+, and Gr-1+/CD34+ cells in the spleens of wild-type, nonleukemic, and leukemia cells from mCG+/PR (+/) and mCGPR/PR (+/+) knock-in animals are shown. 

Phrase: "(C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "The fraction of Gr-1+,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   844   C3642197:Fraction of 1 [Quantitative Concept]
   806   C1264633:Fraction of [Quantitative Concept]
           Fraction
   760   C1554103:Fraction [Idea or Concept]

Phrase: "CD34+,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538723:CD34 [Laboratory Procedure]

Phrase: "and"

Phrase: "Gr-1+/CD34+ cells in the spleens"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   778   C0882849:cd34 cells [Cell]
   748   C0007634:Cells [Cell]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "of wild-type, nonleukemic,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "and"

Phrase: "leukemia cells from mCG+/PR (+/)"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   767   C0524983:G Cells [Cell]
   744   C0007634:Cells [Cell]
   744   C3282337:Cells [Cell]
   718   C1517806:Leukemic Cell [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "mCGPR/PR (+/+) knock-in animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0003062:Animals [Animal]

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.122: Error bars indicate  SEM. 

Phrase: "Error bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: "indicate"

Phrase: "SEM."
Processing 00000000.tx.123: (D) The relative increase in abundance of MMP9 mRNA in individual APL samples after 3 days of treatment with 1 M ATRA relative to diluent alone is shown. 

Phrase: "("

Phrase: "D)"

Phrase: "The relative increase in abundance of MMP9 mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "in individual APL samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   771   C0370003:Sample [Substance]
   771   C2347026:Sample [Conceptual Entity]
   717   C0023487:Acute Promyelocytic Leukemia [Neoplastic Process]

Phrase: "after 3 days"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1442459:3 Days [Temporal Concept]
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "of treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "with 1 M ATRA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0040845:ATRA [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "relative to diluent alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0080103:Relative [Family Group]
   770   C0205345:Relative [Qualitative Concept]
   770   C1547039:*Relative [Quantitative Concept]

Phrase: "is"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.124: Left panel: 5 independent hCGPML-RAR tumors; 

Phrase: "Left panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ":"

Phrase: "5 independent hCGPML-RAR tumors"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0027651:Tumors [Neoplastic Process]
   771 E C1578706:Tumor [Intellectual Product]
   771 E C3273930:Tumor [Finding]

Phrase: ";"
Processing 00000000.tx.125: right panel: 6 independent mCGPR/PR tumors. 

Phrase: "right panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ":"

Phrase: "6 independent mCGPR/PR tumors."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0027651:Tumors [Neoplastic Process]
   771 E C1578706:Tumor [Intellectual Product]
   771 E C3273930:Tumor [Finding]
Processing 00000000.tx.126: MMP9 is normally expressed at its highest levels in terminally differentiated myeloid cells. 

Phrase: "MMP9"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0165519:MMP-9 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1334523:MMP9 [Gene or Genome]
  1000   C2698028:MMP9 [Laboratory Procedure]

Phrase: "is"

Phrase: "normally"

Phrase: "expressed at its highest levels"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
   760   C0441889:Levels [Qualitative Concept]
   760   C1522410:Highest [Qualitative Concept]
   726 E C0205250:High [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1299351:High [Qualitative Concept]
   726 E C1547707:Level [Geographic Area]
   726 E C2700149:HIGH [Intellectual Product]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "in terminally differentiated myeloid cells."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   861   C0887899:Myeloid Cells [Cell]
   827 E C0596993:Myeloid cell [Cell]
   812   C0007634:Cells [Cell]
   812   C0439677:Myeloid [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.127: Expression levels from each sample were normalized by measuring the abundance of GAPDH mRNA, which is expressed at all stages of myeloid development. 

Phrase: "Expression levels from each sample"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   773   C3244092:expression level [Idea or Concept]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "normalized by measuring"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0444706:measuring [Qualitative Concept]
   790   C0449770:measuring [Quantitative Concept]
   790   C1882115:Normalized [Research Activity]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "the abundance of GAPDH mRNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2346714:Abundance [Qualitative Concept]

Phrase: "which"

Phrase: "is"

Phrase: "expressed at all"

Phrase: "stages of myeloid development."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   783   C0870411:Developmental Stage [Temporal Concept]
   770   C0205390:Stage [Temporal Concept]
   770   C0243107:development [Physiologic Function]
   770   C0439677:Myeloid [Qualitative Concept]
   770   C0678723:Development [Organism Function]
   770   C1300072:Stage [Clinical Attribute]
   770   C1306673:Stage [Qualitative Concept]
   770   C1527148:Development [Functional Concept]
Processing 00000000.tx.128: Pairwise comparisons that yielded statistical significance of P < .01 are indicated by asterisks (**).  

Phrase: "Pairwise comparisons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1707455:Comparison [Activity]

Phrase: "that"

Phrase: "yielded"

Phrase: "statistical significance of P < .01"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0237881:Statistical Significance [Quantitative Concept]
           Significance
   806   C1709380:Statistical Significance [Quantitative Concept]
   760   C0038215:Statistical [Occupation or Discipline]
   760   C0750502:Significance [Idea or Concept]

Phrase: "are"

Phrase: "indicated by asterisks"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1444656:Indicated [Finding]
   790   C2945706:asterisks [Conceptual Entity]

Phrase: "("

Phrase: "*"

Phrase: "*"

Phrase: ")."
Processing 00000000.tx.129: View this table: [in this window] [in a new window]  Table 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.130: Peripheral blood counts and splenic flow cytometry on preleukemic and leukemic animals  Aberrant coexpression of CD34 and myeloid differentiation markers in knock-in PML-RAR tumors To characterize the leukemias that developed in the mCG+/PR (PGK-neo) knock-in animals, flow cytometric analyses were performed on the spleen cells of affected animals and compared with tumor spleens from hCGPML-RAR mice. 

Phrase: "Peripheral blood counts"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0439157:counts [Quantitative Concept]
   793 E C0750480:Count [Activity]
   793 E C1705566:Count [Quantitative Concept]
   734   C0229664:peripheral blood [Body Substance]

Phrase: "and"

Phrase: "splenic flow cytometry on preleukemic"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0016263:Flow Cytometry [Laboratory Procedure]
   760   C0806140:Flow [Natural Phenomenon or Process]
   760   C0814048:Cytometry [Laboratory Procedure]

Phrase: "and"

Phrase: "leukemic animals  Aberrant coexpression of CD34"

Phrase: "and"

Phrase: "myeloid differentiation markers in knock-in PML-RAR tumors To"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   756   C0003324:Differentiation Markers [Immunologic Factor]
   754   C1955314:Leukemia markers [Clinical Attribute]
   738   C0007589:Differentiation [Cell Function]
   738   C1511938:Differentiation [Clinical Attribute]
   738   C2945687:Differentiation [Functional Concept]
   737   C0041365:Tumor Markers [Biologically Active Substance]
   737   C1139415:Tumor markers [Indicator, Reagent, or Diagnostic Aid]
   704   C0005516:Marker [Clinical Attribute]

Phrase: "characterize"

Phrase: "the leukemias"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023418:LEUKEMIAS, NOS [Neoplastic Process]

Phrase: "that"

Phrase: "developed"

Phrase: "in the mCG+/PR (PGK-neo) knock-in animals,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   852   C2348877:g/animal [Quantitative Concept]
   790   C0003062:Animals [Animal]

Phrase: "flow cytometric analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]

Phrase: "were"

Phrase: "performed on the spleen cells of affected animals"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   754   C1292725:Affected animal [Functional Concept]
   744   C0003062:Animals [Animal]
   744   C0007634:Cells [Cell]
   744   C0037993:Spleen [Body Part, Organ, or Organ Component]
   744   C0392760:Affected [Functional Concept]
   744   C0771377:SPLEEN [Tissue]
   744   C0884358:Performed [Functional Concept]
   744   C1278932:Spleen [Body Part, Organ, or Organ Component]
   744   C1314939:Affected [Functional Concept]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]
   711 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and"

Phrase: "compared with tumor spleens"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   816   C0037999:tumour spleen [Neoplastic Process]
   770   C0027651:Tumor [Neoplastic Process]
   770   C0037993:Spleens [Body Part, Organ, or Organ Component]
   770   C1578706:Tumor [Intellectual Product]
   770   C1707455:Compared [Activity]
   770   C3273930:Tumor [Finding]
   737 E C0771377:SPLEEN [Tissue]
   737 E C1278932:Spleen [Body Part, Organ, or Organ Component]

Phrase: "from hCGPML-RAR mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
Processing 00000000.tx.131: Analysis of multiple independent tumors demonstrated coexpression of myeloid differentiation markers Gr-1 and Mac-1 in leukemic cells and the absence of B- or T-lymphoid marker expression or the erythroid lineage marker Ter119 (Table 1; Figure 3C; and data not shown). 

Phrase: "Analysis of multiple independent tumors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "demonstrated"

Phrase: "coexpression of myeloid differentiation markers Gr-1"

Phrase: "and"

Phrase: "Mac-1 in leukemic cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0079785:Mac 1 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   760   C3538559:MAC [Cell Component]

Phrase: "and"

Phrase: "the absence of B-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "or"

Phrase: "T-lymphoid marker expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "the erythroid lineage marker Ter119"

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "; Figure 3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: ";"

Phrase: "and"

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.132: The abnormal coexpression of the primitive hematopoietic marker CD34 with Gr-1 was detected in a large population of cells in leukemic spleens, similar to that previously described in hCGPML-RAR mice6,9 (Figure 3A; Table 1). 

Phrase: "The abnormal coexpression of the primitive hematopoietic marker CD34"

Phrase: "with Gr-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552950:[gr] [Quantitative Concept]

Phrase: "was"

Phrase: "detected in a large population of cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   748   C0007634:Cells [Cell]
   748   C0032659:Population [Quantitative Concept]
   748   C0442726:Detected [Finding]
   748   C0549177:Large [Quantitative Concept]
   748   C1257890:Population [Population Group]
   748   C1511790:Detected [Therapeutic or Preventive Procedure]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "in leukemic spleens,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0037993:Spleens [Body Part, Organ, or Organ Component]
   827 E C0771377:SPLEEN [Tissue]
   827 E C1278932:Spleen [Body Part, Organ, or Organ Component]

Phrase: "similar to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C2348205:Similar [Qualitative Concept]

Phrase: "that previously"

Phrase: "described in hCGPML-RAR mice6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1552738:described [Idea or Concept]
   760   C3538821:RAR [Gene or Genome]

Phrase: "9"

Phrase: "(Figure 3A"

Phrase: "; Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.133: Furthermore, the analysis of spleens prior to the development of leukemia demonstrated increased numbers of Gr-1positive cells compared with wild-type mice. 

Phrase: "Furthermore,"

Phrase: "the analysis of spleens"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "prior to the development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "of leukemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023418:Leukaemia [Neoplastic Process]

Phrase: "demonstrated"

Phrase: "increased numbers of Gr-1positive cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0007584:Cell Number [Laboratory Procedure]
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "compared with wild-type mice."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   828   C1520150:Wild Type Mouse [Mammal]
   806   C1883559:Wild Type [Organism Attribute]
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]
   760   C1707455:Compared [Activity]
Processing 00000000.tx.134: A modest but statistically significant increase in Gr-1/CD34 coexpressing cells was also detected in the nonleukemic spleens (Figure 3C). 

Phrase: "A modest"

Phrase: "but"

Phrase: "statistically significant increase in Gr-1/CD34 coexpressing cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "also"

Phrase: "detected in the nonleukemic spleens"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0037993:Spleens [Body Part, Organ, or Organ Component]
   760   C0442726:Detected [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   726 E C0771377:SPLEEN [Tissue]
   726 E C1278932:Spleen [Body Part, Organ, or Organ Component]

Phrase: "(Figure 3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.135: Induction of myeloid differentiation following ATRA treatment To determine whether leukemia cells derived from the knock-in mice respond to ATRA treatment, we devised an assay to measure the induction of MMP9, a gene that is expressed at its highest levels during the late stages of myeloid development.23 RNA isolated from hCGPML-RAR or mCGPR/PR tumor spleens was reverse transcribed into DNA and subjected to quantitative real time PCR amplification. 

Phrase: "Induction of myeloid differentiation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205263:Induction [Functional Concept]
   770   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "ATRA treatment To"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]

Phrase: "determine"

Phrase: "whether"

Phrase: "leukemia cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   947   C1517806:Leukemic Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "derived from the knock-in mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1517676:Knock-in [Research Activity]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C1441547:Derived [Qualitative Concept]
   753   C3245521:derived [Idea or Concept]

Phrase: "respond to ATRA treatment,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0039798:treatment [Functional Concept]
   770   C0040845:ATRA [Organic Chemical,Pharmacologic Substance,Vitamin]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "we"

Phrase: "devised"

Phrase: "an assay to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C1510438:Assay [Laboratory Procedure]

Phrase: "measure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]

Phrase: "the induction of MMP9,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205263:Induction [Functional Concept]
   770   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "a gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "that"

Phrase: "is"

Phrase: "expressed at its highest levels"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
   760   C0441889:Levels [Qualitative Concept]
   760   C1522410:Highest [Qualitative Concept]
   726 E C0205250:High [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1299351:High [Qualitative Concept]
   726 E C1547707:Level [Geographic Area]
   726 E C2700149:HIGH [Intellectual Product]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "during the late stages"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1279941:late stages [Temporal Concept]
   861   C1306673:Stages [Qualitative Concept]
   827 E C0205390:Stage [Temporal Concept]
   827 E C1300072:Stage [Clinical Attribute]

Phrase: "of myeloid development.23 RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "isolated from hCGPML-RAR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0205409:Isolated [Functional Concept]
   770   C1548221:Isolated [Idea or Concept]
   770   C3538821:RAR [Gene or Genome]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "or"

Phrase: "mCGPR/PR tumor spleens"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   844   C0037999:tumour spleen [Neoplastic Process]
   812   C0037993:Spleens [Body Part, Organ, or Organ Component]
   779 E C0771377:SPLEEN [Tissue]
   779 E C1278932:Spleen [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "reverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: "transcribed into DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "subjected to quantitative real time PCR amplification."
Meta Candidates (Total=23; Excluded=0; Pruned=0; Remaining=23)
   882   C3179034:Quantitative Real-Time Polymerase Chain Reaction [Molecular Biology Research Technique]
   849   C1709846:Real-Time Polymerase Chain Reaction [Molecular Biology Research Technique]
   790   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   764   C1550177:Real Time [Idea or Concept]
   762   C0034746:Reaction Time [Temporal Concept]
   742   C0040223:Time [Temporal Concept]
   742   C0237400:Real [Qualitative Concept]
   742   C0337112:Chain [Manufactured Object]
   742   C0392762:Quantitative [Quantitative Concept]
   742   C0443286:Reaction [Functional Concept]
   742   C1114821:Reaction [Clinical Attribute]
   742   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C1517480:Amplification [Molecular Biology Research Technique]
   742   C1521871:Amplification [Phenomenon or Process]
   742   C1524075:Chain [Idea or Concept]
   742   C1705759:Amplification [Cell or Molecular Dysfunction]
   742   C3272377:REAL [Intellectual Product]
   742   C3541383:Time [Temporal Concept]
   708   C0681850:Subject [Group]
   708   C1550501:{Subject} [Idea or Concept]
   708   C1706203:Subject [Idea or Concept]
   708   C2349001:Subject [Human]
   708   C2697811:Subject [Functional Concept]
Processing 00000000.tx.136: We observed 1.5- to 12-fold increases in MMP9 mRNA abundance following treatment of tumor cells from either model with 1 M ATRA for 72 hours over treatment with vehicle alone, after normalization against GAPDH expression levels (Figure 3D). 

Phrase: "We"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "1.5-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0450316:1/5 [Quantitative Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "to 12-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "increases in MMP9 mRNA abundance"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0165519:MMP-9 [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0442805:Increase [Functional Concept]
   760   C1334523:MMP9 [Gene or Genome]
   760   C2346714:Abundance [Qualitative Concept]
   760   C2698028:MMP9 [Laboratory Procedure]
   704 E C1517378:Gain [Quantitative Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "treatment of tumor cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "from either model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "with 1 M ATRA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0040845:ATRA [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "for 72 hours over treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0039798:treatment [Functional Concept]
   812   C0087111:Treatment [Therapeutic or Preventive Procedure]
   812   C1522326:Treatment [Functional Concept]
   812   C1533734:Treatment [Therapeutic or Preventive Procedure]
   812   C1705169:Treatment [Conceptual Entity]
   812   C3538994:TREATMENT [Research Activity]

Phrase: "with vehicle"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0042444:Vehicle [Biomedical or Dental Material]
  1000   C0348005:Vehicle [Manufactured Object]
   928 E C0445373:Vehicular [Functional Concept]

Phrase: "alone,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "after"

Phrase: "normalization against GAPDH expression levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1882115:Normalization [Research Activity]

Phrase: "(Figure"

Phrase: "3D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450363:3D [Spatial Concept]
  1000   C2986797:3D [Functional Concept]

Phrase: ")."
Processing 00000000.tx.137: Increases in MMP9 mRNA levels correlated with an increase in the proportion of mature myeloid cells in the cultures over time (data not shown). 

Phrase: "Increases in MMP9 mRNA levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:increases [Functional Concept]

Phrase: "correlated with an increase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0442805:Increase [Functional Concept]
   770   C1707520:Correlated [Qualitative Concept]

Phrase: "in the proportion"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1709707:Proportion [Quantitative Concept]
   928 E C0205351:Proportional [Qualitative Concept]

Phrase: "of mature myeloid cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   901   C0887899:Myeloid Cells [Cell]
   867 E C0596993:Myeloid cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0439677:Myeloid [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "in the cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "over time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.138: ATRA sensitivity was similar in the transgenic and knock-in tumor cells. 

Phrase: "ATRA sensitivity"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0036667:Sensitivity [Quantitative Concept]
   861   C0312418:Sensitivity [Mental Process]
   861   C0427965:Sensitivity [Finding]
   861   C1511883:Sensitivity [Quantitative Concept]
   861   C1522640:Sensitivity [Qualitative Concept]
   861   C2346484:SENSITIVITY [Phenomenon or Process]
   861   C2349185:Sensitivity [Qualitative Concept]
   789 E C0332324:Sensitive [Functional Concept]
   789 E C1550474:sensitive [Idea or Concept]

Phrase: "was"

Phrase: "similar in the transgenic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "and"

Phrase: "knock-in tumor cells."
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   861   C0431085:Tumor cells [Cell]
   827 E C0597032:Tumor Cell [Cell]
   812   C0007634:Cells [Cell]
   812   C0027651:Tumor [Neoplastic Process]
   812   C1578706:Tumor [Intellectual Product]
   812   C3273930:Tumor [Finding]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.139: Spleen cells from one knock-in tumor did not exhibit an increase in MMP9 expression level or in myeloid differentiation over time. 

Phrase: "Spleen cells from one knock-in tumor"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   774   C0037999:spleen tumor [Neoplastic Process]
   774   C0431085:Tumor cells [Cell]
   757 E C0597032:Tumor Cell [Cell]
   748   C0007634:Cells [Cell]
   748   C0037993:Spleen [Body Part, Organ, or Organ Component]
   748   C0771377:SPLEEN [Tissue]
   748   C1278932:Spleen [Body Part, Organ, or Organ Component]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "an increase in MMP9 expression level"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "or in myeloid differentiation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0007589:Differentiation [Cell Function]
   770   C0439677:Myeloid [Qualitative Concept]
   770   C1511938:Differentiation [Clinical Attribute]
   770   C2945687:Differentiation [Functional Concept]

Phrase: "over time."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]
Processing 00000000.tx.140: A small decrease in leukemia latency with a 2-fold increase in PML-RAR gene dosage To determine the effect of gene dosage on leukemia development, heterozygous mCG+/PR animals (one PML-RAR copy) were bred together to generate offspring homozygous at the CG locus for the PML-RAR knock-in mutation (2 PML-RAR copies). 

Phrase: "A small decrease in leukemia latency"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392756:Decrease [Qualitative Concept]
   753   C0547047:Decrease [Quantitative Concept]

Phrase: "with a 2-fold increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0442805:Increase [Functional Concept]

Phrase: "in PML-RAR gene dosage To"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0178655:Gene Dosage [Quantitative Concept]
   799   C0178602:Dosage [Quantitative Concept]
   700   C1366903:Promyelocytic Leukemia Gene [Gene or Genome]

Phrase: "determine"

Phrase: "the effect of gene dosage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on leukemia development,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: "heterozygous mCG+/PR animals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   829   C2348877:g/animal [Quantitative Concept]
   795   C0003062:Animals [Animal]

Phrase: "(one PML-RAR copy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1948062:Copy [Manufactured Object]

Phrase: ")"

Phrase: "were"

Phrase: "bred"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0006159:breed [Organism Function]
   966   C1704650:Breed [Classification]

Phrase: "together to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883357:Together [Qualitative Concept]

Phrase: "generate"

Phrase: "offspring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680063:Offspring [Family Group]

Phrase: "homozygous at the CG locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0019904:Homozygous [Organism Attribute]

Phrase: "for the PML-RAR knock-in mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0026882:Mutation [Genetic Function]
   799   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(2 PML-RAR copies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1948062:Copies [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.141: Although the high lifetime probability of leukemia development was the same for heterozygous and homozygous animals, the median age at leukemia development was decreased by approximately 6 weeks among homozygous animals (Figure 2B). 

Phrase: "Although"

Phrase: "the high lifetime probability of leukemia development"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0033204:Probability [Quantitative Concept]

Phrase: "was"

Phrase: "the same for heterozygous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0445247:Same [Qualitative Concept]

Phrase: "and"

Phrase: "homozygous animals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]

Phrase: "the median age at leukemia development"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0001779:Age [Organism Attribute]
   748   C2733260:Developmental age [Organism Attribute]

Phrase: "was"

Phrase: "decreased by approximately 6 weeks"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0205216:Decreased [Quantitative Concept]
   760   C0332232:Approximately [Qualitative Concept]
   760   C0392756:Decreased [Qualitative Concept]
   760   C0439230:weeks [Temporal Concept]
   760   C0442797:decreased [Qualitative Concept]
   726 E C0332174:/week [Temporal Concept]
   726 E C0547047:Decrease [Quantitative Concept]

Phrase: "among homozygous animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]

Phrase: "(Figure 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.142: Flow cytometric analysis demonstrated no differences in expression of differentiation markers between PML-RAR heterozygous and homozygous tumors (Figure 3; Table 1). 

Phrase: "Flow cytometric analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "demonstrated"

Phrase: "no differences in expression of differentiation markers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1705241:*Difference [Quantitative Concept]
   714   C1705242:Difference [Qualitative Concept]

Phrase: "between PML-RAR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C3538821:RAR [Gene or Genome]
   734   C0023487:Promyelocytic Leukemia [Neoplastic Process]
   734   C1366903:promyelocytic leukemia [Gene or Genome]
   734   C2745900:Promyelocytic leukemia [Neoplastic Process]

Phrase: "heterozygous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019425:Heterozygous [Organism Attribute]

Phrase: "and"

Phrase: "homozygous tumors"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0027651:Tumors [Neoplastic Process]
   827 E C1578706:Tumor [Intellectual Product]
   827 E C3273930:Tumor [Finding]

Phrase: "(Figure 3"

Phrase: "; Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.143: Moreover, tumor inoculation into secondary recipients showed no difference in the ability of heterozygous versus homozygous tumors to transfer leukemia to wild-type recipients (data not shown). 

Phrase: "Moreover,"

Phrase: "tumor inoculation into secondary recipients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0042196:Inoculation [Therapeutic or Preventive Procedure]
   760   C2987620:Inoculation [Therapeutic or Preventive Procedure]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "no difference in the ability of heterozygous"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1705241:*Difference [Quantitative Concept]
   748   C1705242:Difference [Qualitative Concept]

Phrase: "versus"

Phrase: "homozygous tumors to"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0027651:Tumors [Neoplastic Process]
   793 E C1578706:Tumor [Intellectual Product]
   793 E C3273930:Tumor [Finding]

Phrase: "transfer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040671:Transfer [Mental Process]
  1000   C1705822:Transfer [Activity]

Phrase: "leukemia to wild-type recipients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0023418:leukemia type [Neoplastic Process]
           Leukaemia

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.144: Endogenous cathepsin G loss-of-function does not contribute to leukemia development Because the PML-RAR knock-in mutation results in disruption of one or both mCG loci, it was formally possible that the difference in leukemia incidence between the transgenic and knock-in models resulted from loss of cathepsin G function. 

Phrase: "Endogenous cathepsin G loss-of-function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   799   C0031843:function [Physiologic Function]
   799   C0542341:Function [Functional Concept]
   799   C0700205:FUNCTION [Classification]
   799   C1705273:Function [Intellectual Product]
   727 E C0205245:Functional [Functional Concept]
   727 E C2700217:Functional [Conceptual Entity]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "contribute to leukemia development"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0023418:Leukaemia [Neoplastic Process]
   770   C0243107:development [Physiologic Function]
   770   C0678723:Development [Organism Function]
   770   C1527148:Development [Functional Concept]
   770   C1880177:Contribute [Activity]

Phrase: "Because"

Phrase: "the PML-RAR knock-in mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0026882:Mutation [Genetic Function]
   799   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "results in disruption of one"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205447:One [Quantitative Concept]
   760   C0332453:Disruption [Functional Concept]
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2825142:Result [Finding]

Phrase: "or"

Phrase: "both mCG loci,"

Phrase: "it"

Phrase: "was"

Phrase: "formally possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332149:Possible [Qualitative Concept]
   861   C1705910:Possible [Qualitative Concept]
   861   C2362652:Possible [Qualitative Concept]

Phrase: "that"

Phrase: "the difference in leukemia incidence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1705241:*Difference [Quantitative Concept]
   760   C1705242:Difference [Qualitative Concept]

Phrase: "between the transgenic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003069:Transgenic [Animal]

Phrase: "and"

Phrase: "knock-in models"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C3161035:Models [Intellectual Product]
   734   C1517676:Knock-in [Research Activity]

Phrase: "resulted from loss of cathepsin G function."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C0054868:Cathepsin G [Amino Acid, Peptide, or Protein,Enzyme]
   778   C1413814:CATHEPSIN G [Gene or Genome]
   748   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0031843:function [Physiologic Function]
   748   C0439267:g% [Quantitative Concept]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1517945:Loss [Quantitative Concept]
   748   C1705273:Function [Intellectual Product]
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]
Processing 00000000.tx.145: We considered this possibility to be unlikely, because both CG+/ and CG/ mice lack a detectable hematopoietic phenotype,21 and because acute myelogenous leukemia (AML) has never been observed in any CG+/ or CG/ animal (C. Pham and T.J.L., unpublished observation, 2000). 

Phrase: "We"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "this possibility to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   789   C0332149:Possible [Qualitative Concept]
   789   C1705910:Possible [Qualitative Concept]
   789   C2362652:Possible [Qualitative Concept]

Phrase: "be"

Phrase: "unlikely,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750558:Unlikely [Conceptual Entity]
  1000   C1710571:Unlikely [Qualitative Concept]

Phrase: "because"

Phrase: "both CG+/"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C3540479:CG [Gene or Genome]

Phrase: "and"

Phrase: "CG/ mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "lack"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "a detectable hematopoietic phenotype,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031437:Phenotype [Organism Attribute]
   827   C1285572:Phenotype [Laboratory Procedure]

Phrase: "21"

Phrase: "and"

Phrase: "because"

Phrase: "acute myelogenous leukemia (AML)"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0023467:Acute myelogenous leukaemia [Neoplastic Process]
   913   C0085669:Acute leukaemia [Neoplastic Process]
   913   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   901   C0023470:Myelogenous Leukemia [Neoplastic Process]
   827   C0023418:Leukaemia [Neoplastic Process]
   827   C0205178:acute [Temporal Concept]
   827   C0439677:Myelogenous [Qualitative Concept]

Phrase: "has"

Phrase: "never"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2003901:Never [Temporal Concept]

Phrase: "been"

Phrase: "observed in any CG+/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1441672:Observed [Functional Concept]
   770   C3540479:CG [Gene or Genome]

Phrase: "or"

Phrase: "CG/ animal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animal [Animal]

Phrase: "(C. Pham"

Phrase: "and"

Phrase: "T.J.L., unpublished observation,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   804   C0302523:Observation [Research Activity]
   804   C0700325:observation [Health Care Activity]
   804   C1964257:Observation [Diagnostic Procedure]
   733 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.146: To formally test the effect of mCG loss-of-function in the setting of PML-RAR expression, we bred mCGPR/PR homozygous animals with CG+/ animals. 

Phrase: "To formally"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "the effect of mCG loss-of-function"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1280500:Effect [Qualitative Concept]
   739   C2348382:Effect [Qualitative Concept]

Phrase: "in the setting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0542559:setting [Functional Concept]
  1000   C1318139:{Setting} [Quantitative Concept]

Phrase: "of PML-RAR expression,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "we"

Phrase: "bred"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0006159:breed [Organism Function]
   966   C1704650:Breed [Classification]

Phrase: "mCGPR/PR homozygous animals with CG+/ animals."
Processing 00000000.tx.147: The offspring of these animals all carried a single PML-RAR cDNA inserted into one mCG allele and either a wild-type mCG gene or a null mutation at the other allele. 

Phrase: "The offspring of these animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0680063:Offspring [Family Group]

Phrase: "all"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "a single PML-RAR cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "inserted into one mCG allele"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   770   C0054868:Cathepsin G [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1413814:CATHEPSIN G [Gene or Genome]
   744   C0002085:Allele [Gene or Genome]
   744   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0026809:Murine [Mammal]
   744   C0205447:One [Quantitative Concept]
   744   C0439267:g% [Quantitative Concept]
   744   C0441587:Inserted [Health Care Activity]
   744   C0591833:Murine [Organic Chemical,Pharmacologic Substance]
   744   C1708726:Locus [Gene or Genome]
   711 E C1743766:Insert [Medical Device]
   711 E C1883719:Insert [Functional Concept]

Phrase: "and"

Phrase: "either"

Phrase: "a wild-type mCG gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   852   C1413814:Cathepsin G Gene [Gene or Genome]
   795   C0017337:Gene [Gene or Genome]

Phrase: "or"

Phrase: "a null mutation at the"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0026882:Mutation [Genetic Function]
   760   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "other allele."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.148: These mice were, therefore, either haploinsufficient or null for cathepsin G. 

Phrase: "These mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: ","

Phrase: "therefore,"

Phrase: "either haploinsufficient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C2936267:Haploinsufficiencies [Cell or Molecular Dysfunction]

Phrase: "or"

Phrase: "null for cathepsin G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0456148:Null [Quantitative Concept]
Processing 00000000.tx.149: The probability of leukemia development among these animals was identical, indicating that homozygous loss-of-function for cathepsin G played no detectable role in the development of leukemia in this system (Figure 2C). 

Phrase: "The probability of leukemia development"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033204:Probability [Quantitative Concept]

Phrase: "among these animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "was"

Phrase: "identical,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205280:Identical [Qualitative Concept]

Phrase: "indicating"

Phrase: "that homozygous loss-of-function for cathepsin G"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0031843:function [Physiologic Function]
   744   C0542341:Function [Functional Concept]
   744   C0700205:FUNCTION [Classification]
   744   C1705273:Function [Intellectual Product]

Phrase: "played"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0600138:played [Finding]
   966 E C0032214:Play [Daily or Recreational Activity]

Phrase: "no detectable role in the development of leukemia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "in this system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0449913:System [Functional Concept]
  1000   C1553451:System [Manufactured Object]
  1000   C1704459:System [Medical Device]
   928 E C0205373:Systemic [Functional Concept]

Phrase: "(Figure 2C"

Phrase: ")."
Processing 00000000.tx.150: Expression of PML-RAR mRNA in transgenic versus knock-in mice We designed a quantitative RT-PCR assay to determine the relative levels of PML-RAR mRNA expression in the knock-in model and the hCGPML-RAR transgenic model previously described. 

Phrase: "Expression of PML-RAR mRNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1515670:mRNA Expression [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in transgenic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003069:Transgenic [Animal]

Phrase: "versus"

Phrase: "knock-in mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1517676:Knock-in [Research Activity]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "We"

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "a quantitative RT-PCR assay to"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   835   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   793   C0005507:Assay [Laboratory Procedure]
   793   C0243073:assay [Qualitative Concept]
   793   C0337112:Chain [Manufactured Object]
   793   C0443286:Reaction [Functional Concept]
   793   C1114821:Reaction [Clinical Attribute]
   793   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   793   C1510438:Assay [Laboratory Procedure]
   793   C1524075:Chain [Idea or Concept]

Phrase: "determine"

Phrase: "the relative levels of PML-RAR mRNA expression"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   745   C3244092:expression level [Idea or Concept]
   742   C0441889:Levels [Qualitative Concept]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the knock-in model"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C3161035:Model [Intellectual Product]
   734   C1517676:Knock-in [Research Activity]

Phrase: "and"

Phrase: "the hCGPML-RAR transgenic model previously"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C1519606:Transgenic Model [Experimental Model of Disease]
   804   C3161035:Model [Intellectual Product]

Phrase: "described."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]
Processing 00000000.tx.151: Total RNA was harvested from the bone marrow of 3-month-old C57Bl/6 wild-type mice and from the nonleukemic bone marrow of 3-month-old knock-in and transgenic animals. 

Phrase: "Total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "harvested from the bone marrow"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   827   C0194015:Bone marrow harvest [Therapeutic or Preventive Procedure]
   806   C0005953:Bone Marrow [Tissue]
   770 E C1708973:Medullary Bone [Tissue]
   760   C0086590:Marrow [Food]
   760   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   760   C0376152:Marrow [Body Part, Organ, or Organ Component]
   760   C0391978:Bone [Tissue]
   760   C1266908:Bone [Body Part, Organ, or Organ Component]
   760   C1266909:Bone [Body System]
   760   C1546708:Marrow [Intellectual Product]
   726   C1512335:Harvest [Health Care Activity]
   704 E C0001629:Medullary [Body Part, Organ, or Organ Component]
   704 E C0025148:Medullary [Body Part, Organ, or Organ Component]
   704 E C1550278:Medullary [Body Part, Organ, or Organ Component]

Phrase: "of 3-month-old C57Bl/6 wild-type mice"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   850   C0025921:Mice, C57BL [Mammal]
   844   C1521751:C57BL/6 Mouse [Mammal]
   812   C1883559:Wild Type [Organism Attribute]
   801   C1520150:Wild Type Mouse [Mammal]
   793   C0025914:Mice [Mammal]
   793   C0025929:mice [Mammal]
   793   C0026809:Mice [Mammal]
   793   C0332307:Type [Qualitative Concept]
   793   C0445392:Wild [Intellectual Product]
   793   C1547052:*Type [Quantitative Concept]

Phrase: "and from the nonleukemic bone marrow"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   790   C0005953:Bone Marrow [Tissue]
   756 E C1708973:Medullary Bone [Tissue]
   753   C0086590:Marrow [Food]
   753   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   753   C0376152:Marrow [Body Part, Organ, or Organ Component]
   753   C0391978:Bone [Tissue]
   753   C1266908:Bone [Body Part, Organ, or Organ Component]
   753   C1266909:Bone [Body System]
   753   C1515981:And [Idea or Concept]
   753   C1546708:Marrow [Intellectual Product]

Phrase: "of 3-month-old knock-in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   840   C1517676:Knock-in [Research Activity]

Phrase: "and"

Phrase: "transgenic animals."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003069:Animals, Transgenic [Animal]
   861   C0003062:Animals [Animal]
Processing 00000000.tx.152: Additionally, RNA was harvested from cryopreserved splenic tumors arising from both APL models. 

Phrase: "Additionally,"

Phrase: "RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "harvested from cryopreserved splenic tumors"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0010405:Cryopreserved [Laboratory Procedure]
   760   C0027651:Tumors [Neoplastic Process]
   760   C0037993:Splenic [Body Part, Organ, or Organ Component]
   726   C1512335:Harvest [Health Care Activity]
   726 E C1578706:Tumor [Intellectual Product]
   726 E C3273930:Tumor [Finding]

Phrase: "arising from both APL models."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   814   C0023487:Acute Promyelocytic Leukemia [Neoplastic Process]
           Promyelocytic Leukemia
   778   C1366903:promyelocytic leukemia [Gene or Genome]
   778   C2745900:Promyelocytic leukemia [Neoplastic Process]
   774   C0085669:Acute leukaemia [Neoplastic Process]
   774   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   748   C0023418:Leukaemia [Neoplastic Process]
   748   C0205178:acute [Temporal Concept]
   748   C0332284:arising [Qualitative Concept]
   748   C3161035:Models [Intellectual Product]
Processing 00000000.tx.153: Primers and probes specific for the PML-RAR cDNA, mouse neutrophil elastase, and mouse GAPDH were designed to quantitate PML-RAR abundance with respect to whole cell mRNA abundance (GAPDH) and promyelocyte-specific mRNA abundance (neutrophil elastase). 

Phrase: "Primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "probes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0182400:Probe [Medical Device]
  1000   C1704681:Probe [Gene or Genome]
  1000   C2347609:Probe [Chemical Viewed Functionally]
  1000   C3536729:Probe [Manufactured Object]

Phrase: "specific for the PML-RAR cDNA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205369:Specific [Qualitative Concept]
   748   C1552740:specific [Intellectual Product]

Phrase: "mouse neutrophil elastase,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0064833:Neutrophil Elastase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1414369:ELASTASE, NEUTROPHIL [Gene or Genome]
   901   C1524102:Mouse Neutrophil [Cell]
   827   C0027950:Neutrophile [Cell]
   827   C0030306:Elastase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0699918:Elastase [Amino Acid, Peptide, or Protein,Enzyme]
   755 E C0746885:neutrophilic [Cell Function]
   727 E C0151683:Neutrophilia [Finding]

Phrase: "and"

Phrase: "mouse GAPDH"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   937   C1414968:GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE [Gene or Genome]
   937   C3536868:Glyceraldehyde-3-phosphate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   888   C2260086:dehydrogenase, glyceraldehyde phosphate [Molecular Function]
   884   C0017855:Glyceraldehyde 3-Phosphate [Biologically Active Substance,Carbohydrate]
           glyceraldehyde phosphate
   804   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   804   C0031701:phosphate [Organophosphorus Compound]
   804   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "quantitate"

Phrase: "PML-RAR abundance with respect to whole cell mRNA abundance"

Phrase: "(GAPDH"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C1414968:GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE [Gene or Genome]
  1000   C3536868:Glyceraldehyde-3-phosphate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0017855:Glyceraldehyde 3-Phosphate [Biologically Active Substance,Carbohydrate]
           glyceraldehyde phosphate
   923   C2260086:dehydrogenase, glyceraldehyde phosphate [Molecular Function]
   812   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031701:phosphate [Organophosphorus Compound]
   812   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "and"

Phrase: "promyelocyte-specific mRNA abundance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2346714:Abundance [Qualitative Concept]

Phrase: "(neutrophil elastase"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0064833:Neutrophil Elastase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1414369:ELASTASE, NEUTROPHIL [Gene or Genome]
   861   C0027950:Neutrophile [Cell]
   861   C0030306:Elastase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0699918:Elastase [Amino Acid, Peptide, or Protein,Enzyme]
   789 E C0746885:neutrophilic [Cell Function]
   761 E C0151683:Neutrophilia [Finding]

Phrase: ")."
Processing 00000000.tx.154: Neutrophil elastase (NE) is coordinately regulated with cathepsin G, both of which demonstrate maximal expression in the promyelocyte compartment.24,25 Normalizing PML-RAR mRNA abundance to NE mRNA abundance controls for variation in the number of early myeloid cells in each sample (ie, expression of PML-RAR will not be overestimated in samples with increased numbers of early myeloid cells). 

Phrase: "Neutrophil elastase (NE)"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0064833:Neutrophil Elastase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1414369:ELASTASE, NEUTROPHIL [Gene or Genome]
   861   C0027950:Neutrophile [Cell]
   861   C0030306:Elastase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0699918:Elastase [Amino Acid, Peptide, or Protein,Enzyme]
   789 E C0746885:neutrophilic [Cell Function]
   761 E C0151683:Neutrophilia [Finding]

Phrase: "is"

Phrase: "coordinately"

Phrase: "regulated with cathepsin G,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0054868:Cathepsin G [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1413814:CATHEPSIN G [Gene or Genome]
   770   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0439267:g% [Quantitative Concept]
   770   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "both of which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0238767:Both [Spatial Concept]
   790   C1706086:Both [Qualitative Concept]

Phrase: "demonstrate"

Phrase: "maximal expression in the promyelocyte compartment.24,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "25 Normalizing PML-RAR mRNA abundance to NE mRNA abundance"

Phrase: "controls for variation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0205419:Variation [Qualitative Concept]
   790   C0243148:control [Qualitative Concept]
   790   C1550141:Control [Substance]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]

Phrase: "in the number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237753:*Number [Quantitative Concept]
  1000   C0449788:Number [Quantitative Concept]

Phrase: "of early myeloid cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   901   C0887899:Myeloid Cells [Cell]
   867 E C0596993:Myeloid cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0439677:Myeloid [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "in each sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "("

Phrase: "ie"

Phrase: ","

Phrase: "expression of PML-RAR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "will"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "overestimated in samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0370003:Sample [Substance]
   756   C2347026:Sample [Conceptual Entity]

Phrase: "with increased numbers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0237753:*Number [Quantitative Concept]
   861   C0449788:Number [Quantitative Concept]

Phrase: "of early myeloid cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   901   C0887899:Myeloid Cells [Cell]
   867 E C0596993:Myeloid cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0439677:Myeloid [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.155: Levels of PML-RAR mRNA normalized to GAPDH mRNA yielded similar relative expression values in all samples tested (data not shown). 

Phrase: "Levels of PML-RAR mRNA"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "normalized to GAPDH mRNA"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   853   C1414968:GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE [Gene or Genome]
   853   C3536868:Glyceraldehyde-3-phosphate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   814   C0017855:Glyceraldehyde 3-Phosphate [Biologically Active Substance,Carbohydrate]
           glyceraldehyde phosphate
   804   C2260086:dehydrogenase, glyceraldehyde phosphate [Molecular Function]
   748   C0017854:Glyceraldehyde [Carbohydrate]
   748   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   748   C0031701:phosphate [Organophosphorus Compound]
   748   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   748   C1882115:Normalized [Research Activity]

Phrase: "yielded"

Phrase: "similar relative expression values in all samples"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   757   C0205345:Relative Value [Qualitative Concept]
   748   C0042295:Values [Qualitative Concept]
   714 E C1522609:Value [Quantitative Concept]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.156: Because the transgenic model contains approximately 50 concatamerized copies of the PML-RAR cDNA1 (versus only one copy in the knock-in model), the following steps were taken to avoid DNA contamination in the PCR reaction: (1) RNA samples were treated with DNAseI on a purification column; 

Phrase: "Because"

Phrase: "the transgenic model"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1519606:Transgenic Model [Experimental Model of Disease]
   861   C3161035:Model [Intellectual Product]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "approximately 50 concatamerized copies of the PML-RAR cDNA1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1948062:Copies [Manufactured Object]

Phrase: "("

Phrase: "versus"

Phrase: "only one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205447:One [Quantitative Concept]

Phrase: "copy in the knock-in model"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1517676:Knock-in [Research Activity]
   753   C1948062:Copy [Manufactured Object]
   753   C3161035:Model [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "the following steps"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C1261552:steps [Conceptual Entity]
   827 E C1704379:Step [Functional Concept]
   827 E C1705117:Step [Quantitative Concept]
   827 E C2825408:Step [Manufactured Object]

Phrase: "were"

Phrase: "taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "avoid"

Phrase: "DNA contamination in the PCR reaction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C2936628:DNA Contamination [Human-caused Phenomenon or Process]
   744   C0259846:contamination [Human-caused Phenomenon or Process]
   744   C1881659:CONTAMINATION [Event]
   744   C2349974:Contamination [Idea or Concept]

Phrase: ":"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "RNA samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "treated with DNAseI"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "on a purification column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1185738:Column [Body Part, Organ, or Organ Component]
   861   C1706132:Column [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.157: (2) samples were then digested with HaeIII, which cleaves the PML-RAR cDNA within the 200base pair PCR amplicon; 

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "digested with HaeIII,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0868946:digested [Physiologic Function]

Phrase: "which"

Phrase: "cleaves"

Phrase: "the PML-RAR cDNA within the 200base pair PCR amplicon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   735   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ";"
Processing 00000000.tx.158: and (3) lack of contamination was verified by requiring at least a 5-cycle difference in CT between reactions with and without reverse transcriptase. 

Phrase: "and ("

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "lack of contamination"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0259846:contamination [Human-caused Phenomenon or Process]
   790   C0332268:lack [Qualitative Concept]
   790   C1881659:CONTAMINATION [Event]
   790   C2349974:Contamination [Idea or Concept]

Phrase: "was"

Phrase: "verified by requiring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1711411:Verified [Functional Concept]

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "a 5-cycle difference in CT"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1705241:*Difference [Quantitative Concept]
   753   C1705242:Difference [Qualitative Concept]

Phrase: "between reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0443286:Reaction [Functional Concept]
   966   C1114821:Reaction [Clinical Attribute]

Phrase: "with"

Phrase: "and without reverse transcriptase."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0035379:Reverse Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0040646:Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1515981:And [Idea or Concept]
   770   C1555029:Reverse [Idea or Concept]
   770   C2257077:transcriptase [Genetic Function]
Processing 00000000.tx.159: Bone marrow cells derived from mice with the retained PGK-neo cassette lacked PML-RAR expression that was detectable above the background levels observed in wild-type littermates (Figure 4, inset). 

Phrase: "Bone marrow cells"
Meta Candidates (Total=21; Excluded=9; Pruned=0; Remaining=12)
  1000   C0005955:Bone Marrow Cells [Cell]
   913   C0222677:Bone cells [Cell]
   901   C0005953:Bone Marrow [Tissue]
   896 E C0029432:Bone cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0086590:Marrow [Food]
   827   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   827   C0376152:Marrow [Body Part, Organ, or Organ Component]
   827   C0391978:Bone [Tissue]
   827   C1266908:Bone [Body Part, Organ, or Organ Component]
   827   C1266909:Bone [Body System]
   827   C1546708:Marrow [Intellectual Product]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   771 E C0001629:Medullary [Body Part, Organ, or Organ Component]
   771 E C0025148:Medullary [Body Part, Organ, or Organ Component]
   771 E C1550278:Medullary [Body Part, Organ, or Organ Component]
   755 E C0443157:Bony [Functional Concept]
   743 E C0330477:Marrows [Plant]

Phrase: "derived from mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]
   790   C1441547:Derived [Qualitative Concept]
   790   C3245521:derived [Idea or Concept]

Phrase: "with the retained PGK-neo cassette lacked PML-RAR expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "that"

Phrase: "was"

Phrase: "detectable above the background levels"

Phrase: "observed in wild-type littermates"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1441672:Observed [Functional Concept]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "(Figure 4,"

Phrase: "inset"

Phrase: ")."
Processing 00000000.tx.160: Removal of the PGK-neo cassette, however, led to consistently detectable PML-RAR expression (Figure 4). 

Phrase: "Removal of the PGK-neo cassette,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0015252:Removal [Therapeutic or Preventive Procedure]
   753   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "however,"

Phrase: "led"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C1708698:LED [Manufactured Object]
   966 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   966 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   966 E C1522538:Lead [Functional Concept]
   966 E C2348269:Lead [Element, Ion, or Isotope]
   966 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "to consistently detectable PML-RAR expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(Figure 4"

Phrase: ")."
Processing 00000000.tx.161: Surprisingly, PML-RAR mRNA levels from preleukemic knock-in bone marrow cells were significantly lower than those of similar hCGPML-RAR transgenic mice (48  5.8-fold, P < .005). 

Phrase: "Surprisingly,"

Phrase: "PML-RAR mRNA levels from preleukemic knock-in bone marrow cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   736   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   736   C0441889:Levels [Qualitative Concept]
   703 E C0456079:Level [Classification]
   703 E C1547707:Level [Geographic Area]
   703 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "significantly lower than those of similar hCGPML-RAR transgenic mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0441994:Lower [Spatial Concept]
   739   C1548802:Lower [Body Location or Region]
   739   C2003888:Lower [Activity]

Phrase: "(48  5.8-fold,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332462:Fold [Spatial Concept]
   812   C1880834:FOLD [Phenomenon or Process]

Phrase: "P < .005"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.162: These data were highly reproducible and represent the average expression for 3 mice of each genotype assayed in duplicate in 3 separate experiments. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "highly reproducible"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C1514863:Reproducibility [Qualitative Concept]

Phrase: "and"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the average expression for 3 mice of each genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "assayed in duplicate"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0205173:Duplicate [Functional Concept]
   790   C3539942:Duplicate [Intellectual Product]
   756   C0005507:Assay [Laboratory Procedure]
   756   C0243073:assay [Qualitative Concept]
   756   C1510438:Assay [Laboratory Procedure]

Phrase: "in 3 separate experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.163: This expression relationship was also true for independent tumors that arose in both models (Figure 4). 

Phrase: "This expression relationship"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439849:Relationship [Qualitative Concept]
   861   C1705630:Relationship [Idea or Concept]
   861   C1706279:Relationship [Idea or Concept]
   861   C3540605:Relationship [Intellectual Product]

Phrase: "was"

Phrase: "also true for independent tumors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205238:True [Qualitative Concept]

Phrase: "that"

Phrase: "arose in both models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C3161035:Models [Intellectual Product]

Phrase: "(Figure 4"

Phrase: ")."
Processing 00000000.tx.164: In these samples, in which the cells were nearly all leukemic, the levels of PML-RAR mRNA were again much higher in the tumors derived from the transgenic mice. 

Phrase: "In these samples,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "in which"

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "nearly"

Phrase: "all leukemic,"

Phrase: "the levels of PML-RAR mRNA"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "again much higher in the tumors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0205250:High [Qualitative Concept]
   719   C1299351:High [Qualitative Concept]
   719   C2700149:HIGH [Intellectual Product]

Phrase: "derived from the transgenic mice."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0025936:Mice, Transgenic [Mammal]
   760   C0003069:Transgenic [Animal]
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C1441547:Derived [Qualitative Concept]
   760   C3245521:derived [Idea or Concept]
Processing 00000000.tx.165: These data represent average data from 3 tumors in each model, assayed in duplicate in 2 separate experiments. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "average data from 3 tumors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1511726:Data [Idea or Concept]
   760   C3245479:data [Medical Device]

Phrase: "in each model,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "assayed in duplicate"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0205173:Duplicate [Functional Concept]
   790   C3539942:Duplicate [Intellectual Product]
   756   C0005507:Assay [Laboratory Procedure]
   756   C0243073:assay [Qualitative Concept]
   756   C1510438:Assay [Laboratory Procedure]

Phrase: "in 2 separate experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.166: View larger version (19K): [in this window] [in a new window]  Figure 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(19K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 4."
Processing 00000000.tx.167: Expression of PML-RAR mRNA in nonleukemic and leukemic spleen cells. 

Phrase: "Expression of PML-RAR mRNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1515670:mRNA Expression [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in nonleukemic"

Phrase: "and"

Phrase: "leukemic spleen cells."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   896   C1517806:Leukemic Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0037993:Spleen [Body Part, Organ, or Organ Component]
   827   C0771377:SPLEEN [Tissue]
   827   C1278932:Spleen [Body Part, Organ, or Organ Component]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.168: Real time quantitative PCR was performed on the bone marrow RNA derived from 3 nonleukemic animals of each genotype at 3 to 6 months of age and on 3 independent splenic tumors each from leukemic mCG+/PR (PGK-neo) or transgenic hCGPML-RAR animals. 

Phrase: "Real time quantitative PCR"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   929   C1709846:Real-Time Polymerase Chain Reaction [Molecular Biology Research Technique]
   876   C0034746:time reaction [Temporal Concept]
   861   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   827   C1550177:Real Time [Idea or Concept]
   799   C0040223:Time [Temporal Concept]
   799   C0237400:Real [Qualitative Concept]
   799   C0337112:Chain [Manufactured Object]
   799   C0392762:Quantitative [Quantitative Concept]
   799   C0443286:Reaction [Functional Concept]
   799   C1114821:Reaction [Clinical Attribute]
   799   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C1524075:Chain [Idea or Concept]
   799   C3272377:REAL [Intellectual Product]
   799   C3541383:Time [Temporal Concept]
   743 E C0442043:Temporal [Spatial Concept]
   743 E C2362314:Temporal [Temporal Concept]
   716 E C1632851:Times [Quantitative Concept]

Phrase: "was"

Phrase: "performed on the bone marrow RNA"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   790   C0005953:Bone Marrow [Tissue]
   756 E C1708973:Medullary Bone [Tissue]
   753   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0086590:Marrow [Food]
   753   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   753   C0376152:Marrow [Body Part, Organ, or Organ Component]
   753   C0391978:Bone [Tissue]
   753   C0884358:Performed [Functional Concept]
   753   C1266908:Bone [Body Part, Organ, or Organ Component]
   753   C1266909:Bone [Body System]
   753   C1546708:Marrow [Intellectual Product]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "derived from 3 nonleukemic animals of each genotype"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0003062:Animals [Animal]
   744   C0017431:Genotype [Organism Attribute]
   744   C1441547:Derived [Qualitative Concept]
   744   C3245521:derived [Idea or Concept]

Phrase: "at 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "to 6 months"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]

Phrase: "of age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "and on 3 independent splenic tumors"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0027651:Tumors [Neoplastic Process]
   753   C0037993:Splenic [Body Part, Organ, or Organ Component]
   753   C0085862:Independent [Idea or Concept]
   753   C1299583:Independent [Finding]
   753   C1515981:And [Idea or Concept]
   719 E C1578706:Tumor [Intellectual Product]
   719 E C3273930:Tumor [Finding]

Phrase: "each from leukemic mCG+/PR (PGK-"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   764   C0054868:Cathepsin G [Amino Acid, Peptide, or Protein,Enzyme]
   764   C1413814:CATHEPSIN G [Gene or Genome]
   742   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0026809:Murine [Mammal]
   742   C0279759:PR+ [Laboratory or Test Result]
   742   C0279766:PR- [Laboratory or Test Result]
   742   C0439267:g% [Quantitative Concept]
   742   C0591833:Murine [Organic Chemical,Pharmacologic Substance]
   742   C1150521:PGK [Molecular Function]
   742   C1418864:PR@ [Gene or Genome]
   742   C1418929:PGK [Gene or Genome]
   742   C1457900:Each [Quantitative Concept]
   742   C1708726:Locus [Gene or Genome]
   742   C3538934:PR [Intellectual Product]
   742   C3538935:PR [Idea or Concept]

Phrase: "neo)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1366752:NEO [Gene or Genome]

Phrase: "or"

Phrase: "transgenic hCGPML-RAR animals."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   902   C0003069:Animals, Transgenic [Animal]
   812   C0003062:Animals [Animal]
Processing 00000000.tx.169: Each sample was analyzed in duplicate at least twice. 

Phrase: "Each sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "was"

Phrase: "analyzed in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0936012:Analyzed [Research Activity]

Phrase: "duplicate at least twice."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205173:Duplicate [Functional Concept]
   770   C1720725:Twice [Intellectual Product]
   770   C1948050:Twice [Quantitative Concept]
   770   C3539942:Duplicate [Intellectual Product]
Processing 00000000.tx.170: Levels of human PML-RAR mRNA were normalized to levels of endogenous mouse neutrophil elastase mRNA to control for the contribution of early myeloid cells, which express abundant neutrophil elastase mRNA, in each sample. 

Phrase: "Levels of human PML-RAR mRNA"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "normalized to levels of endogenous mouse neutrophil elastase mRNA to"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   760   C0064833:Neutrophil Elastase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1414369:ELASTASE, NEUTROPHIL [Gene or Genome]
   760   C1524102:Mouse Neutrophil [Cell]
   739   C0025914:Mouse [Mammal]
   739   C0025929:mouse [Mammal]
   739   C0026809:Mouse [Mammal]
   739   C0027950:Neutrophile [Cell]
   739   C0030306:Elastase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0205227:Endogenous [Functional Concept]
   739   C0441889:Levels [Qualitative Concept]
   739   C0699918:Elastase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C1882115:Normalized [Research Activity]
   706 E C0456079:Level [Classification]
   706 E C1547707:Level [Geographic Area]
   706 E C2946261:Level [Pharmacologic Substance]

Phrase: "control for the contribution of early myeloid cells,"
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
   770   C0887899:Myeloid Cells [Cell]
   744   C0007634:Cells [Cell]
   744   C0243148:control [Qualitative Concept]
   744   C0439677:Myeloid [Qualitative Concept]
   744   C1279919:Early [Temporal Concept]
   744   C1550141:Control [Substance]
   744   C1880177:Contribution [Activity]
   744   C1882979:Control [Conceptual Entity]
   744   C2587213:Control [Functional Concept]
   744   C3274648:Control [Qualitative Concept]
   744   C3282337:Cells [Cell]
   737 E C0596993:Myeloid cell [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "which"

Phrase: "express"

Phrase: "abundant neutrophil elastase mRNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "in each sample."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.171: All of the normalized data were pooled and averaged; 

Phrase: "All of the normalized data"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0444868:All [Quantitative Concept]
   760   C1511726:Data [Idea or Concept]
   760   C1882115:Normalized [Research Activity]
   760   C3245479:data [Medical Device]
   760   C3539085:All [Idea or Concept]

Phrase: "were"

Phrase: "pooled"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1709595:Pooled [Conceptual Entity]
  1000   C2349200:Pooled [Functional Concept]
   966 E C0337051:Pool [Geographic Area]
   966 E C1509144:pool [Clinical Attribute]

Phrase: "and"

Phrase: "averaged"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1510992:Average [Quantitative Concept]
   966   C2825518:AVERAGE [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.172: means and standard errors of the mean are shown. 

Phrase: "means"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704970:Means [Conceptual Entity]
   966 E C0444504:Mean [Quantitative Concept]
   966 E C2347634:Mean [Quantitative Concept]
   966 E C2348143:Mean [Quantitative Concept]

Phrase: "and"

Phrase: "standard errors of the mean"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   991   C1710181:Standard Error of the Mean [Quantitative Concept]
           Standard Error
   760   C0743559:errors [Qualitative Concept]
   760   C1442989:Standard [Qualitative Concept]
   760   C2828392:Standard [Intellectual Product]
   726 E C1608199:Error [Functional Concept]

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.173: Statistical significance was determined by a 2-tailed Student t test. 

Phrase: "Statistical significance"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0237881:Statistical Significance [Quantitative Concept]
           Significance
  1000   C1709380:Statistical Significance [Quantitative Concept]
   861   C0038215:Statistical [Occupation or Discipline]
   861   C0750502:Significance [Idea or Concept]
   789 E C1546944:Significant [Qualitative Concept]

Phrase: "was"

Phrase: "determined by a 2-tailed Student t test."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0022885:Test [Laboratory Procedure]
   744   C0038492:student [Professional or Occupational Group]
   744   C0039259:tailed [Body Part, Organ, or Organ Component]
   744   C0039593:Test [Functional Concept]
   744   C0392366:test [Intellectual Product]
   744   C1551041:student [Idea or Concept]
   744   C1552573:student [Intellectual Product]
Processing 00000000.tx.174: Inset: enlarged view of PML-RAR expression in the nonleukemic bone marrow RNAs of C57Bl/6 wild-type, mCG+/PR (+PGK-neo), and mCG+/PR (PGK-neo) animals. 

Phrase: "Inset"

Phrase: ":"

Phrase: "enlarged view of PML-RAR expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449911:View [Spatial Concept]

Phrase: "in the nonleukemic bone marrow RNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0035668:rnas [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "of C57Bl/6 wild-type, mCG+/PR (+PGK-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1150521:PGK [Molecular Function]
   790   C1418929:PGK [Gene or Genome]

Phrase: "neo),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1366752:NEO [Gene or Genome]

Phrase: "and"

Phrase: "mCG+/PR (PGK-neo) animals."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   847   C2348877:g/animal [Quantitative Concept]
   793   C0003062:Animals [Animal]
Processing 00000000.tx.175: *P < .005 versus mCG+/PR (PGK-neo). 

Phrase: "*P < .005"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "versus"

Phrase: "mCG+/PR (PGK-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1150521:PGK [Molecular Function]
   799   C1418929:PGK [Gene or Genome]

Phrase: "neo)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1366752:NEO [Gene or Genome]
Processing 00000000.tx.176: #P < .005 versus mCG+/PR (+PKG-neo).  

Phrase: "#P < .005"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "versus"

Phrase: "mCG+/PR (+PKG-"

Phrase: "neo)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1366752:NEO [Gene or Genome]
Processing 00000000.tx.177: Undetectable expression of PML-RAR protein in transgenic and knock-in APL cells Total cellular protein was extracted from wild-type C57Bl/6 bone marrow cells, 3-month-old nonleukemic transgenic, and knock-in bone marrow cells and from several independent tumors arising in each mouse model. 

Phrase: "Undetectable expression of PML-RAR protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1171362:expression protein [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in transgenic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003069:Transgenic [Animal]

Phrase: "and"

Phrase: "knock-in APL cells Total cellular protein"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   858   C0146495:Promyelocytic Leukemia Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   858   C3476424:Promyelocytic leukemia protein [Amino Acid, Peptide, or Protein]
   817   C0555903:Total protein [Laboratory Procedure]
   817   C1261360:total protein [Laboratory or Test Result]
   807   C1441375:Cells.total [Cell]
   791   C0007634:Cellular [Cell]
   791   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   791   C0178539:Cellular [Functional Concept]
   791   C0439175:% total [Quantitative Concept]
   791   C0439810:Total [Qualitative Concept]
   720 E C1516377:Cellularity [Qualitative Concept]

Phrase: "was"

Phrase: "extracted from wild-type C57Bl/6 bone marrow cells,"
Meta Candidates (Total=31; Excluded=7; Pruned=0; Remaining=24)
   790   C0005955:Bone Marrow Cells [Cell]
   784   C1283695:type bone marrow [Tissue]
   764   C0005953:Bone Marrow [Tissue]
   764   C1521751:C57BL/6 [Mammal]
   764   C1883559:Wild Type [Organism Attribute]
   762   C0222677:Bone cells [Cell]
   762   C0449475:cells type [Intellectual Product]
   762   C1283557:bone type [Body Part, Organ, or Organ Component]
   762   C1960442:Type 6 [Intellectual Product]
   745 E C0007634:Cell Type [Cell]
           Cells
   745 E C0029432:Bone cell [Cell]
   742   C0025921:C57BL [Mammal]
   742   C0086590:Marrow [Food]
   742   C0185115:Extracted [Therapeutic or Preventive Procedure]
   742   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   742   C0332307:Type [Qualitative Concept]
   742   C0376152:Marrow [Body Part, Organ, or Organ Component]
   742   C0391978:Bone [Tissue]
   742   C0445392:Wild [Intellectual Product]
   742   C1266908:Bone [Body Part, Organ, or Organ Component]
   742   C1266909:Bone [Body System]
   742   C1546708:Marrow [Intellectual Product]
   742   C1547052:*Type [Quantitative Concept]
   742   C3282337:Cells [Cell]
   742   C3541890:EXTRACTED [Finding]
   734 E C1708973:Medullary Bone [Tissue]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]
   708 E C2828366:Extract [Substance]

Phrase: "3-month-old nonleukemic transgenic,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0003069:Transgenic [Animal]

Phrase: "and"

Phrase: "knock-in bone marrow cells"
Meta Candidates (Total=21; Excluded=9; Pruned=0; Remaining=12)
   884   C0005955:Bone Marrow Cells [Cell]
   853   C0222677:Bone cells [Cell]
   840   C0005953:Bone Marrow [Tissue]
   836 E C0029432:Bone cell [Cell]
   804   C0007634:Cells [Cell]
   804   C0086590:Marrow [Food]
   804   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   804   C0376152:Marrow [Body Part, Organ, or Organ Component]
   804   C0391978:Bone [Tissue]
   804   C1266908:Bone [Body Part, Organ, or Organ Component]
   804   C1266909:Bone [Body System]
   804   C1546708:Marrow [Intellectual Product]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   748 E C0001629:Medullary [Body Part, Organ, or Organ Component]
   748 E C0025148:Medullary [Body Part, Organ, or Organ Component]
   748 E C1550278:Medullary [Body Part, Organ, or Organ Component]
   733 E C0443157:Bony [Functional Concept]
   721 E C0330477:Marrows [Plant]

Phrase: "and from several independent tumors"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0027651:Tumors [Neoplastic Process]
   760   C0085862:Independent [Idea or Concept]
   760   C1299583:Independent [Finding]
   760   C1515981:And [Idea or Concept]
   726 E C1578706:Tumor [Intellectual Product]
   726 E C3273930:Tumor [Finding]

Phrase: "arising in each mouse model."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0332284:Arising in [Qualitative Concept]
           arising
   806   C2986594:Mouse Model [Experimental Model of Disease]
   760   C0025914:Mouse [Mammal]
   760   C0025929:mouse [Mammal]
   760   C0026809:Mouse [Mammal]
   760   C3161035:Model [Intellectual Product]
Processing 00000000.tx.178: Western blotting was performed using several different antibodies directed against RAR or PML. 

Phrase: "Western blotting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "several different antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "directed against RAR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C3538821:RAR [Gene or Genome]
   756   C0439851:Direct [Qualitative Concept]
   756   C1947931:Direct [Qualitative Concept]

Phrase: "or"

Phrase: "PML."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0023487:Promyelocytic Leukemia [Neoplastic Process]
  1000   C1366903:promyelocytic leukemia [Gene or Genome]
  1000   C2745900:Promyelocytic leukemia [Neoplastic Process]
   861   C0023418:Leukaemia [Neoplastic Process]
Processing 00000000.tx.179: In Figure 5, lane 3 represents U937 cells transiently expressing the human bcr-1 PML-RAR cDNA that was used to create the knock-in and transgenic mouse models. 

Phrase: "In Figure 5,"

Phrase: "lane 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "U937 cells transiently"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0600531:U937 Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "the human bcr-1 PML-RAR cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "that"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "create"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1706214:Create [Activity]
  1000   C3244320:create [Functional Concept]

Phrase: "the knock-in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517676:Knock-in [Research Activity]

Phrase: "and"

Phrase: "transgenic mouse models."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   896   C1519606:Transgenic Model [Experimental Model of Disease]
   884   C2986594:Mouse Model [Experimental Model of Disease]
   827   C3161035:Models [Intellectual Product]
   734   C0025936:Mouse, Transgenic [Mammal]
Processing 00000000.tx.180: Full-length PML-RAR protein is detected at approximately 120 kDa. 

Phrase: "Full-length PML-RAR protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   867   C0146495:Promyelocytic Leukemia Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   867   C3476424:Promyelocytic leukemia protein [Amino Acid, Peptide, or Protein]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "detected at approximately 120 kDa."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0332232:Approximately [Qualitative Concept]
   760   C0442726:Detected [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C1532717:kDa [Quantitative Concept]
Processing 00000000.tx.181: Despite using highly sensitive chemiluminescence reagents and long exposure times, full-length PML-RAR protein was not detected in nonleukemic bone marrow cells from either model (data not shown). 

Phrase: "Despite"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "highly sensitive chemiluminescence reagents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "long exposure times,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   867   C2348485:Exposure Time [Quantitative Concept]
   827   C0040223:times [Temporal Concept]
   827   C0274281:Exposure, NOS [Injury or Poisoning]
   827   C0332157:Exposure [Clinical Attribute]
   827   C1632851:Times [Quantitative Concept]
   793 E C3541383:Time [Temporal Concept]
   755 E C0442043:Temporal [Spatial Concept]
   755 E C2362314:Temporal [Temporal Concept]

Phrase: "full-length PML-RAR protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   867   C0146495:Promyelocytic Leukemia Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   867   C3476424:Promyelocytic leukemia protein [Amino Acid, Peptide, or Protein]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detected in nonleukemic bone marrow cells"
Meta Candidates (Total=19; Excluded=5; Pruned=0; Remaining=14)
   833   C0005955:Bone Marrow Cells [Cell]
   790   C0005953:Bone Marrow [Tissue]
   783   C0222677:Bone cells [Cell]
   767 E C0029432:Bone cell [Cell]
   756 E C1708973:Medullary Bone [Tissue]
   753   C0007634:Cells [Cell]
   753   C0086590:Marrow [Food]
   753   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   753   C0376152:Marrow [Body Part, Organ, or Organ Component]
   753   C0391978:Bone [Tissue]
   753   C0442726:Detected [Finding]
   753   C1266908:Bone [Body Part, Organ, or Organ Component]
   753   C1266909:Bone [Body System]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C1546708:Marrow [Intellectual Product]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "from either model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.182: Furthermore, in the tumor cells, which represent a more homogeneous cell population, endogenous mouse RAR protein was detectable at approximately 55 kDa, but, again, full-length PML-RAR was undetectable (Figure 5, lanes 5-9). 

Phrase: "Furthermore,"

Phrase: "in the tumor cells,"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
  1000   C0431085:Tumor cells [Cell]
   966 E C0597032:Tumor Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0027651:Tumor [Neoplastic Process]
   861   C1578706:Tumor [Intellectual Product]
   861   C3273930:Tumor [Finding]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "which"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a more homogeneous cell population,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0032659:Population [Quantitative Concept]
   812   C1257890:Population [Population Group]

Phrase: "endogenous mouse RAR protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   875   C1334805:Mouse Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "detectable at approximately 55 kDa,"

Phrase: "but"

Phrase: ","

Phrase: "again,"

Phrase: "full-length PML-RAR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C3538821:RAR [Gene or Genome]

Phrase: "was"

Phrase: "undetectable"

Phrase: "(Figure 5,"

Phrase: "lanes 5-9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.183: Similarly, if anti-PML blots were highly overexposed, endogenous mouse PML was visible at approximately 70 kDa, but full-length PML-RAR remained below the limit of detection (data not shown). 

Phrase: "Similarly,"

Phrase: "if"

Phrase: "anti-PML blots"

Phrase: "were"

Phrase: "highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:Highly [Qualitative Concept]

Phrase: "overexposed"

Phrase: ","

Phrase: "endogenous mouse PML"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   875   C0596978:Mouse Leukemia [Neoplastic Process]
   861   C0023487:Promyelocytic Leukemia [Neoplastic Process]
   861   C1366903:promyelocytic leukemia [Gene or Genome]
   861   C2745900:Promyelocytic leukemia [Neoplastic Process]
   812   C0023418:Leukaemia [Neoplastic Process]

Phrase: "was"

Phrase: "visible at approximately 70 kDa,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205379:Visible [Qualitative Concept]

Phrase: "but"

Phrase: "full-length PML-RAR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C3538821:RAR [Gene or Genome]

Phrase: "remained below the limit of detection"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C2718050:Limit of Detection [Quantitative Concept]
           Detection Limit
   753   C0439801:limit [Functional Concept]
   753   C1511790:Detection [Therapeutic or Preventive Procedure]
   753   C1549649:Limit [Idea or Concept]
   753   C2349209:Limit [Conceptual Entity]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.184: These sensitive Western blots were repeated with a second rabbit polyclonal antibody to PML and with 2 different monoclonal antibodies against mouse PML. 

Phrase: "These sensitive Western blots"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0949466:Western Blots [Laboratory Procedure]
   867 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   827   C1705493:Western [Spatial Concept]

Phrase: "were"

Phrase: "repeated with a second rabbit polyclonal antibody"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   778   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   774   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0034493:Rabbit [Mammal]
   748   C0205341:Repeated [Functional Concept]
   748   C0205436:Second [Quantitative Concept]
   748   C0457385:Second [Temporal Concept]
   748   C0565930:/second [Quantitative Concept]
   748   C1561503:second [Idea or Concept]
   748   C1705190:Second [Qualitative Concept]
   714 E C1547730:Repeat [Temporal Concept]
   714 E C1705914:Repeat [Conceptual Entity]

Phrase: "to PML"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0023487:Promyelocytic Leukemia [Neoplastic Process]
  1000   C1366903:promyelocytic leukemia [Gene or Genome]
  1000   C2745900:Promyelocytic leukemia [Neoplastic Process]
   861   C0023418:Leukaemia [Neoplastic Process]

Phrase: "and with 2 different monoclonal antibodies"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0746619:monoclonal [Finding]
   753   C1515981:And [Idea or Concept]
   753   C1705242:Different [Qualitative Concept]
   719 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "against mouse PML."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0596978:Mouse Leukemia [Neoplastic Process]
   901   C0023487:Promyelocytic Leukemia [Neoplastic Process]
   901   C1366903:promyelocytic leukemia [Gene or Genome]
   901   C2745900:Promyelocytic leukemia [Neoplastic Process]
   827   C0023418:Leukaemia [Neoplastic Process]
Processing 00000000.tx.185: In no case was full-length PML-RAR detectable nor was it detectable in several other tumors from each mouse model (data not shown). 

Phrase: "In no case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "was"

Phrase: "full-length PML-RAR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C3538821:RAR [Gene or Genome]

Phrase: "detectable"

Phrase: "nor"

Phrase: "was"

Phrase: "it detectable in several"

Phrase: "other tumors from each mouse model"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   767   C1710493:Tumor Model [Intellectual Product]
   753   C0027651:Tumors [Neoplastic Process]
   719 E C1578706:Tumor [Intellectual Product]
   719 E C3273930:Tumor [Finding]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.186: Further, lysis by boiling in loading buffer containing 2% SDS did not change these results (data not shown). 

Phrase: "Further,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "lysis by boiling"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0024348:Lysis [Pathologic Function]
   790   C1536403:lysis [Cell Function]
   718 E C0439680:Lytic [Qualitative Concept]

Phrase: "in loading buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "2% SDS"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.187: Together, these data indicate that the abundance of PML-RAR protein is less than that of endogenous PML and RAR in both nonleukemic marrow and splenic tumors derived from both mouse models. 

Phrase: "Together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "that"

Phrase: "the abundance of PML-RAR protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2346714:Abundance [Qualitative Concept]

Phrase: "is"

Phrase: "less than that of endogenous PML"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0023487:Promyelocytic Leukemia [Neoplastic Process]
   778   C0439092:Less Than [Intellectual Product]
           less
   778   C1366903:promyelocytic leukemia [Gene or Genome]
   778   C2745900:Promyelocytic leukemia [Neoplastic Process]
   748   C0023418:Leukaemia [Neoplastic Process]
   748   C0205227:Endogenous [Functional Concept]
   748   C0547044:Less [Qualitative Concept]

Phrase: "and"

Phrase: "RAR in both nonleukemic marrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3538821:RAR [Gene or Genome]

Phrase: "and"

Phrase: "splenic tumors"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0027651:Tumors [Neoplastic Process]
   827 E C1578706:Tumor [Intellectual Product]
   827 E C3273930:Tumor [Finding]

Phrase: "derived from both mouse models."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C2986594:Mouse Model [Experimental Model of Disease]
   760   C0025914:Mouse [Mammal]
   760   C0025929:mouse [Mammal]
   760   C0026809:Mouse [Mammal]
   760   C1441547:Derived [Qualitative Concept]
   760   C3161035:Models [Intellectual Product]
   760   C3245521:derived [Idea or Concept]
Processing 00000000.tx.188: View larger version (47K): [in this window] [in a new window]  Figure 5. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(47K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 5."
Processing 00000000.tx.189: Expression of PML-RAR protein in leukemic spleen cells. 

Phrase: "Expression of PML-RAR protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1171362:expression protein [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in leukemic spleen cells."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   896   C1517806:Leukemic Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0037993:Spleen [Body Part, Organ, or Organ Component]
   827   C0771377:SPLEEN [Tissue]
   827   C1278932:Spleen [Body Part, Organ, or Organ Component]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.190: Western blots were performed for RAR and actin on transiently transfected U937 cells (harvested 4 hours after transfection) and on independent tumors from each model. 

Phrase: "Western blots"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0949466:Western Blots [Laboratory Procedure]
   966 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   861   C1705493:Western [Spatial Concept]

Phrase: "were"

Phrase: "performed for RAR"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0884358:Performed [Functional Concept]
   790   C3538821:RAR [Gene or Genome]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and"

Phrase: "actin on transiently transfected U937 cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "("

Phrase: "harvested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512335:Harvest [Health Care Activity]

Phrase: "4 hours after transfection"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C1292426:4 Hours [Temporal Concept]
   770   C0439227:hours [Temporal Concept]
   737 E C0564385:/hour [Quantitative Concept]

Phrase: ")"

Phrase: "and on independent tumors"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0027651:Tumors [Neoplastic Process]
   770   C0085862:Independent [Idea or Concept]
   770   C1299583:Independent [Finding]
   770   C1515981:And [Idea or Concept]
   737 E C1578706:Tumor [Intellectual Product]
   737 E C3273930:Tumor [Finding]

Phrase: "from each model."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]
Processing 00000000.tx.191: Lane 1 represents U937 cells electroporated with an empty expression plasmid; 

Phrase: "Lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "U937 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0600531:U937 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "electroporated with an empty expression plasmid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C1880497:Empty [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.192: lane 2, U937 cells expressing the RAR portion of human PML-RAR (RAR exons 3-9); 

Phrase: "lane 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "U937 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0600531:U937 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "the RAR portion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449719:Portion [Spatial Concept]

Phrase: "of human PML-RAR (RAR exons 3-9"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0023487:Promyelocytic Leukemia [Neoplastic Process]
   812   C1366903:promyelocytic leukemia [Gene or Genome]
   812   C2745900:Promyelocytic leukemia [Neoplastic Process]
   793   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   793   C0023418:Leukaemia [Neoplastic Process]
   793   C0086418:Human [Human]
   793   C3538821:RAR [Gene or Genome]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.193: and lane 3, U937 cells expressing full-length human PML-RAR (importantly, high-level expression of PML-RAR in these cells is highly toxic, causing the death of most U937 cells within 24 hours of transfection27). 

Phrase: "and"

Phrase: "lane 3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "U937 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0600531:U937 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "full-length human PML-RAR (importantly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C3538821:RAR [Gene or Genome]

Phrase: "high-level expression of PML-RAR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C3244092:expression level [Idea or Concept]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in these cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "highly toxic,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0600688:toxic [Injury or Poisoning]
   861   C1407029:Toxic [Qualitative Concept]

Phrase: "causing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0678227:Causing [Functional Concept]
   966 E C0015127:cause [Functional Concept]
   966 E C1524003:Cause [Conceptual Entity]

Phrase: "the death of most U937 cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0007587:cells death [Cell Function]
   753   C0011065:Death [Organism Function]
   753   C1306577:Death, NOS [Finding]

Phrase: "within 24 hours"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0439584:24 hours [Temporal Concept]
  1000   C0456696:/24 hours [Temporal Concept]
  1000   C1442770:24 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "of transfection27"

Phrase: ")."
Processing 00000000.tx.194: Lanes 4-6 represent hCG-PR tumors; 

Phrase: "Lanes 4-6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "hCG-PR tumors"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0027651:Tumors [Neoplastic Process]
   771 E C1578706:Tumor [Intellectual Product]
   771 E C3273930:Tumor [Finding]

Phrase: ";"
Processing 00000000.tx.195: lanes 7-8, mCG+/PR (PGK-neo) tumors. 

Phrase: "lanes 7-8,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: "mCG+/PR (PGK-neo) tumors."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   793   C0027651:Tumors [Neoplastic Process]
   760 E C1578706:Tumor [Intellectual Product]
   760 E C3273930:Tumor [Finding]
Processing 00000000.tx.196: The positions of RAR (55 kDa) and full-length PML-RAR (120 kDa) are marked. 

Phrase: "The positions of RAR (55 kDa)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0733755:positions [Spatial Concept]

Phrase: "and"

Phrase: "full-length PML-RAR (120 kDa)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C1532717:kDa [Quantitative Concept]

Phrase: "are"

Phrase: "marked."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]
Processing 00000000.tx.197: A band of approximately 50 kDa marked * represents an unknown protein recognized by the RAR antibody in hCGPML-RAR tumors. 

Phrase: "A band of approximately 50 kDa"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0230715:A band [Cell Component]
   753   C0175723:Band [Medical Device]
   753   C0439645:Band [Spatial Concept]
   753   C1521913:band [Cell Component]

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: "*"

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "an unknown protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "recognized by the RAR antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C3538821:RAR [Gene or Genome]

Phrase: "in hCGPML-RAR tumors."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0027651:Tumors [Neoplastic Process]
   793 E C1578706:Tumor [Intellectual Product]
   793 E C3273930:Tumor [Finding]
Processing 00000000.tx.198: It could potentially represent an altered PML-RAR protein.  

Phrase: "It"

Phrase: "could"

Phrase: "potentially"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "an altered PML-RAR protein."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   888   C0146495:Promyelocytic Leukemia Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   888   C3476424:Promyelocytic leukemia protein [Amino Acid, Peptide, or Protein]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.199: An interstitial deletion of chromosome 2 is found in a small fraction of knock-in tumor cells We analyzed 9 cryopreserved tumor samples with FISH using a chromosome 2specific painting probe and by posthybridization DAPI (46'-diamidino-2-phenylindole-2 HCl)produced G-like banding (Table 2). 

Phrase: "An interstitial deletion of chromosome 2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0008628:Deletion of chromosome NOS [Cell or Molecular Dysfunction]
           Chromosome Deletion
   753   C1442161:Deletion [Cell or Molecular Dysfunction]
   753   C1511760:Deletion [Genetic Function]
   753   C1880274:Deletion [Activity]

Phrase: "is"

Phrase: "found in a small fraction of knock-in tumor cells"
Meta Candidates (Total=19; Excluded=5; Pruned=0; Remaining=14)
   760   C0431085:Tumor cells [Cell]
   760   C1264633:Fraction of [Quantitative Concept]
           Fraction
   757   C0475277:Small tumor [Qualitative Concept]
   757   C1517676:Knock-in [Research Activity]
   741   C0805525:Cell Fraction [Cell Component]
   739   C0007634:Cells [Cell]
   739   C0027651:Tumor [Neoplastic Process]
   739   C0150312:Found [Quantitative Concept]
   739   C0700321:Small [Quantitative Concept]
   739   C1554103:Fraction [Idea or Concept]
   739   C1578706:Tumor [Intellectual Product]
   739   C3273930:Tumor [Finding]
   739   C3282337:Cells [Cell]
   726 E C0597032:Tumor Cell [Cell]
   706 E C0243095:Find [Finding]
   706 E C1269647:Cell [Cell]
   706 E C1704653:Cell [Medical Device]
   706 E C1948049:Cell [Spatial Concept]

Phrase: "We"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "9 cryopreserved tumor samples with FISH"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0475358:Tumor Sample [Tissue]
   708   C0370003:Sample [Substance]
   708   C2347026:Sample [Conceptual Entity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a chromosome 2specific painting probe"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0182400:Probe [Medical Device]
   812   C1704681:Probe [Gene or Genome]
   812   C2347609:Probe [Chemical Viewed Functionally]
   812   C3536729:Probe [Manufactured Object]
   708   C0600509:Chromosome Painting [Laboratory Procedure,Molecular Biology Research Technique]

Phrase: "and"

Phrase: "by posthybridization DAPI (46'-diamidino-2-phenylindole-2 HCl)produced G-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0439267:g% [Quantitative Concept]

Phrase: "like banding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185014:Banding [Therapeutic or Preventive Procedure]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.200: Six tumors from mCG+/PR mice (13437, 13441, 13487, 13644, 13646, and 13659) had a homogenous, near diploid cell population with a chromosome number ranging from 38 to 46; 

Phrase: "Six tumors from mCG+/PR mice"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   742   C0027651:Tumors [Neoplastic Process]
   708 E C1578706:Tumor [Intellectual Product]
   708 E C3273930:Tumor [Finding]

Phrase: "(13437,"

Phrase: "13441,"

Phrase: "13487,"

Phrase: "13644,"

Phrase: "13646,"

Phrase: "and"

Phrase: "13659"

Phrase: ")"

Phrase: "had"

Phrase: "a homogenous, near diploid cell population with a chromosome number ranging"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0032659:Population [Quantitative Concept]
   738   C1257890:Population [Population Group]

Phrase: "from 38"

Phrase: "to 46"

Phrase: ";"
Processing 00000000.tx.201: most of the cells from these 6 tumors contained 40 chromosomes. 

Phrase: "most of the cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C0205393:Most [Quantitative Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "from these 6 tumors"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0027651:Tumors [Neoplastic Process]
   827 E C1578706:Tumor [Intellectual Product]
   827 E C3273930:Tumor [Finding]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "40 chromosomes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0008633:Chromosomes [Cell Component]
Processing 00000000.tx.202: Among these, tumor 13437 had fewer cells with the normal chromosome number (2n = 40). 

Phrase: "Among these,"

Phrase: "tumor 13437"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0027651:Tumor [Neoplastic Process]
   861   C1578706:Tumor [Intellectual Product]
   861   C3273930:Tumor [Finding]

Phrase: "had"

Phrase: "fewer cells with the normal chromosome number"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   757   C0007584:Cell Number [Laboratory Procedure]
   757   C0007634:Normal cell [Cell]
           Cells
   757   C1268443:Normal cell [Cell]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "(2n"

Phrase: "= 40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.203: Tumors 13498 and 13499 showed wider variations in chromosome number, which ranged from 39 to 50 and 36 to 62, respectively. 

Phrase: "Tumors 13498"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0027651:Tumors [Neoplastic Process]
   827 E C1578706:Tumor [Intellectual Product]
   827 E C3273930:Tumor [Finding]

Phrase: "and"

Phrase: "13499"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "wider variations in chromosome number,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205419:variations [Qualitative Concept]

Phrase: "which"

Phrase: "ranged from 39"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1514721:Range [Quantitative Concept]
   756   C2348147:Range [Quantitative Concept]
   756   C3542016:Range [Intellectual Product]

Phrase: "to 50"

Phrase: "and"

Phrase: "36 to 62,"

Phrase: "respectively."
Processing 00000000.tx.204: Only one tumor (13843) consisted of 2 subpopulations with near-diploid and near-tetraploid chromosome numbers (ranging from 40-47 to 71-81 chromosomes, respectively). 

Phrase: "Only one tumor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0027651:Tumor [Neoplastic Process]
   827   C1578706:Tumor [Intellectual Product]
   827   C3273930:Tumor [Finding]

Phrase: "(13843"

Phrase: ")"

Phrase: "consisted of 2 subpopulations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0332529:CONSIST [Qualitative Concept]
   737   C1257890:Subpopulation [Population Group]

Phrase: "with near-diploid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012568:Diploid [Organism Attribute]

Phrase: "and"

Phrase: "near-tetraploid chromosome numbers"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1953343:Chromosome number [Cell]
   812   C0008633:Chromosome [Cell Component]
   812   C0237753:*Number [Quantitative Concept]
   812   C0449788:Number [Quantitative Concept]

Phrase: "(ranging from 40-47"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1514721:Range [Quantitative Concept]
   737   C2348147:Range [Quantitative Concept]
   737   C3542016:Range [Intellectual Product]

Phrase: "to 71-81 chromosomes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0008633:Chromosomes [Cell Component]

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.205: All lines were examined for alterations of chromosome 2, which is a recurrent alteration in tumors derived from hCGPML-RAR transgenic animals.9 An interstitial deletion of chromosome 2, similar to the deletion previously described for transgenic hCGPML-RAR x hCGRAR-PML tumors9 was detected in tumors 13843 and 13499. 

Phrase: "All lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205132:lines [Spatial Concept]
   966 E C1550648:Line [Substance]
   966 E C1552960:Line [Quantitative Concept]

Phrase: "were"

Phrase: "examined for alterations of chromosome 2,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0008662:Chromosome 2 [Cell Component]
   783   C0008625:Chromosome Alterations [Cell or Molecular Dysfunction]
   753   C0008633:Chromosome [Cell Component]
   753   C0332128:Examined [Finding]
   719   C1515926:Alteration [Idea or Concept]

Phrase: "which"

Phrase: "is"

Phrase: "a recurrent alteration in tumors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1515926:Alteration [Idea or Concept]

Phrase: "derived from hCGPML-RAR transgenic animals.9"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0003069:Animals, Transgenic [Animal]
           Transgenic
   748   C0003062:Animals [Animal]
   748   C1441547:Derived [Qualitative Concept]
   748   C3245521:derived [Idea or Concept]
   748   C3538821:RAR [Gene or Genome]

Phrase: "An interstitial deletion of chromosome 2,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0008628:Deletion of chromosome NOS [Cell or Molecular Dysfunction]
           Chromosome Deletion
   753   C1442161:Deletion [Cell or Molecular Dysfunction]
   753   C1511760:Deletion [Genetic Function]
   753   C1880274:Deletion [Activity]

Phrase: "similar to the deletion previously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]

Phrase: "described for transgenic hCGPML-RAR x hCGRAR-PML tumors9"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0023487:Promyelocytic Leukemia [Neoplastic Process]
   760   C1366903:promyelocytic leukemia [Gene or Genome]
   760   C2745900:Promyelocytic leukemia [Neoplastic Process]
   739   C0003069:Transgenic [Animal]
   739   C0023418:Leukaemia [Neoplastic Process]
   739   C1552738:described [Idea or Concept]
   739   C3538821:RAR [Gene or Genome]

Phrase: "was"

Phrase: "detected in tumors 13843"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0027651:Tumors [Neoplastic Process]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   737 E C1578706:Tumor [Intellectual Product]
   737 E C3273930:Tumor [Finding]

Phrase: "and"

Phrase: "13499."
Processing 00000000.tx.206: The deleted material from chromosome 2 was not translocated to any other chromosome. 

Phrase: "The deleted material from chromosome 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0520510:Material [Substance]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "translocated to any"

Phrase: "other chromosome."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008633:Chromosome [Cell Component]
Processing 00000000.tx.207: No other gross chromosomal abnormalities were identified. 

Phrase: "No"

Phrase: "other gross chromosomal abnormalities"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   901   C0008625:Abnormalities, Chromosomal [Cell or Molecular Dysfunction]
   901   C0008626:Abnormalities, Chromosomal [Disease or Syndrome]
   827   C0000768:Abnormalities [Congenital Abnormality]
   827   C0000769:abnormalities [Functional Concept]
   793 E C1704258:Abnormality [Finding]
   743 E C0205161:Abnormal [Qualitative Concept]
   743 E C2347472:% Abnormal [Quantitative Concept]
   743 E C2699333:ABNORMAL [Intellectual Product]

Phrase: "were"

Phrase: "identified."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]
Processing 00000000.tx.208: View this table: [in this window] [in a new window]  Table 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.209: Molecular cytogenetic analysis of mCG+/PR splenic tumors   Discussion Top Abstract Introduction Materials and methods Results Discussion References  In this report, we describe mice that express PML-RAR under control of the endogenous murine cathepsin G locus. 

Phrase: "Molecular cytogenetic analysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C1513380:Molecular Analysis [Molecular Biology Research Technique]
   901   C0752095:Cytogenetic Analysis [Molecular Biology Research Technique]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "of mCG+/PR splenic tumors   Discussion Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   787   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References  In this report,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0684224:Report [Intellectual Product]
   770   C0700287:Report [Health Care Activity]
   770   C1514811:Reference [Idea or Concept]
   770   C1706462:Reference [Conceptual Entity]
   770   C3273238:Report [Intellectual Product]

Phrase: "we"

Phrase: "describe"

Phrase: "mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "that"

Phrase: "express"

Phrase: "PML-RAR under control of the endogenous murine cathepsin G locus."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C3538821:RAR [Gene or Genome]
Processing 00000000.tx.210: Mice heterozygous or homozygous for this mutation (which also creates a null cathepsin G allele) are viable and fertile, but all display a myeloproliferative syndrome early in life. 

Phrase: "Mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "heterozygous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019425:Heterozygous [Organism Attribute]

Phrase: "or"

Phrase: "homozygous for this mutation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0019904:Homozygous [Organism Attribute]

Phrase: "("

Phrase: "which also"

Phrase: "creates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1706214:Create [Activity]
  1000   C3244320:create [Functional Concept]

Phrase: "a null cathepsin G allele"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   902   C2985437:Null Allele [Cell or Molecular Dysfunction]
   812   C0002085:Allele [Gene or Genome]

Phrase: ")"

Phrase: "are"

Phrase: "viable"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443348:Viable [Qualitative Concept]

Phrase: "and"

Phrase: "fertile,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0015895:Fertile [Organism Function]
   928 E C0200069:Fertility [Diagnostic Procedure]
   928 E C2986895:Fertility [Idea or Concept]

Phrase: "but"

Phrase: "all"

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "a myeloproliferative syndrome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039082:Syndrome [Disease or Syndrome]

Phrase: "early in life."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0376558:Life [Idea or Concept]
   827   C1279919:Early [Temporal Concept]
   743 E C0595998:lives [Finding]
Processing 00000000.tx.211: After a long latent period, mice bearing this mutation develop a fatal APL-like syndrome that is characterized by the accumulation of early myeloid cells in the bone marrow, spleen, and liver, as well as sensitivity to ATRA in vitro. 

Phrase: "After a long latent period,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   825   C0023103:Latency Period [Temporal Concept]
   812   C0205275:Latent [Qualitative Concept]
   812   C0439531:/period [Temporal Concept]
   812   C1948053:Period [Temporal Concept]
   741 E C0332182:Periodic [Temporal Concept]
   741 E C1706381:PERIODIC [Intellectual Product]
   712 E C0031084:Periodicities [Temporal Concept]

Phrase: "mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "bearing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704689:Bearing [Medical Device]
   966 E C0004897:Bear [Mammal]

Phrase: "this mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "develop"

Phrase: "a fatal APL-"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   923   C0023487:Acute Promyelocytic Leukemia [Neoplastic Process]
           Promyelocytic Leukemia
   875   C0085669:Acute leukaemia [Neoplastic Process]
   875   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   861   C1366903:promyelocytic leukemia [Gene or Genome]
   861   C2745900:Promyelocytic leukemia [Neoplastic Process]
   812   C0023418:Leukaemia [Neoplastic Process]
   812   C0205178:acute [Temporal Concept]

Phrase: "like syndrome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039082:Syndrome [Disease or Syndrome]

Phrase: "that"

Phrase: "is"

Phrase: "characterized by the accumulation of early myeloid cells"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   770   C0887899:Myeloid Cells [Cell]
   744   C0007634:Cells [Cell]
   744   C0439677:Myeloid [Qualitative Concept]
   744   C1279919:Early [Temporal Concept]
   744   C1880022:Characterized [Activity]
   744   C3282337:Cells [Cell]
   737 E C0596993:Myeloid cell [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "in the bone marrow,"
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
  1000   C0005953:Bone Marrow [Tissue]
   861   C0086590:Marrow [Food]
   861   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   861   C0376152:Marrow [Body Part, Organ, or Organ Component]
   861   C0391978:Bone [Tissue]
   861   C1266908:Bone [Body Part, Organ, or Organ Component]
   861   C1266909:Bone [Body System]
   861   C1546708:Marrow [Intellectual Product]
   805 E C0001629:Medullary [Body Part, Organ, or Organ Component]
   805 E C0025148:Medullary [Body Part, Organ, or Organ Component]
   805 E C1550278:Medullary [Body Part, Organ, or Organ Component]
   789 E C0443157:Bony [Functional Concept]
   777 E C0330477:Marrows [Plant]

Phrase: "spleen,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037993:Spleen [Body Part, Organ, or Organ Component]
  1000   C0771377:SPLEEN [Tissue]
  1000   C1278932:Spleen [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "liver,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "as well as"

Phrase: "sensitivity to ATRA"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   847   C0332324:Sensitive to [Functional Concept]
       E   Sensitive
   790   C0036667:Sensitivity [Quantitative Concept]
   790   C0312418:Sensitivity [Mental Process]
   790   C0427965:Sensitivity [Finding]
   790   C1511883:Sensitivity [Quantitative Concept]
   790   C1522640:Sensitivity [Qualitative Concept]
   790   C2346484:SENSITIVITY [Phenomenon or Process]
   790   C2349185:Sensitivity [Qualitative Concept]
   718 E C1550474:sensitive [Idea or Concept]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.212: In contrast to the low penetrance of APL (15%-20%) observed in transgenic mice expressing PML-RAR under control of a human cathepsin G targeting cassette, the penetrance of APL in the knock-in mice was more than 90%. 

Phrase: "In contrast to the low penetrance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0524899:Penetrance [Quantitative Concept]

Phrase: "of APL"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0023487:Acute Promyelocytic Leukemia [Neoplastic Process]
           Promyelocytic Leukemia
   913   C0085669:Acute leukaemia [Neoplastic Process]
   913   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   901   C1366903:promyelocytic leukemia [Gene or Genome]
   901   C2745900:Promyelocytic leukemia [Neoplastic Process]
   827   C0023418:Leukaemia [Neoplastic Process]
   827   C0205178:acute [Temporal Concept]

Phrase: "(15%-20%"

Phrase: ")"

Phrase: "observed in transgenic mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0025936:Mice, Transgenic [Mammal]
   770   C0003069:Transgenic [Animal]
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C1441672:Observed [Functional Concept]

Phrase: "expressing"

Phrase: "PML-RAR under control of a human cathepsin G targeting cassette,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C3538821:RAR [Gene or Genome]

Phrase: "the penetrance of APL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0524899:Penetrance [Quantitative Concept]

Phrase: "in the knock-in mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1517676:Knock-in [Research Activity]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "was"

Phrase: "more than 90%."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205172:More [Functional Concept]
   790   C0439083:>90 [Quantitative Concept]
   790   C0439087:<90 [Quantitative Concept]
Processing 00000000.tx.213: The latency of the 2 models was similar, however, suggesting that both require additional genetic events for APL progression. 

Phrase: "The latency of the 2 models"

Phrase: "was"

Phrase: "similar, however,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2348205:Similar [Qualitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "both"

Phrase: "require"

Phrase: "additional genetic events for APL progression."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0441471:Events [Event]
   744   C3541888:Events [Classification]
Processing 00000000.tx.214: Although we predicted that the knock-in model would express PML-RAR at high levels in early myeloid cells, expression was actually much lower than that observed in the previous transgenic model. 

Phrase: "Although"

Phrase: "we"

Phrase: "predicted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681842:Predicted [Idea or Concept]
  1000   C1882327:%{Predicted} [Quantitative Concept]

Phrase: "that"

Phrase: "the knock-in model"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C3161035:Model [Intellectual Product]
   734   C1517676:Knock-in [Research Activity]

Phrase: "would"

Phrase: "express"

Phrase: "PML-RAR at high levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3538821:RAR [Gene or Genome]

Phrase: "in early myeloid cells,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   901   C0887899:Myeloid Cells [Cell]
   867 E C0596993:Myeloid cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0439677:Myeloid [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "actually much lower than that"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0441994:Lower [Spatial Concept]
   760   C1548802:Lower [Body Location or Region]
   760   C2003888:Lower [Activity]

Phrase: "observed in the previous transgenic model."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1519606:Transgenic Model [Experimental Model of Disease]
   753   C0003069:Transgenic [Animal]
   753   C0205156:Previous [Temporal Concept]
   753   C1441672:Observed [Functional Concept]
   753   C1552607:previous [Temporal Concept]
   753   C3161035:Model [Intellectual Product]
Processing 00000000.tx.215: These results suggest that there may be an optimal level of PML-RAR expression that facilitates APL development and that this level is lower than that previously predicted. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that there"

Phrase: "may"

Phrase: "be"

Phrase: "an optimal level of PML-RAR expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C3244092:expression level [Idea or Concept]
   744   C0441889:Level [Qualitative Concept]
   744   C0456079:Level [Classification]
   744   C1547707:Level [Geographic Area]
   744   C2946261:Level [Pharmacologic Substance]

Phrase: "that"

Phrase: "facilitates"

Phrase: "APL development"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   812   C0243107:development [Physiologic Function]
   812   C0678723:Development [Organism Function]
   812   C1527148:Development [Functional Concept]
   756   C0023487:Acute Promyelocytic Leukemia [Neoplastic Process]
   741 E C0458003:Developmental [Qualitative Concept]
   708   C0085669:Acute leukaemia [Neoplastic Process]
   708   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]

Phrase: "and"

Phrase: "that"

Phrase: "this level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0441889:Level [Qualitative Concept]
  1000   C0456079:Level [Classification]
  1000   C1547707:Level [Geographic Area]
  1000   C2946261:Level [Pharmacologic Substance]

Phrase: "is"

Phrase: "lower than"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0441994:Lower [Spatial Concept]
   833   C1548802:Lower [Body Location or Region]
   833   C2003888:Lower [Activity]

Phrase: "that previously"

Phrase: "predicted."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681842:Predicted [Idea or Concept]
  1000   C1882327:%{Predicted} [Quantitative Concept]
Processing 00000000.tx.216: The most striking feature of the knock-in model was the very high penetrance of APL. 

Phrase: "The most striking feature of the knock-in model"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C1521970:Feature [Qualitative Concept]
   742   C1706388:Feature [Conceptual Entity]
   742   C2346469:Feature [Qualitative Concept]
   742   C2348519:Feature [Qualitative Concept]

Phrase: "was"

Phrase: "the very high penetrance of APL."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0524899:Penetrance [Quantitative Concept]
Processing 00000000.tx.217: In previously reported experiments, we and others have demonstrated that an identical PML-RAR cDNA, when expressed in transgenic mice under the control of human cathepsin G regulatory sequences, results in a myeloproliferative syndrome in all of the mice, but APL development in only 15% to 20%, and only after a latent period of 6 to 14 months.1,2,4,5 Similarly, mice that express PML-RAR under control of the MRP8 promoter (which is expressed in both early and late myeloid cells) have a low frequency of APL development also characterized by long latency.3 Our previously reported hCG transgenic mouse model exhibited relatively low levels of expression of PML-RAR mRNA in the bone marrow, compared with endogenous PML and/or endogenous cathepsin G1; 

Phrase: "In previously reported experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "we"

Phrase: "and"

Phrase: "others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that"

Phrase: "an identical PML-RAR cDNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "when"

Phrase: "expressed in transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0025936:Mice, Transgenic [Mammal]
   770   C0003069:Transgenic [Animal]
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]

Phrase: "under the control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "of human cathepsin G regulatory sequences,"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   806   C0314642:Regulatory sequence [Nucleotide Sequence]
   804   C0162326:Sequences [Nucleotide Sequence]
   804   C0220905:regulatory [Regulation or Law]
   804   C1704735:Regulatory [Conceptual Entity]
   771 E C0004793:Sequence [Nucleotide Sequence]
   771 E C0162327:Sequence [Nucleotide Sequence]
   771 E C1519249:Sequence [Functional Concept]
   721 E C1548958:Sequential [Idea or Concept]
   721 E C1705294:Sequential [Qualitative Concept]

Phrase: "results in a myeloproliferative syndrome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0039082:Syndrome [Disease or Syndrome]
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2825142:Result [Finding]

Phrase: "in all"

Phrase: "of the mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "but"

Phrase: "APL development in only 15%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0243107:development [Physiologic Function]
   748   C0678723:Development [Organism Function]
   748   C1527148:Development [Functional Concept]

Phrase: "to 20%,"

Phrase: "and"

Phrase: "only after a latent period of 6"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0205171:Only [Quantitative Concept]
   748   C0205275:Latent [Qualitative Concept]
   748   C0439531:/period [Temporal Concept]
   748   C1720467:Only [Intellectual Product]
   748   C1948053:Period [Temporal Concept]
   743   C0023103:Latency Period [Temporal Concept]

Phrase: "to 14 months.1,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439231:months [Temporal Concept]
   793 E C0439507:/month [Temporal Concept]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "4,"

Phrase: "5 Similarly,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: "mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "that"

Phrase: "express"

Phrase: "PML-RAR under control of the MRP8 promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C3538821:RAR [Gene or Genome]

Phrase: "("

Phrase: "which"

Phrase: "is"

Phrase: "expressed in both early"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1279919:Early [Temporal Concept]

Phrase: "and"

Phrase: "late myeloid cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   901   C0887899:Myeloid Cells [Cell]
   867 E C0596993:Myeloid cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0439677:Myeloid [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "have"

Phrase: "a low frequency of APL development also"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   764   C0205213:Low frequency [Temporal Concept]
   742   C0205251:low [Qualitative Concept]
   742   C0376249:frequency [Quantitative Concept]
   742   C0439603:Frequency [Temporal Concept]
   742   C0871396:Frequency [Quantitative Concept]
   742   C1299352:Low [Qualitative Concept]
   742   C1550472:low [Idea or Concept]
   742   C1561548:Frequency [Qualitative Concept]
   742   C1705502:Frequency [Quantitative Concept]

Phrase: "characterized by long latency.3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205166:Long [Qualitative Concept]
   760   C1706317:Long [Qualitative Concept]
   760   C1880022:Characterized [Activity]

Phrase: "Our previously reported hCG transgenic mouse model"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   822   C1519606:Transgenic Model [Experimental Model of Disease]
   812   C2986594:Mouse Model [Experimental Model of Disease]
   793   C3161035:Model [Intellectual Product]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "relatively low levels of expression of PML-RAR mRNA"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   741   C3244092:expression level [Idea or Concept]
   739   C0441889:Levels [Qualitative Concept]
   706 E C0456079:Level [Classification]
   706 E C1547707:Level [Geographic Area]
   706 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the bone marrow,"
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
  1000   C0005953:Bone Marrow [Tissue]
   861   C0086590:Marrow [Food]
   861   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   861   C0376152:Marrow [Body Part, Organ, or Organ Component]
   861   C0391978:Bone [Tissue]
   861   C1266908:Bone [Body Part, Organ, or Organ Component]
   861   C1266909:Bone [Body System]
   861   C1546708:Marrow [Intellectual Product]
   805 E C0001629:Medullary [Body Part, Organ, or Organ Component]
   805 E C0025148:Medullary [Body Part, Organ, or Organ Component]
   805 E C1550278:Medullary [Body Part, Organ, or Organ Component]
   789 E C0443157:Bony [Functional Concept]
   777 E C0330477:Marrows [Plant]

Phrase: "compared with endogenous PML"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0023487:Promyelocytic Leukemia [Neoplastic Process]
   806   C1366903:promyelocytic leukemia [Gene or Genome]
   806   C2745900:Promyelocytic leukemia [Neoplastic Process]
   760   C0023418:Leukaemia [Neoplastic Process]
   760   C0205227:Endogenous [Functional Concept]
   760   C1707455:Compared [Activity]

Phrase: "and/or"

Phrase: "endogenous cathepsin G1"

Phrase: ";"
Processing 00000000.tx.218: none of 8 transgenic lines expressing hCGPML-RAR expressed high levels of PML-RAR mRNA.1 In contrast, the unmanipulated 6.0-kB human cathepsin G cassette was expressed at high levels in most transgenic founders, although it did exhibit integration sitespecific variegation.26 These results suggested that high-level expression of PML-RAR could not be achieved in the early myeloid cells of transgenic mice. 

Phrase: "none of 8 transgenic lines"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0003069:Transgenic [Animal]
   760   C0205132:lines [Spatial Concept]
   760   C0456148:None [Quantitative Concept]
   760   C0549184:None [Quantitative Concept]
   726 E C1550648:Line [Substance]
   726 E C1552960:Line [Quantitative Concept]

Phrase: "expressing"

Phrase: "hCGPML-RAR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538821:RAR [Gene or Genome]

Phrase: "expressed"

Phrase: "high levels of PML-RAR mRNA.1"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   750   C0456947:Level 1 [Intellectual Product]
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the unmanipulated 6.0-kB human cathepsin G cassette"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0450240:Cassette [Medical Device]
   793   C1706210:Cassette [Manufactured Object]

Phrase: "was"

Phrase: "expressed at high levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0205250:High [Qualitative Concept]
   770   C0441889:Levels [Qualitative Concept]
   770   C1299351:High [Qualitative Concept]
   770   C2700149:HIGH [Intellectual Product]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "in most transgenic founders,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0263541:founders [Disease or Syndrome]

Phrase: "although"

Phrase: "it"

Phrase: "did"

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "integration sitespecific variegation.26"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1158478:Integration [Genetic Function]
   812   C1705422:Integration [Machine Activity]

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that high-level expression of PML-RAR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C3244092:expression level [Idea or Concept]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "achieved in the early myeloid cells of transgenic mice."
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   764   C0025936:Mice, Transgenic [Mammal]
   764   C0887899:Myeloid Cells [Cell]
   742   C0003069:Transgenic [Animal]
   742   C0007634:Cells [Cell]
   742   C0025914:Mice [Mammal]
   742   C0025929:mice [Mammal]
   742   C0026809:Mice [Mammal]
   742   C0439677:Myeloid [Qualitative Concept]
   742   C1279919:Early [Temporal Concept]
   742   C3282337:Cells [Cell]
   731 E C0596993:Myeloid cell [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.219: There are at least 3 possibilities for why this might occur: (1) Insertion of the PML-RAR cDNA into the 5'-untranslated region (UT) of the cathepsin G gene disrupted a critical regulatory element. 

Phrase: "There"

Phrase: "are at least 3 possibilities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1551058:Are [Quantitative Concept]

Phrase: "for why"

Phrase: "this"

Phrase: "might"

Phrase: "occur"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: ":"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "Insertion of the PML-RAR cDNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0021107:Insertion [Therapeutic or Preventive Procedure]
   748   C0441587:Insertion [Health Care Activity]
   748   C1512796:Insertion [Genetic Function]
   748   C1883719:Insertion [Functional Concept]

Phrase: "into the 5'-untranslated region"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0600493:5' Untranslated Region [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   913   C1883644:5' Region [Nucleotide Sequence]
   901   C0600680:Untranslated Region [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "(UT) of the cathepsin G gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0042124:UT [Geographic Area]

Phrase: "disrupted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:Disrupted [Qualitative Concept]

Phrase: "a critical regulatory element."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0034987:Regulatory Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0013879:Element [Element, Ion, or Isotope]
   827   C0220905:regulatory [Regulation or Law]
   827   C1704735:Regulatory [Conceptual Entity]
   827   C1705248:Element [Conceptual Entity]
Processing 00000000.tx.220: (2) A critical regulatory element(s) (eg, an enhancer or locus control region) that is required for high-level expression is missing from the 6.0-kB human cathepsin G targeting cassette. 

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "A critical regulatory element"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0034987:Regulatory Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0013879:Element [Element, Ion, or Isotope]
   827   C0220905:regulatory [Regulation or Law]
   827   C1704735:Regulatory [Conceptual Entity]
   827   C1705248:Element [Conceptual Entity]

Phrase: "("

Phrase: "s) ("

Phrase: "eg,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013715:EG [Geographic Area]
  1000   C1705651:EG [Idea or Concept]

Phrase: "an enhancer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "or"

Phrase: "locus control region"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C0525013:Locus Control Region [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   901   C0023953:locus control [Idea or Concept]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1708726:Locus [Gene or Genome]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: ")"

Phrase: "that"

Phrase: "is"

Phrase: "required for high-level expression"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   797   C3244092:expression level [Idea or Concept]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0205250:High [Qualitative Concept]
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1299351:High [Qualitative Concept]
   760   C1514873:Required [Functional Concept]
   760   C1547707:Level [Geographic Area]
   760   C2700149:HIGH [Intellectual Product]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "is"

Phrase: "missing from the 6.0-kB human cathepsin G targeting cassette."
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   756   C0054868:Cathepsin G [Amino Acid, Peptide, or Protein,Enzyme]
   756   C1413814:CATHEPSIN G [Gene or Genome]
   754   C0963165:cathepsin-6 [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0086418:Human [Human]
   738   C0439267:g% [Quantitative Concept]
   738   C0450240:Cassette [Medical Device]
   738   C1521840:Targeting [Functional Concept]
   738   C1551393:Missing [Idea or Concept]
   738   C1705492:Missing [Qualitative Concept]
   738   C1706210:Cassette [Manufactured Object]
   738   C3272743:MISSING [Qualitative Concept]
   704 E C2349206:Miss [Conceptual Entity]
   704 E C2986546:TARGET [Diagnostic Procedure]
Processing 00000000.tx.221: (3) PML-RAR is toxic to the early myeloid cells in which it is expressed. 

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "PML-RAR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C3538821:RAR [Gene or Genome]
   734   C0023487:Promyelocytic Leukemia [Neoplastic Process]
   734   C1366903:promyelocytic leukemia [Gene or Genome]
   734   C2745900:Promyelocytic leukemia [Neoplastic Process]

Phrase: "is"

Phrase: "toxic to the early myeloid cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0600688:toxic [Injury or Poisoning]
   753   C1407029:Toxic [Qualitative Concept]

Phrase: "in which"

Phrase: "it"

Phrase: "is"

Phrase: "expressed."
Processing 00000000.tx.222: To address some of these issues, we generated the knock-in model described in this report. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "some of these issues,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205392:Some [Quantitative Concept]
   770   C3540770:Some [Intellectual Product]
   737   C0033213:Issue [Finding]
   737   C1706387:Issue [Intellectual Product]

Phrase: "we"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "the knock-in model"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C3161035:Model [Intellectual Product]
   734   C1517676:Knock-in [Research Activity]

Phrase: "described in this report."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0684224:Report [Intellectual Product]
   770   C0700287:Report [Health Care Activity]
   770   C1552738:described [Idea or Concept]
   770   C3273238:Report [Intellectual Product]
Processing 00000000.tx.223: The same PML-RAR cDNA was targeted (via homologous recombination) into the identical position of the murine cathepsin G 5' untranslated region as in the human cathepsin G transgene. 

Phrase: "The same PML-RAR cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "targeted"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521840:Targeted [Functional Concept]
   966 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "("

Phrase: "via homologous recombination"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0599773:Homologous Recombination [Genetic Function]
  1000   C2984295:Homologous recombination [Functional Concept]
   861   C0034865:Recombination [Genetic Function]
   861   C1334043:Homologous [Gene or Genome]

Phrase: ")"

Phrase: "into the identical position"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:Position [Spatial Concept]
   789 E C0240795:POSITIONAL [Finding]

Phrase: "of the murine cathepsin G 5' untranslated region"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0600680:Untranslated Region [Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0017446:Region [Geographic Area]
   799   C0205147:Region [Spatial Concept]
   727 E C0205276:Regional [Spatial Concept]
   727 E C1947913:Regional [Spatial Concept]

Phrase: "as in the human cathepsin G transgene."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0054868:Cathepsin G [Amino Acid, Peptide, or Protein,Enzyme]
   778   C1413814:CATHEPSIN G [Gene or Genome]
   748   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0086418:Human [Human]
   748   C0282641:Transgene [Gene or Genome]
   748   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.224: With this approach, any missing regulatory element in the cathepsin G locus would be captured. 

Phrase: "With this approach,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449445:Approach [Spatial Concept]

Phrase: "any"

Phrase: "missing"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1551393:Missing [Idea or Concept]
  1000   C1705492:Missing [Qualitative Concept]
  1000   C3272743:MISSING [Qualitative Concept]
   966 E C2349206:Miss [Conceptual Entity]

Phrase: "regulatory element in the cathepsin G locus"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0034987:Regulatory Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0013879:Element [Element, Ion, or Isotope]
   748   C0220905:regulatory [Regulation or Law]
   748   C1704735:Regulatory [Conceptual Entity]
   748   C1705248:Element [Conceptual Entity]

Phrase: "would"

Phrase: "be"

Phrase: "captured."
Processing 00000000.tx.225: When the PGK-neo cassette was left in the mutant locus, virtually no expression of the cDNA was detected, strongly suggesting that the retained PGK-neo cassette dramatically reduced expression from the mutant locus.20 We, therefore, removed the PGK-neo cassette by expressing Cre-recombinase in the targeted embryonic stem cell line. 

Phrase: "When"

Phrase: "the PGK-neo cassette"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0450240:Cassette [Medical Device]
   827   C1706210:Cassette [Manufactured Object]

Phrase: "was"

Phrase: "left in the mutant locus,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205091:Left [Spatial Concept]
   760   C0596988:Mutant [Cell or Molecular Dysfunction]
   760   C1552822:left [Functional Concept]
   760   C1708726:Locus [Gene or Genome]

Phrase: "virtually"

Phrase: "no expression of the cDNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1515563:cDNA Expression [Molecular Biology Research Technique]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: ","

Phrase: "strongly"

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the retained PGK-neo cassette dramatically reduced expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "from the mutant locus.20"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0596988:Mutant [Cell or Molecular Dysfunction]
   827   C1708726:Locus [Gene or Genome]

Phrase: "We,"

Phrase: "therefore,"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "the PGK-neo cassette by expressing Cre-recombinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0450240:Cassette [Medical Device]
   744   C1706210:Cassette [Manufactured Object]

Phrase: "in the targeted embryonic stem cell line."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   937   C1512140:Embryonic Stem Cell Line [Cell]
   840   C0007600:Cell Line [Cell]
   804   C0205132:Line [Spatial Concept]
   804   C1550648:Line [Substance]
   804   C1552960:Line [Quantitative Concept]
   717   C0596508:Embryonic stem cell [Cell]
Processing 00000000.tx.226: This manipulation yielded a functional mutant allele, whose expression could readily be detected, but only with RT-PCR. 

Phrase: "This manipulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0185111:Manipulation, NOS [Therapeutic or Preventive Procedure]
  1000   C0947647:Manipulation [Therapeutic or Preventive Procedure]

Phrase: "yielded"

Phrase: "a functional mutant allele,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0002085:Allele [Gene or Genome]

Phrase: "whose expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "could"

Phrase: "readily"

Phrase: "be"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: ","

Phrase: "but"

Phrase: "only with RT-PCR."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   814   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0205171:Only [Quantitative Concept]
   748   C0337112:Chain [Manufactured Object]
   748   C0443286:Reaction [Functional Concept]
   748   C1114821:Reaction [Clinical Attribute]
   748   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1524075:Chain [Idea or Concept]
   748   C1555029:Reverse [Idea or Concept]
   748   C1720467:Only [Intellectual Product]
Processing 00000000.tx.227: The expression level from the mutant allele was dramatically less than that of the unmodified cathepsin G allele in heterozygous animals (data not shown). 

Phrase: "The expression level from the mutant allele"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C3244092:expression level [Idea or Concept]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "dramatically less than that of the unmodified cathepsin G allele"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0054868:Cathepsin G [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1413814:CATHEPSIN G [Gene or Genome]
   739   C0002085:Allele [Gene or Genome]
   739   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0439267:g% [Quantitative Concept]

Phrase: "in heterozygous animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.228: When expression from the knock-in allele was compared with PML-RAR expression in a transgenic hCGPML-RAR founder line, we were surprised to find that it was much lower. 

Phrase: "When"

Phrase: "expression from the knock-in allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "compared with PML-RAR expression"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0023487:Promyelocytic Leukemia [Neoplastic Process]
   790   C1366903:promyelocytic leukemia [Gene or Genome]
   790   C2745900:Promyelocytic leukemia [Neoplastic Process]
   753   C0023418:Leukaemia [Neoplastic Process]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C1707455:Compared [Activity]
   753   C3538821:RAR [Gene or Genome]

Phrase: "in a transgenic hCGPML-RAR founder line,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0205132:Line [Spatial Concept]
   804   C1550648:Line [Substance]
   804   C1552960:Line [Quantitative Concept]

Phrase: "we"

Phrase: "were"

Phrase: "surprised"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "that"

Phrase: "it"

Phrase: "was"

Phrase: "much lower."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441994:Lower [Spatial Concept]
   861   C1548802:Lower [Body Location or Region]
   861   C2003888:Lower [Activity]
Processing 00000000.tx.229: We and others14 had predicted that the opposite would occur. 

Phrase: "We"

Phrase: "and"

Phrase: "others14"

Phrase: "had"

Phrase: "predicted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681842:Predicted [Idea or Concept]
  1000   C1882327:%{Predicted} [Quantitative Concept]

Phrase: "that"

Phrase: "the opposite"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1521805:Opposite [Spatial Concept]

Phrase: "would"

Phrase: "occur."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.230: Furthermore, full-length PML-RAR protein could not be detected in the bone marrow of nonleukemic mice, nor in tumors derived from knock-in or transgenic mice, using antibodies that can detect endogenous levels of PML and RAR. 

Phrase: "Furthermore,"

Phrase: "full-length PML-RAR protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   867   C0146495:Promyelocytic Leukemia Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   867   C3476424:Promyelocytic leukemia protein [Amino Acid, Peptide, or Protein]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "detected in the bone marrow of nonleukemic mice,"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   776   C1511243:Mouse Bone Marrow [Tissue]
   770   C0005953:Bone Marrow [Tissue]
   750   C1511240:Mouse Bone [Tissue]
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]
   744   C0086590:Marrow [Food]
   744   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   744   C0376152:Marrow [Body Part, Organ, or Organ Component]
   744   C0391978:Bone [Tissue]
   744   C0442726:Detected [Finding]
   744   C1266908:Bone [Body Part, Organ, or Organ Component]
   744   C1266909:Bone [Body System]
   744   C1511790:Detected [Therapeutic or Preventive Procedure]
   744   C1546708:Marrow [Intellectual Product]
   739 E C1708973:Medullary Bone [Tissue]

Phrase: "nor in tumors"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0027651:Tumors [Neoplastic Process]
   790   C0028423:NOR [Geographic Area]
   790   C0028609:NOR [Cell Component]
   790   C1513854:NOR [Mammal]
   756 E C1578706:Tumor [Intellectual Product]
   756 E C3273930:Tumor [Finding]

Phrase: "derived from knock-in"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1517676:Knock-in [Research Activity]
   770   C1441547:Derived [Qualitative Concept]
   770   C3245521:derived [Idea or Concept]

Phrase: "or"

Phrase: "transgenic mice,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "that"

Phrase: "can"

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "endogenous levels of PML"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "RAR."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538821:RAR [Gene or Genome]
Processing 00000000.tx.231: This high-penetrance model of APL is, therefore, associated with an extremely low level of PML-RAR expression in early myeloid cells. 

Phrase: "This high-penetrance model of APL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C3161035:Model [Intellectual Product]

Phrase: "is"

Phrase: ","

Phrase: "therefore,"

Phrase: "associated with an extremely low level of PML-RAR expression"
Meta Candidates (Total=18; Excluded=2; Pruned=0; Remaining=16)
   756   C0023487:Promyelocytic Leukemia [Neoplastic Process]
   756   C0332281:Associated with [Qualitative Concept]
           Associated
   756   C1366903:promyelocytic leukemia [Gene or Genome]
   756   C2745900:Promyelocytic leukemia [Neoplastic Process]
   754   C3244092:expression level [Idea or Concept]
   738   C0023418:Leukaemia [Neoplastic Process]
   738   C0185117:Expression [Therapeutic or Preventive Procedure]
   738   C0205251:low [Qualitative Concept]
   738   C0441889:Level [Qualitative Concept]
   738   C0456079:Level [Classification]
   738   C1299352:Low [Qualitative Concept]
   738   C1547707:Level [Geographic Area]
   738   C1550472:low [Idea or Concept]
   738   C2946261:Level [Pharmacologic Substance]
   738   C3538821:RAR [Gene or Genome]
   704 E C0750490:Associate [Idea or Concept]
   704 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in early myeloid cells."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   901   C0887899:Myeloid Cells [Cell]
   867 E C0596993:Myeloid cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0439677:Myeloid [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.232: A number of explanations could account for these unexpected results: first, the mouse strains used to generate the 2 models are different. 

Phrase: "A number of explanations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "could"

Phrase: "account for these unexpected results"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C1551359:account [Idea or Concept]
   760   C2741673:Account # [Clinical Attribute]
   760   C2981730:Account [Classification]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: ":"

Phrase: "first,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "the mouse strains"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1513684:Mouse Strains [Mammal]
   861   C0080194:Strains [Injury or Poisoning]
   861   C0456178:strains [Intellectual Product]
   827 E C1518614:Strain [Organism]
   827 E C2987481:Strain [Mental Process]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "generate"

Phrase: "the 2 models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Models [Intellectual Product]

Phrase: "are"

Phrase: "different."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1705242:Different [Qualitative Concept]
   928 E C1705241:*Difference [Quantitative Concept]
   900 E C0443199:Differential [Qualitative Concept]
Processing 00000000.tx.233: Our transgenic model was made in C3H x C57Bl/6 mice, and the knock-in model was made in 129/SvJ x C57Bl/6 mice. 

Phrase: "Our transgenic model"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1519606:Transgenic Model [Experimental Model of Disease]
   861   C3161035:Model [Intellectual Product]

Phrase: "was"

Phrase: "made in C3H x C57Bl/6 mice,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   802   C1521751:C57BL/6 Mouse [Mammal]
           C57BL/6
   774   C0025920:Mice, C3H [Mammal]
           C3H
   774   C0025921:Mice, C57BL [Mammal]
           C57BL
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]
   714   C1881534:Make [Functional Concept]

Phrase: "and"

Phrase: "the knock-in model"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C3161035:Model [Intellectual Product]
   734   C1517676:Knock-in [Research Activity]

Phrase: "was"

Phrase: "made in 129/SvJ x C57Bl/6 mice."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   789   C1521751:C57BL/6 Mouse [Mammal]
           C57BL/6
   767   C0025921:Mice, C57BL [Mammal]
           C57BL
   767   C1520439:Mice, 129 [Mammal]
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]
   711   C1881534:Make [Functional Concept]
Processing 00000000.tx.234: The 129/SvJ component could potentially provide a susceptibility locus for APL development that has not yet been characterized. 

Phrase: "The 129/SvJ component"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449432:Component [Manufactured Object]
   827   C1705248:Component [Conceptual Entity]

Phrase: "could"

Phrase: "potentially"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "a susceptibility locus for APL development"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1708726:Locus [Gene or Genome]

Phrase: "that"

Phrase: "has"

Phrase: "not yet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "characterized."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]
Processing 00000000.tx.235: This possibility seems unlikely to us, because the PML-RAR cDNA has previously been expressed in a number of different genetic backgrounds, and the latency and penetrance of APL development in all strains has been similar.1-5 However, this remains a formal possibility, and a backcross to C57Bl/6 mice is, therefore, in progress; 

Phrase: "This possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]

Phrase: "seems"

Phrase: "unlikely to us,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0750558:Unlikely [Conceptual Entity]
   790   C1710571:Unlikely [Qualitative Concept]

Phrase: "because"

Phrase: "the PML-RAR cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "has"

Phrase: "previously"

Phrase: "been"

Phrase: "expressed in a number of different genetic backgrounds,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   774   C3172256:Number of birth [Finding]
   744   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   744   C0237753:*Number [Quantitative Concept]
   744   C0314603:Genetic [Functional Concept]
   744   C0449788:Number [Quantitative Concept]
   744   C1705242:Different [Qualitative Concept]
   711   C1706907:Background [Conceptual Entity]

Phrase: "and"

Phrase: "the latency"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0205275:Latent [Qualitative Concept]

Phrase: "and"

Phrase: "penetrance of APL development"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0524899:Penetrance [Quantitative Concept]

Phrase: "in all"

Phrase: "strains"
Meta Candidates (Total=11; Excluded=7; Pruned=0; Remaining=4)
  1000   C0080194:Strain [Injury or Poisoning]
  1000   C0456178:strain [Intellectual Product]
  1000   C1518614:Strain [Organism]
  1000   C2987481:Strain [Mental Process]
   944 E C0180860:Filter [Manufactured Object]
   944 E C0581406:Filter [Medical Device]
   944 E C1522664:Filter [Intellectual Product]
   944 E C1704449:Filter [Conceptual Entity]
   944 E C1704684:Filter [Medical Device]
   944 E C1875155:FILTER [Medical Device]
   916 E C0442694:Straining [Physiologic Function]

Phrase: "has"

Phrase: "been"

Phrase: "similar.1-5 However,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2348205:Similar [Qualitative Concept]

Phrase: "this"

Phrase: "remains"

Phrase: "a formal possibility,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   789   C0332149:Possible [Qualitative Concept]
   789   C1705910:Possible [Qualitative Concept]
   789   C2362652:Possible [Qualitative Concept]

Phrase: "and"

Phrase: "a backcross to C57Bl/6 mice"

Phrase: "is"

Phrase: ","

Phrase: "therefore,"

Phrase: "in progress"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1272688:In progress [Functional Concept]
           progress
  1000   C1548387:in progress [Idea or Concept]
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]
   861   C1280477:Progress [Functional Concept]

Phrase: ";"
Processing 00000000.tx.236: this experiment will require another 2 to 3 years to complete. 

Phrase: "this experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "will"

Phrase: "require"

Phrase: "another 2 to 3 years to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0439234:years [Temporal Concept]
   719 E C0439508:/year [Temporal Concept]

Phrase: "complete."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Complete [Qualitative Concept]
Processing 00000000.tx.237: Second, the knock-in mutation actually results in both a gain-of-function and a loss-of-function change in each cathepsin G locus. 

Phrase: "Second,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "the knock-in mutation actually"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0026882:Mutation [Genetic Function]
   812   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "results in both"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1274040:Result [Functional Concept]
   790   C1546471:Result [Idea or Concept]
   790   C2825142:Result [Finding]

Phrase: "a gain-of-function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0031843:function [Physiologic Function]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1705273:Function [Intellectual Product]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]

Phrase: "and"

Phrase: "a loss-of-function change in each cathepsin G locus."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0392747:Change [Functional Concept]
   739   C0443172:change [Quantitative Concept]
   739   C1705241:Change [Quantitative Concept]
Processing 00000000.tx.238: The gain-of-function mutation is provided by the PML-RAR cDNA placed in the 5'-UT of the cathepsin G gene. 

Phrase: "The gain-of-function mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0026882:Mutation [Genetic Function]
   812   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "is"

Phrase: "provided by the PML-RAR cDNA"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0023487:Promyelocytic Leukemia [Neoplastic Process]
   778   C1366903:promyelocytic leukemia [Gene or Genome]
   778   C2745900:Promyelocytic leukemia [Neoplastic Process]
   748   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0023418:Leukaemia [Neoplastic Process]
   748   C1999230:Provided [Activity]
   748   C3538821:RAR [Gene or Genome]

Phrase: "placed in the 5'-UT of the cathepsin G gene."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   782   C1413814:Cathepsin G Gene [Gene or Genome]
           CATHEPSIN G
   760   C0054868:Cathepsin G [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0017337:Gene [Gene or Genome]
   739   C0042124:UT [Geographic Area]
   739   C0439267:g% [Quantitative Concept]
   706   C0442504:Place [Spatial Concept]
   706   C1704765:Place [Functional Concept]
   706   C1882509:Place [Activity]
   706   C3496241:place [Disease or Syndrome]
Processing 00000000.tx.239: This mutation also causes a loss-of-function change: a null mutation of the same cathepsin G gene. 

Phrase: "This mutation also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "a loss-of-function change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0392747:Change [Functional Concept]
   812   C0443172:change [Quantitative Concept]
   812   C1705241:Change [Quantitative Concept]

Phrase: ":"

Phrase: "a null mutation of the same cathepsin G gene."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0596611:Gene Mutation [Genetic Function]
   742   C0026882:Mutation [Genetic Function]
   742   C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.240: However, it does not appear that the loss-of-function mutation plays a significant role in the phenotype. 

Phrase: "However,"

Phrase: "it"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "that"

Phrase: "the loss-of-function mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0026882:Mutation [Genetic Function]
   812   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a significant role in the phenotype."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.241: We did not observe a further alteration in the latency or penetrance of APL in knock-in mice that had a null mutation of cathepsin G on the residual allele. 

Phrase: "We"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observe"

Phrase: "a further alteration in the latency"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1515926:Alteration [Idea or Concept]

Phrase: "or"

Phrase: "penetrance of APL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0524899:Penetrance [Quantitative Concept]

Phrase: "in knock-in mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1517676:Knock-in [Research Activity]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "that"

Phrase: "had"

Phrase: "a null mutation of cathepsin G"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0026882:Mutation [Genetic Function]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "on the residual allele."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.242: Furthermore, because cathepsin G null mice lack any detectable alterations in myeloid development21 and do not develop AML, the cathepsin G haploinsufficiency caused by the targeting event is unlikely to have affected these results. 

Phrase: "Furthermore,"

Phrase: "because"

Phrase: "cathepsin G null mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   844   C0206745:Null Mouse [Mammal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "lack"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "any detectable alterations in myeloid development21"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1515926:Alteration [Idea or Concept]

Phrase: "and"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "develop"

Phrase: "AML,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0023467:Acute myelogenous leukaemia [Neoplastic Process]
   913   C0085669:Acute leukaemia [Neoplastic Process]
   913   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   901   C0023470:Myelogenous Leukemia [Neoplastic Process]
   827   C0023418:Leukaemia [Neoplastic Process]
   827   C0205178:acute [Temporal Concept]
   827   C0439677:Myelogenous [Qualitative Concept]

Phrase: "the cathepsin G haploinsufficiency"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C2936267:Haploinsufficiency [Cell or Molecular Dysfunction]
   734   C0054868:Cathepsin G [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1413814:CATHEPSIN G [Gene or Genome]

Phrase: "caused by the targeting event"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0441471:Event [Event]
   760   C1521840:Targeting [Functional Concept]
   726   C0015127:cause [Functional Concept]
   726   C1524003:Cause [Conceptual Entity]
   726 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "is"

Phrase: "unlikely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0750558:Unlikely [Conceptual Entity]
   861   C1710571:Unlikely [Qualitative Concept]

Phrase: "have"

Phrase: "affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "these results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]
Processing 00000000.tx.243: Third, it is possible that there is a difference in the early myeloid compartment targeted by the human cathepsin G transgene versus the knock-in cathepsin G locus. 

Phrase: "Third,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205437:Third [Quantitative Concept]

Phrase: "it"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that there"

Phrase: "is"

Phrase: "a difference in the early myeloid compartment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1705241:*Difference [Quantitative Concept]
   748   C1705242:Difference [Qualitative Concept]

Phrase: "targeted by the human cathepsin G transgene"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   778   C0054868:Cathepsin G [Amino Acid, Peptide, or Protein,Enzyme]
   778   C1413814:CATHEPSIN G [Gene or Genome]
   748   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0086418:Human [Human]
   748   C0282641:Transgene [Gene or Genome]
   748   C0439267:g% [Quantitative Concept]
   748   C1521840:Targeted [Functional Concept]
   714 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "versus"

Phrase: "the knock-in cathepsin G locus."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1708726:Locus [Gene or Genome]
Processing 00000000.tx.244: To explore this possibility, we purified Sca+Lineage mononuclear cells from 5-fluorouracil (5-FU)treated transgenic and knock-in bone marrow cells maintained in stem cell factor, Flt3 ligand, interleukin 3 (IL-3), and thrombopoietin (TPO) for 3 days. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "explore"

Phrase: "this possibility,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]

Phrase: "we"

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "Sca+Lineage mononuclear cells from 5-fluorouracil (5-FU)"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   778   C0806987:Mononuclear cells [Cell]
   757   C0282637:Cell Lineage [Idea or Concept]
   748   C0007634:Cells [Cell]
   748   C1513475:Mononuclear [Clinical Attribute]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "transgenic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003069:Transgenic [Animal]

Phrase: "and"

Phrase: "knock-in bone marrow cells"
Meta Candidates (Total=21; Excluded=9; Pruned=0; Remaining=12)
   884   C0005955:Bone Marrow Cells [Cell]
   853   C0222677:Bone cells [Cell]
   840   C0005953:Bone Marrow [Tissue]
   836 E C0029432:Bone cell [Cell]
   804   C0007634:Cells [Cell]
   804   C0086590:Marrow [Food]
   804   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   804   C0376152:Marrow [Body Part, Organ, or Organ Component]
   804   C0391978:Bone [Tissue]
   804   C1266908:Bone [Body Part, Organ, or Organ Component]
   804   C1266909:Bone [Body System]
   804   C1546708:Marrow [Intellectual Product]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   748 E C0001629:Medullary [Body Part, Organ, or Organ Component]
   748 E C0025148:Medullary [Body Part, Organ, or Organ Component]
   748 E C1550278:Medullary [Body Part, Organ, or Organ Component]
   733 E C0443157:Bony [Functional Concept]
   721 E C0330477:Marrows [Plant]

Phrase: "maintained in stem cell factor,"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   862   C0143630:Stem Cell Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C0038250:Stem cell [Cell]
   760   C0007634:Cell [Cell]
   760   C0242767:Stem [Plant]
   760   C1186763:Stem [Body Part, Organ, or Organ Component]
   760   C1269647:Cell [Cell]
   760   C1314677:Maintained [Functional Concept]
   760   C1521761:Factor [Functional Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C2827422:Factor [Conceptual Entity]
   726 E C0024501:Maintain [Activity]

Phrase: "Flt3 ligand,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0249989:FLT3 ligand [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1442820:FLT 3 Ligand [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522457:FLT 3 Ligand [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0023688:Ligand [Chemical]
   861   C0251006:FLT-3 [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "interleukin 3 (IL-3),"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021757:Interleukin-3 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1334117:INTERLEUKIN 3 [Gene or Genome]
   861   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "thrombopoietin (TPO) for 3 days."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0040052:Thrombopoietin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0812443:THROMBOPOIETIN [Gene or Genome]
Processing 00000000.tx.245: Analysis of these populations does not show any significant difference in PML-RAR mRNA expression measured by real time RT-PCR. 

Phrase: "Analysis of these populations"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C1514228:Population Analysis [Research Activity]
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "any significant difference in PML-RAR mRNA expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1705241:*Difference [Quantitative Concept]
   742   C1705242:Difference [Qualitative Concept]

Phrase: "measured by real time RT-PCR."
Meta Candidates (Total=18; Excluded=2; Pruned=0; Remaining=16)
   832   C1709846:Real-Time Polymerase Chain Reaction [Molecular Biology Research Technique]
   790   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   764   C1550177:Real Time [Idea or Concept]
   762   C0034746:Reaction Time [Temporal Concept]
   742   C0040223:Time [Temporal Concept]
   742   C0237400:Real [Qualitative Concept]
   742   C0337112:Chain [Manufactured Object]
   742   C0443286:Reaction [Functional Concept]
   742   C0444706:Measured [Qualitative Concept]
   742   C1114821:Reaction [Clinical Attribute]
   742   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C1524075:Chain [Idea or Concept]
   742   C1555029:Reverse [Idea or Concept]
   742   C3272377:REAL [Intellectual Product]
   742   C3541383:Time [Temporal Concept]
   742   C3541902:MEASURED [Diagnostic Procedure]
   708 E C0079809:Measure [Quantitative Concept]
   708 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.246: Culturing these cells for 2 days in media containing stem cell factor and granulocyte colony-stimulating factor (G-CSF) induces differentiation of the immature progenitor cells into a predominantly promyelocytic population; 

Phrase: "Culturing"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0010453:Culture [Idea or Concept]
   966   C0220814:culture [Functional Concept]
   966   C0430400:Culture [Laboratory Procedure]
   966   C2242979:Culture [Laboratory Procedure]

Phrase: "these cells for 2 days"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "in media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "stem cell factor"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0143630:Stem Cell Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0038250:Stem cell [Cell]
   827   C0007634:Cell [Cell]
   827   C0242767:Stem [Plant]
   827   C1186763:Stem [Body Part, Organ, or Organ Component]
   827   C1269647:Cell [Cell]
   827   C1521761:Factor [Functional Concept]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "granulocyte colony-stimulating factor (G-CSF)"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0079459:Granulocyte Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   923   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0018183:granulocyte [Cell]
   812   C0439158:colony [Quantitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C1947989:Colony [Cell]
   812   C1948023:Stimulating [Natural Phenomenon or Process]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "differentiation of the immature progenitor cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0007589:cells differentiation [Cell Function]
           Differentiation
   753   C1511938:Differentiation [Clinical Attribute]
   753   C2945687:Differentiation [Functional Concept]

Phrase: "into a predominantly promyelocytic population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032659:Population [Quantitative Concept]
   827   C1257890:Population [Population Group]

Phrase: ";"
Processing 00000000.tx.247: these cells display the same relative levels of PML-RAR expression as seen in Figure 4 (Lane et al27 and A.A.L. and T.J.L., unpublished observation). 

Phrase: "these cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "the same relative levels of PML-RAR expression"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   745   C3244092:expression level [Idea or Concept]
   742   C0441889:Levels [Qualitative Concept]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "as"

Phrase: "seen in Figure 4"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0205397:Seen [Qualitative Concept]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]

Phrase: "(Lane et al27"

Phrase: "and"

Phrase: "A.A.L."

Phrase: "and"

Phrase: "T.J.L., unpublished observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   804   C0302523:Observation [Research Activity]
   804   C0700325:observation [Health Care Activity]
   804   C1964257:Observation [Diagnostic Procedure]
   733 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: ")."
Processing 00000000.tx.248: This observation suggests that the knock-in mCG locus does not target expression to a significantly earlier myeloid progenitor compartment than the hCG transgene. 

Phrase: "This observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the knock-in mCG locus"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "target"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521840:Target [Functional Concept]
  1000   C2986546:TARGET [Diagnostic Procedure]

Phrase: "expression to a significantly earlier myeloid progenitor compartment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "than the hCG transgene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0282641:Transgene [Gene or Genome]
Processing 00000000.tx.249: Fourth, the translatability of the PML-RAR mRNA produced in the knock-in mice may be greater than that of the transgenic model, in which the mRNA is produced from a long concatemer of transgenes. 

Phrase: "Fourth,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205438:Fourth [Quantitative Concept]
  1000   C1706303:Fourth [Qualitative Concept]

Phrase: "the translatability of the PML-RAR mRNA"

Phrase: "produced in the knock-in mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C1517676:Knock-in [Research Activity]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]

Phrase: "may"

Phrase: "be"

Phrase: "greater than that of the transgenic model,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   778   C0439093:Greater Than [Quantitative Concept]
   748   C0443228:greater [Quantitative Concept]
   748   C1704243:Greater [Quantitative Concept]
   714 E C0549177:Great [Quantitative Concept]

Phrase: "in which"

Phrase: "the mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "produced from a long concatemer of transgenes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0205166:Long [Qualitative Concept]
   748   C0282641:Transgenes [Gene or Genome]
   748   C1706317:Long [Qualitative Concept]
Processing 00000000.tx.250: We cannot directly address this point, because we cannot accurately measure total PML-RAR protein levels via sensitive Western blotting techniques. 

Phrase: "We"

Phrase: "cannot"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "this point,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552961:Point [Quantitative Concept]
  1000   C2347617:point [Quantitative Concept]

Phrase: "because"

Phrase: "we"

Phrase: "cannot"

Phrase: "accurately"

Phrase: "measure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]

Phrase: "total PML-RAR protein levels via sensitive Western blotting techniques."
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   772   C0146495:Promyelocytic Leukemia Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   772   C3476424:Promyelocytic leukemia protein [Amino Acid, Peptide, or Protein]
   754   C0005863:protein blotting [Laboratory Procedure,Molecular Biology Research Technique]
   754   C0439177:Protein.total [Quantitative Concept]
   754   C0555903:Total protein [Laboratory Procedure]
   754   C1261360:total protein [Laboratory or Test Result]
   754   C3539752:Protein Rar [Amino Acid, Peptide, or Protein]
   738   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0441889:Levels [Qualitative Concept]
   722   C0428479:Protein level [Laboratory or Test Result]
   704 E C0456079:Level [Classification]
   704 E C1547707:Level [Geographic Area]
   704 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.251: However, in many previous studies of multicopy transgenic mice in which RNA and protein levels could be measured, direct correlations were observed.28-30 For this reason, we feel that this explanation for these results is unlikely. 

Phrase: "However,"

Phrase: "in many previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "of multicopy transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0025936:Mice, Transgenic [Mammal]
   827   C0003069:Transgenic [Animal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "in which RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "protein levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   966   C0428479:Protein level [Laboratory or Test Result]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "could"

Phrase: "be"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: ","

Phrase: "direct correlations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1707520:Correlation [Qualitative Concept]

Phrase: "were"

Phrase: "observed.28-30 For this reason,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392360:Reason [Idea or Concept]
   753   C1441672:Observed [Functional Concept]

Phrase: "we"

Phrase: "feel"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013987:feel [Mental Process]
   916 E C1527305:Feeling, NOS [Mental Process]

Phrase: "that"

Phrase: "this explanation for these results"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0681841:Explanation [Intellectual Product]

Phrase: "is"

Phrase: "unlikely."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750558:Unlikely [Conceptual Entity]
  1000   C1710571:Unlikely [Qualitative Concept]
Processing 00000000.tx.252: Finally, it is possible that there is a narrow "window" of PML-RAR expression in early myeloid cells that is optimal to cause the changes that ultimately lead to the development of APL. 

Phrase: "Finally,"

Phrase: "it"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that there"

Phrase: "is"

Phrase: "a narrow ""window"""
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "of PML-RAR expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in early myeloid cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   901   C0887899:Myeloid Cells [Cell]
   867 E C0596993:Myeloid cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0439677:Myeloid [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "is"

Phrase: "optimal to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2698651:Optimal [Qualitative Concept]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "the changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "that ultimately"

Phrase: "lead to the development of APL."
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   800   C0023487:Acute Promyelocytic Leukemia [Neoplastic Process]
           Promyelocytic Leukemia
   770   C1366903:promyelocytic leukemia [Gene or Genome]
   770   C2745900:Promyelocytic leukemia [Neoplastic Process]
   767   C0085669:Acute leukaemia [Neoplastic Process]
   767   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   744   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   744   C0023418:Leukaemia [Neoplastic Process]
   744   C0205178:acute [Temporal Concept]
   744   C0243107:development [Physiologic Function]
   744   C0678723:Development [Organism Function]
   744   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   744   C1522538:Lead [Functional Concept]
   744   C1527148:Development [Functional Concept]
   744   C2348269:Lead [Element, Ion, or Isotope]
   744   C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.253: If levels of this protein are too high in these cells, they may die or become disabled, so that they cannot contribute to APL development. 

Phrase: "If"

Phrase: "levels of this protein"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   802   C0428479:Protein level [Laboratory or Test Result]
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "too high in these cells,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205250:High [Qualitative Concept]
   760   C1299351:High [Qualitative Concept]
   760   C2700149:HIGH [Intellectual Product]

Phrase: "they"

Phrase: "may"

Phrase: "die"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   944   C0011065:Expired [Organism Function]
   944   C0231800:Expired [Organ or Tissue Function]
   944   C1704631:Expire [Idea or Concept]
   916 E C0184532:dying [Organism Function]
   916 E C1546956:Died [Finding]
   916 E C1553404:terminated [Idea or Concept]
   916 E C2348570:Terminated [Functional Concept]

Phrase: "or"

Phrase: "become"

Phrase: "disabled, so"

Phrase: "that"

Phrase: "they"

Phrase: "cannot"

Phrase: "contribute to APL development."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C0023487:Acute Promyelocytic Leukemia [Neoplastic Process]
           Promyelocytic Leukemia
   790   C1366903:promyelocytic leukemia [Gene or Genome]
   790   C2745900:Promyelocytic leukemia [Neoplastic Process]
   783   C0085669:Acute leukaemia [Neoplastic Process]
   783   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   753   C0023418:Leukaemia [Neoplastic Process]
   753   C0205178:acute [Temporal Concept]
   753   C0243107:development [Physiologic Function]
   753   C0678723:Development [Organism Function]
   753   C1527148:Development [Functional Concept]
   753   C1880177:Contribute [Activity]
Processing 00000000.tx.254: A larger pool of cells expressing a smaller amount of protein may make it more likely that the critical "hits" needed for APL progression may occur in a larger fraction of mice. 

Phrase: "A larger pool of cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0337051:Pool [Geographic Area]
   760   C1509144:pool [Clinical Attribute]
   760   C2349200:Pool [Functional Concept]

Phrase: "expressing"

Phrase: "a smaller amount of protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "may"

Phrase: "make"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "it more likely"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205172:More [Functional Concept]
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "that"

Phrase: "the critical """
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511545:Critical [Qualitative Concept]

Phrase: "hits"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0272285:HIT [Disease or Syndrome]
  1000   C0332159:hit [Functional Concept]
  1000   C0596020:Hits [Finding]
  1000   C1708373:Hit [Functional Concept]

Phrase: """"

Phrase: "needed for APL progression"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C0023487:Acute Promyelocytic Leukemia [Neoplastic Process]
           Promyelocytic Leukemia
   790   C1366903:promyelocytic leukemia [Gene or Genome]
   790   C2745900:Promyelocytic leukemia [Neoplastic Process]
   783   C0085669:Acute leukaemia [Neoplastic Process]
   783   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   753   C0023418:Leukaemia [Neoplastic Process]
   753   C0027552:Needed [Qualitative Concept]
   753   C0205178:acute [Temporal Concept]
   753   C0242656:progression [Pathologic Function]
   753   C0449258:Progression [Functional Concept]
   753   C0686904:needed [Functional Concept]

Phrase: "may"

Phrase: "occur in a larger fraction of mice."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   778   C1264633:Fraction of [Quantitative Concept]
           Fraction
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]
   748   C0443228:larger [Quantitative Concept]
   748   C0549177:Larger [Quantitative Concept]
   748   C1554103:Fraction [Idea or Concept]
   748   C1704243:Larger [Quantitative Concept]
   748   C1709305:Occur [Activity]
   748   C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.255: The slightly decreased latency seen with 2 copies of PML-RAR may reflect a narrow dose response for this protein, perhaps by increasing the proportion of early myeloid cells that are susceptible for secondary transforming events. 

Phrase: "The slightly decreased latency"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   755   C0205275:Latent [Qualitative Concept]

Phrase: "seen with 2 copies of PML-RAR"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   770   C0023487:Promyelocytic Leukemia [Neoplastic Process]
   770   C1366903:promyelocytic leukemia [Gene or Genome]
   770   C2745900:Promyelocytic leukemia [Neoplastic Process]
   767   C1425419:Rar-2 [Gene or Genome]
   744   C0023418:Leukaemia [Neoplastic Process]
   744   C0205397:Seen [Qualitative Concept]
   744   C1948062:Copies [Manufactured Object]
   744   C3538821:RAR [Gene or Genome]
   711 E C0042789:see [Organism Function]
   711 E C1947903:See [Activity]

Phrase: "may"

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "a narrow dose response for this protein,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0178602:Dose [Quantitative Concept]
   748   C0869039:Dose [Quantitative Concept]
   748   C0871261:Response [Organism Attribute]
   748   C1114758:Dose # [Clinical Attribute]
   748   C1704632:Response [Finding]
   748   C1706817:Response [Intellectual Product]
   748   C2911692:Response [Mental Process]

Phrase: "perhaps by increasing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0442808:Increasing [Functional Concept]
   756 E C0442805:Increase [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "the proportion of early myeloid cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1709707:Proportion [Quantitative Concept]

Phrase: "that"

Phrase: "are"

Phrase: "susceptible for secondary transforming events."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0231204:Susceptible [Functional Concept]
   760   C2827758:SUSCEPTIBLE [Laboratory or Test Result]
Processing 00000000.tx.256: These observations are supported by observations from Grignani et al31 and Ferrucci et al32 that have shown that PML-RAR can be toxic to hematopoietic cells when overexpressed. 

Phrase: "These observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "are"

Phrase: "supported by observations"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0302523:observations [Research Activity]
   790   C0700325:observations [Health Care Activity]
   790   C1521721:Supported [Conceptual Entity]
   790   C3244290:observations [Functional Concept]
   756 E C0183683:Support [Medical Device]
   756 E C1964257:Observation [Diagnostic Procedure]
   706 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "from Grignani et al31"

Phrase: "and"

Phrase: "Ferrucci et al32"

Phrase: "that"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that PML-RAR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C3538821:RAR [Gene or Genome]
   734   C0023487:Promyelocytic Leukemia [Neoplastic Process]
   734   C1366903:promyelocytic leukemia [Gene or Genome]
   734   C2745900:Promyelocytic leukemia [Neoplastic Process]

Phrase: "can"

Phrase: "be"

Phrase: "toxic to hematopoietic cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0600688:toxic [Injury or Poisoning]
   770   C1407029:Toxic [Qualitative Concept]

Phrase: "when"

Phrase: "overexpressed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]
Processing 00000000.tx.257: Furthermore, in a recent study from Minucci et al,33 splenic APL tumors derived from cells transduced with a retrovirus expressing PML-RAR and an IRES-GFP cassette yielded no detectable green fluorescent protein (GFP)positive cells. 

Phrase: "Furthermore,"

Phrase: "in a recent study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "from Minucci et al,33 splenic APL tumors"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   791   C0027651:Tumors [Neoplastic Process]
   758 E C1578706:Tumor [Intellectual Product]
   758 E C3273930:Tumor [Finding]

Phrase: "derived from cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0007634:Cells [Cell]
   790   C1441547:Derived [Qualitative Concept]
   790   C3245521:derived [Idea or Concept]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "transduced with a retrovirus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0035366:Retrovirus [Virus]

Phrase: "expressing"

Phrase: "PML-RAR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C3538821:RAR [Gene or Genome]
   734   C0023487:Promyelocytic Leukemia [Neoplastic Process]
   734   C1366903:promyelocytic leukemia [Gene or Genome]
   734   C2745900:Promyelocytic leukemia [Neoplastic Process]

Phrase: "and"

Phrase: "an IRES-GFP cassette"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0450240:Cassette [Medical Device]
   804   C1706210:Cassette [Manufactured Object]
   717   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "yielded"

Phrase: "no detectable green fluorescent protein (GFP)positive cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0439178:% positive cells [Quantitative Concept]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.258: These results support the hypothesis that cells expressing high levels of PML-RAR may be deleted in vivo. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "high levels of PML-RAR"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "may"

Phrase: "be"

Phrase: "deleted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880274:Deleted [Activity]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.259: An interstitial deletion of chromosome 2 was detected in 2 of 9 APL tumors obtained from the knock-in mice. 

Phrase: "An interstitial deletion of chromosome 2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0008628:Deletion of chromosome NOS [Cell or Molecular Dysfunction]
           Chromosome Deletion
   753   C1442161:Deletion [Cell or Molecular Dysfunction]
   753   C1511760:Deletion [Genetic Function]
   753   C1880274:Deletion [Activity]

Phrase: "was"

Phrase: "detected in 2 of 9 APL tumors"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   790   C0023487:Acute Promyelocytic Leukemia [Neoplastic Process]
           Promyelocytic Leukemia
   764   C1366903:promyelocytic leukemia [Gene or Genome]
   764   C2745900:Promyelocytic leukemia [Neoplastic Process]
   762   C0085669:Acute leukaemia [Neoplastic Process]
   762   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   742   C0023418:Leukaemia [Neoplastic Process]
   742   C0027651:Tumors [Neoplastic Process]
   742   C0205178:acute [Temporal Concept]
   742   C0442726:Detected [Finding]
   742   C1511790:Detected [Therapeutic or Preventive Procedure]
   708 E C1578706:Tumor [Intellectual Product]
   708 E C3273930:Tumor [Finding]

Phrase: "obtained from the knock-in mice."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C1517676:Knock-in [Research Activity]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C1301820:Obtained [Functional Concept]
   719 E C1706701:Obtain [Activity]
Processing 00000000.tx.260: This frequency is similar to that detected in transgenic hCGPML-RAR mice (1 of 5) and in MRP8PML-RAR mice (3 of 30),10 but it is significantly different (P < .05) from that seen in transgenic hCGPML-RAR x hCGRAR-PML mice, in which 11 of 13 tumors contained del(2).9 These results show that a high-penetrance model of APL is not necessarily associated with a high frequency of del(2) during progression. 

Phrase: "This frequency"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0376249:frequency [Quantitative Concept]
  1000   C0439603:Frequency [Temporal Concept]
  1000   C0871396:Frequency [Quantitative Concept]
  1000   C1561548:Frequency [Qualitative Concept]
  1000   C1705502:Frequency [Quantitative Concept]
   928 E C0332183:Frequent [Temporal Concept]

Phrase: "is"

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "detected in transgenic hCGPML-RAR mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   783   C0025936:Mice, Transgenic [Mammal]
   753   C0003069:Transgenic [Animal]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0442726:Detected [Finding]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C3538821:RAR [Gene or Genome]

Phrase: "(1 of 5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C0450316:1/5 [Quantitative Concept]
   790   C2827734:1+ [Quantitative Concept]
   790   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and in MRP8PML-RAR mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C1515981:And [Idea or Concept]
   760   C3538821:RAR [Gene or Genome]

Phrase: "(3 of 30"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0439086:<3 [Quantitative Concept]
   790   C2827736:3+ [Quantitative Concept]
   790   C2981702:3+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "10"

Phrase: "but"

Phrase: "it"

Phrase: "is"

Phrase: "significantly different"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1705242:Different [Qualitative Concept]
   789 E C1705241:*Difference [Quantitative Concept]
   761 E C0443199:Differential [Qualitative Concept]

Phrase: "(P < .05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "from that"

Phrase: "seen in transgenic hCGPML-RAR x hCGRAR-PML mice,"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   760   C0023487:Promyelocytic Leukemia [Neoplastic Process]
   760   C1366903:promyelocytic leukemia [Gene or Genome]
   760   C2745900:Promyelocytic leukemia [Neoplastic Process]
   757   C0025936:Mice, Transgenic [Mammal]
   741   C0596978:Mouse Leukemia [Neoplastic Process]
   739   C0003069:Transgenic [Animal]
   739   C0023418:Leukaemia [Neoplastic Process]
   739   C0025914:Mice [Mammal]
   739   C0025929:mice [Mammal]
   739   C0026809:Mice [Mammal]
   739   C0205397:Seen [Qualitative Concept]
   739   C3538821:RAR [Gene or Genome]
   706 E C0042789:see [Organism Function]
   706 E C1947903:See [Activity]

Phrase: "in which 11"

Phrase: "of 13 tumors"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0027651:Tumors [Neoplastic Process]
   827 E C1578706:Tumor [Intellectual Product]
   827 E C3273930:Tumor [Finding]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "del(2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0008628:del [Cell or Molecular Dysfunction]

Phrase: ").9"

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "a high-penetrance model of APL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C3161035:Model [Intellectual Product]

Phrase: "is"

Phrase: "not necessarily"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "associated with a high frequency of del(2"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   770   C0205212:High frequency [Temporal Concept]
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   744   C0008628:del [Cell or Molecular Dysfunction]
   744   C0205250:High [Qualitative Concept]
   744   C0376249:frequency [Quantitative Concept]
   744   C0439603:Frequency [Temporal Concept]
   744   C0871396:Frequency [Quantitative Concept]
   744   C1299351:High [Qualitative Concept]
   744   C1561548:Frequency [Qualitative Concept]
   744   C1705502:Frequency [Quantitative Concept]
   744   C2700149:HIGH [Intellectual Product]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]

Phrase: ")"

Phrase: "during progression."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242656:progression [Pathologic Function]
  1000   C0449258:Progression [Functional Concept]
Processing 00000000.tx.261: The data also support the hypothesis that it is truly the expression of the RAR-PML cDNA that facilitates the acquisition of del(2) in hCGPML-RAR x hCGRAR-PML mice.9 Collectively, these results suggest that there are many kinds of genetic events that can contribute to APL progression in the mouse model and that del(2) is simply one of the most obvious and frequently detected at the whole chromosome level. 

Phrase: "The data also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that"

Phrase: "it"

Phrase: "is"

Phrase: "truly"

Phrase: "the expression of the RAR-PML cDNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1515563:cDNA Expression [Molecular Biology Research Technique]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "that"

Phrase: "facilitates"

Phrase: "the acquisition of del(2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1706701:Acquisition [Activity]

Phrase: ")"

Phrase: "in hCGPML-RAR x hCGRAR-PML mice.9 Collectively,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   807   C0023487:Promyelocytic Leukemia [Neoplastic Process]
   807   C1366903:promyelocytic leukemia [Gene or Genome]
   807   C2745900:Promyelocytic leukemia [Neoplastic Process]
   791   C0023418:Leukaemia [Neoplastic Process]
   791   C0025914:Mice [Mammal]
   791   C0025929:mice [Mammal]
   791   C0026809:Mice [Mammal]
   791   C3538821:RAR [Gene or Genome]

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that there"

Phrase: "are"

Phrase: "many kinds of genetic events"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0332307:Kind [Qualitative Concept]

Phrase: "that"

Phrase: "can"

Phrase: "contribute to APL progression"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   833   C0023487:Acute Promyelocytic Leukemia [Neoplastic Process]
           Promyelocytic Leukemia
   790   C1366903:promyelocytic leukemia [Gene or Genome]
   790   C2745900:Promyelocytic leukemia [Neoplastic Process]
   783   C0085669:Acute leukaemia [Neoplastic Process]
   783   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   753   C0023418:Leukaemia [Neoplastic Process]
   753   C0205178:acute [Temporal Concept]
   753   C0242656:progression [Pathologic Function]
   753   C0449258:Progression [Functional Concept]
   753   C1880177:Contribute [Activity]

Phrase: "in the mouse model"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2986594:Mouse Model [Experimental Model of Disease]
   861   C3161035:Model [Intellectual Product]

Phrase: "and"

Phrase: "that del(2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0008628:del [Cell or Molecular Dysfunction]

Phrase: ")"

Phrase: "is"

Phrase: "simply one of the most obvious"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205447:One [Quantitative Concept]

Phrase: "and"

Phrase: "frequently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Frequently [Temporal Concept]

Phrase: "detected at the whole chromosome level."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0450238:Whole chromosome [Gene or Genome]
   753   C0008633:Chromosome [Cell Component]
   753   C0441889:Level [Qualitative Concept]
   753   C0442726:Detected [Finding]
   753   C0444667:Whole [Quantitative Concept]
   753   C0456079:Level [Classification]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C1547707:Level [Geographic Area]
   753   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.262: The results presented in this study indirectly address the hypothesis that PML-RAR contributes to the pathogenesis of APL by acting predominantly as a dominant-negative molecule for PML and RAR. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "presented in this study indirectly"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0449450:Presented [Idea or Concept]
   760   C0557651:Study [Manufactured Object]
   760   C2603343:Study [Research Activity]
   726 E C0150312:Present [Quantitative Concept]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that PML-RAR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C3538821:RAR [Gene or Genome]
   734   C0023487:Promyelocytic Leukemia [Neoplastic Process]
   734   C1366903:promyelocytic leukemia [Gene or Genome]
   734   C2745900:Promyelocytic leukemia [Neoplastic Process]

Phrase: "contributes to the pathogenesis of APL"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   800   C0023487:Acute Promyelocytic Leukemia [Neoplastic Process]
           Promyelocytic Leukemia
   770   C1366903:promyelocytic leukemia [Gene or Genome]
   770   C2745900:Promyelocytic leukemia [Neoplastic Process]
   767   C0085669:Acute leukaemia [Neoplastic Process]
   767   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   744   C0023418:Leukaemia [Neoplastic Process]
   744   C0205178:acute [Temporal Concept]
   744   C0543483:pathogenesis [Functional Concept]
   744   C0699748:Pathogenesis [Pathologic Function]
   744   C1880177:Contribute [Activity]

Phrase: "by acting predominantly"

Phrase: "as a dominant-negative molecule"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0567416:Molecule [Substance]
   755 E C1521991:Molecular [Qualitative Concept]
   734   C1512032:Dominant Negative [Cell or Molecular Dysfunction]

Phrase: "for PML"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0023487:Promyelocytic Leukemia [Neoplastic Process]
  1000   C1366903:promyelocytic leukemia [Gene or Genome]
  1000   C2745900:Promyelocytic leukemia [Neoplastic Process]
   861   C0023418:Leukaemia [Neoplastic Process]

Phrase: "and"

Phrase: "RAR."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538821:RAR [Gene or Genome]
Processing 00000000.tx.263: In vitro, PML-RAR can clearly act as a dominant-negative factor to inhibit both PML and RAR function when overexpressed.12-14 Furthermore, PML haploinsufficiency in hCGPML-RAR mice appeared to increase the likelihood of APL development, suggesting that PML loss-of-function might somehow "cooperate" with PML-RAR, perhaps by enforcing a dominant-negative signal.18 However, the results presented here suggest that low levels of PML-RAR expression are more efficient at producing APL than higher levels. 

Phrase: "In vitro, PML-RAR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C3538821:RAR [Gene or Genome]

Phrase: "can"

Phrase: "clearly"

Phrase: "act as a dominant-negative factor to"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   774   C0960756:factor A [Organic Chemical]
   748   C0079613:ACT [Therapeutic or Preventive Procedure]
   748   C0205160:Negative [Qualitative Concept]
   748   C1513916:Negative [Finding]
   748   C1521761:Factor [Functional Concept]
   748   C1527180:Dominant [Functional Concept]
   748   C2825415:Negative [Conceptual Entity]
   748   C2825491:Negative [Qualitative Concept]
   748   C2827422:Factor [Conceptual Entity]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "both PML"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0023487:Promyelocytic Leukemia [Neoplastic Process]
  1000   C1366903:promyelocytic leukemia [Gene or Genome]
  1000   C2745900:Promyelocytic leukemia [Neoplastic Process]
   861   C0023418:Leukaemia [Neoplastic Process]

Phrase: "and"

Phrase: "RAR function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "when"

Phrase: "overexpressed.12-14 Furthermore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1514559:overexpress [Genetic Function]

Phrase: "PML haploinsufficiency in hCGPML-RAR mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2936267:Haploinsufficiency [Cell or Molecular Dysfunction]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the likelihood of APL development,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0033204:Likelihood [Quantitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that PML loss-of-function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   804   C0031843:function [Physiologic Function]
   804   C0542341:Function [Functional Concept]
   804   C0700205:FUNCTION [Classification]
   804   C1705273:Function [Intellectual Product]
   733 E C0205245:Functional [Functional Concept]
   733 E C2700217:Functional [Conceptual Entity]

Phrase: "might"

Phrase: "somehow """

Phrase: "cooperate"

Phrase: """"

Phrase: "with PML-RAR,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C3538821:RAR [Gene or Genome]
   734   C0023487:Promyelocytic Leukemia [Neoplastic Process]
   734   C1366903:promyelocytic leukemia [Gene or Genome]
   734   C2745900:Promyelocytic leukemia [Neoplastic Process]

Phrase: "perhaps by enforcing"

Phrase: "a dominant-negative signal.18 However,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   840   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   804   C0205160:Negative [Qualitative Concept]
   804   C1513916:Negative [Finding]
   804   C1527180:Dominant [Functional Concept]
   804   C1710082:Signal [Phenomenon or Process]
   804   C2825415:Negative [Conceptual Entity]
   804   C2825491:Negative [Qualitative Concept]

Phrase: "the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "here"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that low levels of PML-RAR expression"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   750   C3244092:expression level [Idea or Concept]
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "more efficient at producing APL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442799:Efficient [Qualitative Concept]

Phrase: "than higher levels."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.264: The data are more consistent with the hypothesis that there is an optimal pathogenetic PML-RAR "dose" that produces disease. 

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "more consistent with the hypothesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that there"

Phrase: "is"

Phrase: "an optimal pathogenetic PML-RAR ""dose"""
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0178602:Dose [Quantitative Concept]
   799   C0869039:Dose [Quantitative Concept]
   799   C1114758:Dose # [Clinical Attribute]

Phrase: "that"

Phrase: "produces"

Phrase: "disease."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.265: Expression levels that are too low result in no disease, whereas levels that are too high may result in toxicity and select against the expressing cells. 

Phrase: "Expression levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   966   C3244092:expression level [Idea or Concept]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "that"

Phrase: "are"

Phrase: "too low result in no disease,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1274040:Result [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C2825142:Result [Finding]

Phrase: "whereas"

Phrase: "levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "that"

Phrase: "are"

Phrase: "too high"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205250:High [Qualitative Concept]
   861   C1299351:High [Qualitative Concept]
   861   C2700149:HIGH [Intellectual Product]

Phrase: "may"

Phrase: "result in toxicity"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0040539:toxicity [Qualitative Concept]
   790   C0600688:Toxicity [Injury or Poisoning]
   790   C1274040:Result [Functional Concept]
   790   C1546471:Result [Idea or Concept]
   790   C2825142:Result [Finding]
   718 E C1407029:Toxic [Qualitative Concept]

Phrase: "and"

Phrase: "select against the expressing cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0007634:Cells [Cell]
   760   C1707391:Select [Activity]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.266: Levels that are most appropriate lead to alterations in expressing cells that make it more likely that they will acquire the critical progression mutations that lead to the development of APL. 

Phrase: "Levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "that"

Phrase: "are"

Phrase: "most appropriate lead to alterations"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in expressing cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "make"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "it more likely"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205172:More [Functional Concept]
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "that"

Phrase: "they"

Phrase: "will"

Phrase: "acquire"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1706701:Acquire [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the critical progression mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "that"

Phrase: "lead to the development of APL."
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   800   C0023487:Acute Promyelocytic Leukemia [Neoplastic Process]
           Promyelocytic Leukemia
   770   C1366903:promyelocytic leukemia [Gene or Genome]
   770   C2745900:Promyelocytic leukemia [Neoplastic Process]
   767   C0085669:Acute leukaemia [Neoplastic Process]
   767   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   744   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   744   C0023418:Leukaemia [Neoplastic Process]
   744   C0205178:acute [Temporal Concept]
   744   C0243107:development [Physiologic Function]
   744   C0678723:Development [Organism Function]
   744   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   744   C1522538:Lead [Functional Concept]
   744   C1527148:Development [Functional Concept]
   744   C2348269:Lead [Element, Ion, or Isotope]
   744   C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.267: Further experiments designed to rigorously test this hypothesis are in progress.  

Phrase: "Further experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "to rigorously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "this hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "are"

Phrase: "in progress."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1272688:In progress [Functional Concept]
           progress
  1000   C1548387:in progress [Idea or Concept]
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]
   861   C1280477:Progress [Functional Concept]
Processing 00000000.tx.268: Acknowledgements  We thank Kelly Schrimpf for blastocyst injections and Mieke Hoock for excellent mouse colony management. 

Phrase: "Acknowledgements"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Kelly Schrimpf for blastocyst injections"

Phrase: "and"

Phrase: "Mieke Hoock for excellent mouse colony management."
Processing 00000000.tx.269: Elaine Ross and Jacque Mudd provided excellent assistance with the ES targeting work. 

Phrase: "Elaine Ross"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0331968:Ross [Health Care Related Organization]
   861   C2699100:Ross [Bird]

Phrase: "and"

Phrase: "Jacque Mudd"

Phrase: "provided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provided [Activity]

Phrase: "excellent assistance with the ES targeting work."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0018896:Assistance [Social Behavior]
Processing 00000000.tx.270: Nancy Reidelberger provided expert editorial assistance.  

Phrase: "Nancy Reidelberger provided expert editorial assistance."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0018896:Assistance [Social Behavior]
Processing 00000000.tx.271: Footnotes  Submitted December 13, 2002; 

Phrase: "Footnotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2825232:Footnote [Intellectual Product]

Phrase: "Submitted December 13,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1515023:Submitted [Functional Concept]

Phrase: "2002"

Phrase: ";"
Processing 00000000.tx.272: accepted May 4, 2003. 

Phrase: "accepted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1272684:Accepted [Qualitative Concept]
  1000   C1548435:Accepted [Idea or Concept]
   966 E C1548601:Accept [Idea or Concept]

Phrase: "May 4,"

Phrase: "2003."
Processing 00000000.tx.273: Prepublished online as Blood First Edition Paper, May 15, 2003; 

Phrase: "Prepublished online as Blood First Edition Paper,"

Phrase: "May 15,"

Phrase: "2003"

Phrase: ";"
Processing 00000000.tx.274: DOI 10.1182/blood-2002-12-3779. 

Phrase: "DOI 10.1182/blood-2002-12-3779."
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   795   C0005767:Blood [Tissue]
   795   C0005768:blood [Body Substance]
   795   C0229664:Blood [Body Substance]
   795   C2348291:DOI [Classification]
   724 E C0333275:Bloody [Qualitative Concept]
   712 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   712 E C0392895:Bloods [Population Group]
   712 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   712 E C1511228:VESSEL, BLOOD [Tissue]
Processing 00000000.tx.275: Supported by National Institutes of Health grants CA83962 (T.J.L.), HL0399102 (P.W.), and T32 HLO 7088 (A.A.L.), and by the Buder Charitable Foundation (T.J.L.). 

Phrase: "Supported by National Institutes of Health grants CA83962"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   833   C0027468:National Institutes of Health [Health Care Related Organization]
           national health institutes
   744   C0018173:Grants [Quantitative Concept]
   744   C0018684:Health [Idea or Concept]
   744   C0021622:Institutes [Organization]
   744   C1521721:Supported [Conceptual Entity]
   744   C3245503:national [Intellectual Product]
   711 E C0183683:Support [Medical Device]
   711 E C1272753:Institute [Idea or Concept]
   711 E C1548284:Grant [Idea or Concept]

Phrase: "(T.J."

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "HL0399102"

Phrase: "(P.W."

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "T32 HLO 7088"

Phrase: "(A.A.L."

Phrase: ")"

Phrase: ","

Phrase: "and by the Buder Charitable Foundation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0016617:Foundation [Organization]
   753   C1515981:And [Idea or Concept]

Phrase: "(T.J."

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.276: P.W. and A.A.L. contributed equally to this work. 

Phrase: "P.W."

Phrase: "and"

Phrase: "A.A.L."

Phrase: "contributed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1880177:Contribute [Activity]

Phrase: "equally to this work."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0043227:Work [Occupational Activity]
Processing 00000000.tx.277: The publication costs of this article were defrayed in part by page charge payment. 

Phrase: "The publication"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0034036:Publication [Intellectual Product,Manufactured Object]
  1000   C0034037:Publication [Occupational Activity]
  1000   C1704324:Publication [Intellectual Product]

Phrase: "costs of this article"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0010186:Cost [Quantitative Concept]
   770   C0220812:Costs [Quantitative Concept]
   770   C1706852:Article [Intellectual Product]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by page charge payment."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0220808:payment [Quantitative Concept]
   827   C0680264:payment [Quantitative Concept]
Processing 00000000.tx.278: Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 U.S.C. section 1734. 

Phrase: "Therefore,"

Phrase: "and"

Phrase: "solely to"

Phrase: "indicate"

Phrase: "this fact,"

Phrase: "this article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "is"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18 U.S.C. section 1734."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0041703:U S [Geographic Area]
   799   C0205155:Section [Spatial Concept]
   799   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   799   C1522472:Section [Substance]
   799   C1552923:Section [Quantitative Concept]
   799   C1705191:Section [Physical Object]
Processing 00000000.tx.279: Reprints: Timothy J. 

Phrase: "Reprints"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3273171:Reprint [Intellectual Product]

Phrase: ":"

Phrase: "Timothy J."
Processing 00000000.tx.280: Ley, Washington University, Division of Oncology, 660 S Euclid Ave, Campus Box 8007, St Louis, MO 63110-1093; 

Phrase: "Ley,"

Phrase: "Washington University,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041740:University [Manufactured Object,Organization]
   861   C0043038:Washington [Geographic Area]

Phrase: "Division of Oncology,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1293097:Division [Therapeutic or Preventive Procedure]
   790   C2919030:Division [Organization]
   790   C2919031:Division [Activity]

Phrase: "660 S Euclid Ave,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0108844:AVE [Therapeutic or Preventive Procedure]

Phrase: "Campus Box 8007,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0179400:Box [Manufactured Object]
   827   C1533124:Box [Medical Device]

Phrase: "St Louis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3272372:ST [Intellectual Product]

Phrase: "MO 63110-1093"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3538743:MO [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.281: e-mail: tley{at}im.wustl.edu .  References Top Abstract Introduction Materials and methods Results Discussion References  Grisolano JL, Wesselschmidt RL, Pelicci PG, Ley TJ. 

Phrase: "e-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "tley{at}im.wustl.edu ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0059804:EDU [Organic Chemical,Pharmacologic Substance]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Grisolano JL,"

Phrase: "Wesselschmidt RL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419337:RL [Gene or Genome]
   861   C3539667:RL [Gene or Genome]

Phrase: "Pelicci PG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1266240:PG [Laboratory Procedure]

Phrase: "Ley TJ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039247:TJ [Geographic Area]
Processing 00000000.tx.282: Altered myeloid development and acute leukemia in transgenic mice expressing PML-RAR under control of cathepsin G regulatory sequences. 

Phrase: "Altered myeloid development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0243107:development [Physiologic Function]
   827   C0678723:Development [Organism Function]
   827   C1527148:Development [Functional Concept]
   755 E C0458003:Developmental [Qualitative Concept]

Phrase: "and"

Phrase: "acute leukemia in transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0085669:Acute leukaemia [Neoplastic Process]
   806   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   781   C0596978:Mouse Leukemia [Neoplastic Process]
   760   C0023418:Leukaemia [Neoplastic Process]
   760   C0205178:acute [Temporal Concept]

Phrase: "expressing"

Phrase: "PML-RAR under control of cathepsin G regulatory sequences."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C3538821:RAR [Gene or Genome]
Processing 00000000.tx.283: Blood. 

Phrase: "Blood."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.284: 1997;89: 376-387.[Abstract/Free FullText] He L-Z, Tribioli C, Rivi R, et al. 

Phrase: "1997"

Phrase: ";89"

Phrase: ":"

Phrase: "376-387."

Phrase: "[Abstract/Free FullText"

Phrase: "]"

Phrase: "He L-Z,"

Phrase: "Tribioli C,"

Phrase: "Rivi R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "et al."
Processing 00000000.tx.285: Acute leukemia with promyelocytic features in PML/RAR transgenic mice. 

Phrase: "Acute leukemia with promyelocytic features"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   835   C0023487:Acute Promyelocytic Leukemia [Neoplastic Process]
           Promyelocytic Leukemia
   806   C0085669:Acute leukaemia [Neoplastic Process]
   806   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   797   C1366903:promyelocytic leukemia [Gene or Genome]
   797   C2745900:Promyelocytic leukemia [Neoplastic Process]
   760   C0023418:Leukaemia [Neoplastic Process]
   760   C0205178:acute [Temporal Concept]

Phrase: "in PML/RAR transgenic mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0025936:Mice, Transgenic [Mammal]
   804   C0003069:Transgenic [Animal]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]
Processing 00000000.tx.286: Proc Natl Acad Sci U S A. 

Phrase: "Proc Natl Acad Sci U S A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   845   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.287: 1997;94: 5302-5307.[Abstract/Free FullText] Brown D, Kogan S, Lagasse E, et al. 

Phrase: "1997"

Phrase: ";94"

Phrase: ":"

Phrase: "5302-5307."

Phrase: "[Abstract/Free FullText"

Phrase: "] Brown D,"

Phrase: "Kogan S,"

Phrase: "Lagasse E,"

Phrase: "et al."
Processing 00000000.tx.288: A PML-RAR transgene initiates murine acute promyelocytic leukemia. 

Phrase: "A PML-RAR transgene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0282641:Transgene [Gene or Genome]

Phrase: "initiates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1548602:Initiate [Idea or Concept]
  1000   C1704686:Initiate [Functional Concept]

Phrase: "murine acute promyelocytic leukemia."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   923   C0023487:Acute Promyelocytic Leukemia [Neoplastic Process]
           Promyelocytic Leukemia
   875   C0085669:Acute leukaemia [Neoplastic Process]
   875   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   861   C1366903:promyelocytic leukemia [Gene or Genome]
   861   C2745900:Promyelocytic leukemia [Neoplastic Process]
   812   C0023418:Leukaemia [Neoplastic Process]
   812   C0205178:acute [Temporal Concept]
Processing 00000000.tx.289: Proc Natl Acad Sci U S A. 

Phrase: "Proc Natl Acad Sci U S A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   845   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.290: 1997;94: 2551-2556.[Abstract/Free FullText] He L-Z, Guidez F, Tribioli C, et al. 

Phrase: "1997"

Phrase: ";94"

Phrase: ":"

Phrase: "2551-2556."

Phrase: "[Abstract/Free FullText"

Phrase: "]"

Phrase: "He L-Z,"

Phrase: "Guidez F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Tribioli C,"

Phrase: "et al."
Processing 00000000.tx.291: Distinct interactions of PML-RARalpha and PLZF-RARalpha with corepressors determine differential responses to RA in APL. 

Phrase: "Distinct interactions of PML-RARalpha"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "PLZF-RARalpha with corepressors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0765587:PLZF-RARalpha [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0140279:RAR alpha [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "determine"

Phrase: "differential responses to RA"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0871261:responses [Organism Attribute]
   737 E C1704632:Response [Finding]
   737 E C1706817:Response [Intellectual Product]
   737 E C2911692:Response [Mental Process]

Phrase: "in APL."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0023487:Acute Promyelocytic Leukemia [Neoplastic Process]
           Promyelocytic Leukemia
   913   C0085669:Acute leukaemia [Neoplastic Process]
   913   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   901   C1366903:promyelocytic leukemia [Gene or Genome]
   901   C2745900:Promyelocytic leukemia [Neoplastic Process]
   827   C0023418:Leukaemia [Neoplastic Process]
   827   C0205178:acute [Temporal Concept]
Processing 00000000.tx.292: Nat Genet. 

Phrase: "Nat Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]
Processing 00000000.tx.293: 1998;18: 126-135.[Medline] [OrderarticleviaInfotrieve] Cheng G-X, Zhu X-H, Men X-Q, et al. 

Phrase: "1998"

Phrase: ";18"

Phrase: ":"

Phrase: "126-135."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Cheng G-X,"

Phrase: "Zhu X-H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "Men X-Q,"

Phrase: "et al."
Processing 00000000.tx.294: Distinct leukemia phenotypes in transgenic mice and different corepressor interactions generated by promyelocytic leukemia variant fusion genes PLZF-RAR and NPM-RAR. 

Phrase: "Distinct leukemia phenotypes in transgenic mice"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0031437:Phenotypes [Organism Attribute]
   719 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "and"

Phrase: "different corepressor interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1704675:Interaction [Functional Concept]

Phrase: "generated by promyelocytic leukemia variant fusion genes PLZF-RAR"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   767   C1366903:Promyelocytic Leukemia Gene [Gene or Genome]
           promyelocytic leukemia
   764   C0023487:Promyelocytic Leukemia [Neoplastic Process]
   764   C2745900:Promyelocytic leukemia [Neoplastic Process]
   748   C1533585:Fusion Gene [Gene or Genome]
   745 E C0178648:Gene Fusion [Molecular Biology Research Technique]
   745 E C1705736:Gene Fusion [Cell or Molecular Dysfunction]
   742   C0017337:Genes [Gene or Genome]
   742   C0023418:Leukaemia [Neoplastic Process]
   742   C0205419:Variant [Qualitative Concept]
   742   C0332466:Fusion [Functional Concept]
   742   C1293131:Fusion [Therapeutic or Preventive Procedure]
   742   C1538149:PLZF [Gene or Genome]
   742   C1706252:PLZF [Gene or Genome]
   742   C3146294:Generated [Activity]
   742   C3538821:RAR [Gene or Genome]

Phrase: "and"

Phrase: "NPM-RAR."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538821:RAR [Gene or Genome]
Processing 00000000.tx.295: Proc Natl Acad Sci U S A. 

Phrase: "Proc Natl Acad Sci U S A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   845   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.296: 1999;96: 6318-6323.[Abstract/Free FullText] Pollock JL, Westervelt P, Kurichety AK, Pelicci PG, Grisolano JL, Ley TJ. 

Phrase: "1999"

Phrase: ";96"

Phrase: ":"

Phrase: "6318-6323."

Phrase: "[Abstract/Free FullText"

Phrase: "] Pollock JL,"

Phrase: "Westervelt P,"

Phrase: "Kurichety AK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001905:AK [Geographic Area]
   861   C1412243:AK [Gene or Genome]

Phrase: "Pelicci PG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1266240:PG [Laboratory Procedure]

Phrase: "Grisolano JL,"

Phrase: "Ley TJ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039247:TJ [Geographic Area]
Processing 00000000.tx.297: A bcr-3 isoform of RAR-PML potentiates the development of PML-RAR-driven acute promyelocytic leukemia. 

Phrase: "A bcr-3 isoform of RAR-PML"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0597298:Isoform [Amino Acid, Peptide, or Protein]

Phrase: "potentiates"

Phrase: "the development of PML-RAR-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0243107:development [Physiologic Function]
   753   C0678723:Development [Organism Function]
   753   C1527148:Development [Functional Concept]

Phrase: "driven"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0013126:Drive [Mental Process]

Phrase: "acute promyelocytic leukemia."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0023487:Acute Promyelocytic Leukemia [Neoplastic Process]
           Promyelocytic Leukemia
   913   C0085669:Acute leukaemia [Neoplastic Process]
   913   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   901   C1366903:promyelocytic leukemia [Gene or Genome]
   901   C2745900:Promyelocytic leukemia [Neoplastic Process]
   827   C0023418:Leukaemia [Neoplastic Process]
   827   C0205178:acute [Temporal Concept]
Processing 00000000.tx.298: Proc Natl Acad Sci U S A. 

Phrase: "Proc Natl Acad Sci U S A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   845   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.299: 1999;96: 15103-15108.[Abstract/Free FullText] Pollock JL, Westervelt P, Walter MJ, Lane AA, Ley TJ. 

Phrase: "1999"

Phrase: ";96"

Phrase: ":"

Phrase: "15103-15108."

Phrase: "[Abstract/Free FullText"

Phrase: "] Pollock JL,"

Phrase: "Westervelt P,"

Phrase: "Walter MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Lane AA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1235746:Aa [Plant]
   861   C1882141:aa [Qualitative Concept]

Phrase: "Ley TJ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039247:TJ [Geographic Area]
Processing 00000000.tx.300: Mouse models of acute promyelocytic leukemia. 

Phrase: "Mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "models of acute promyelocytic leukemia."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C0023487:Acute Promyelocytic Leukemia [Neoplastic Process]
           Promyelocytic Leukemia
   806   C1366903:promyelocytic leukemia [Gene or Genome]
   806   C2745900:Promyelocytic leukemia [Neoplastic Process]
   797   C0085669:Acute leukaemia [Neoplastic Process]
   797   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   760   C0023418:Leukaemia [Neoplastic Process]
   760   C0205178:acute [Temporal Concept]
   760   C3161035:Model [Intellectual Product]
Processing 00000000.tx.301: Curr Opin Hematol. 

Phrase: "Curr Opin Hematol."
Processing 00000000.tx.302: 2001;8: 206-211.[CrossRef][Medline] [OrderarticleviaInfotrieve] Zimonjic DB, Pollock JL, Westervelt P, Popescu NC, Ley TJ. 

Phrase: "2001"

Phrase: ";8"

Phrase: ":"

Phrase: "206-211."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Zimonjic DB,"

Phrase: "Pollock JL,"

Phrase: "Westervelt P,"

Phrase: "Popescu NC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0027964:NC [Geographic Area]
   861   C0028407:NC [Geographic Area]
   861   C0067895:NC [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Ley TJ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039247:TJ [Geographic Area]
Processing 00000000.tx.303: Acquired, nonrandom chromosomal abnormalities associated with the development of acute promyelocytic leukemia in transgenic mice. 

Phrase: "Acquired"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0439661:Acquired [Temporal Concept]
  1000   C3245488:acquired [Intellectual Product]
   966 E C1706701:Acquire [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]

Phrase: ","

Phrase: "nonrandom chromosomal abnormalities"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   901   C0008625:Abnormalities, Chromosomal [Cell or Molecular Dysfunction]
   901   C0008626:Abnormalities, Chromosomal [Disease or Syndrome]
   827   C0000768:Abnormalities [Congenital Abnormality]
   827   C0000769:abnormalities [Functional Concept]
   793 E C1704258:Abnormality [Finding]
   743 E C0205161:Abnormal [Qualitative Concept]
   743 E C2347472:% Abnormal [Quantitative Concept]
   743 E C2699333:ABNORMAL [Intellectual Product]

Phrase: "associated with the development of acute promyelocytic leukemia"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   800   C0023487:Acute Promyelocytic Leukemia [Neoplastic Process]
           Promyelocytic Leukemia
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C1366903:promyelocytic leukemia [Gene or Genome]
   770   C2745900:Promyelocytic leukemia [Neoplastic Process]
   767   C0085669:Acute leukaemia [Neoplastic Process]
   767   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   744   C0023418:Leukaemia [Neoplastic Process]
   744   C0205178:acute [Temporal Concept]
   744   C0243107:development [Physiologic Function]
   744   C0678723:Development [Organism Function]
   744   C1527148:Development [Functional Concept]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in transgenic mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
Processing 00000000.tx.304: Proc Natl Acad Sci U S A. 

Phrase: "Proc Natl Acad Sci U S A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   845   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.305: 2000;97: 13306-13311.[Abstract/Free FullText] Le Beau M, Bitts S, Davis EM, Kogan SC. 

Phrase: "2000"

Phrase: ";97"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439073:97 [Intellectual Product]
  1000   C0439082:>97 [Quantitative Concept]

Phrase: ":"

Phrase: "13306-13311."

Phrase: "[Abstract/Free FullText"

Phrase: "] Le Beau M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "Bitts S,"

Phrase: "Davis EM,"

Phrase: "Kogan SC."
Processing 00000000.tx.306: Recurring chromosomal abnormalities in leukemia in PML-RAR transgenic mice parallel human acute promyelocytic leukemia. 

Phrase: "Recurring"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034897:recurring [Phenomenon or Process]
  1000   C2945760:Recurring [Temporal Concept]

Phrase: "chromosomal abnormalities in leukemia"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0008625:Abnormalities, Chromosomal [Cell or Molecular Dysfunction]
   833   C0008626:Abnormalities, Chromosomal [Disease or Syndrome]
   770   C0000768:Abnormalities [Congenital Abnormality]
   770   C0000769:abnormalities [Functional Concept]
   737 E C1704258:Abnormality [Finding]

Phrase: "in PML-RAR transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0025936:Mice, Transgenic [Mammal]
   804   C0003069:Transgenic [Animal]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "parallel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2348042:Parallel [Qualitative Concept]
  1000   C2826345:PARALLEL [Research Activity]

Phrase: "human acute promyelocytic leukemia."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   923   C0023487:Acute Promyelocytic Leukemia [Neoplastic Process]
           Promyelocytic Leukemia
   875   C0085669:Acute leukaemia [Neoplastic Process]
   875   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   861   C1366903:promyelocytic leukemia [Gene or Genome]
   861   C2745900:Promyelocytic leukemia [Neoplastic Process]
   812   C0023418:Leukaemia [Neoplastic Process]
   812   C0205178:acute [Temporal Concept]
Processing 00000000.tx.307: Blood. 

Phrase: "Blood."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.308: 2002;99: 2985-2991.[Abstract/Free FullText] Kogan SC, Brown DE, Schultz DB, et al. 

Phrase: "2002"

Phrase: ";99"

Phrase: ":"

Phrase: "2985-2991."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kogan SC,"

Phrase: "Brown DE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011198:DE [Geographic Area]
   861   C0017480:DE [Geographic Area]
   861   C3541240:DE [Idea or Concept]

Phrase: "Schultz DB,"

Phrase: "et al."
Processing 00000000.tx.309: BCL-2 cooperates with promyelocytic leukemia retinoic acid recepter chimeric protein (PMLRAR)to block neutrophil differentiation and initiate acute leukemia. 

Phrase: "BCL-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376515:Bcl-2 [Gene or Genome]

Phrase: "cooperates with promyelocytic leukemia retinoic acid recepter chimeric protein"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   784   C0146495:Promyelocytic Leukemia Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   784   C3476424:Promyelocytic leukemia protein [Amino Acid, Peptide, or Protein]
   764   C0023487:Promyelocytic Leukemia [Neoplastic Process]
   764   C0040845:Retinoic Acid [Organic Chemical,Pharmacologic Substance,Vitamin]
   764   C0162768:Chimeric Protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   764   C1366903:promyelocytic leukemia [Gene or Genome]
   764   C2745900:Promyelocytic leukemia [Neoplastic Process]
   742   C0001128:Acid [Chemical]
   742   C0008109:chimeric [Organism]
   742   C0023418:Leukaemia [Neoplastic Process]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0202406:Acid [Laboratory Procedure]

Phrase: "(PMLRAR"

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "neutrophil differentiation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C1159958:neutrophil differentiation [Cell Function]
   861   C0007589:Differentiation [Cell Function]
   861   C1511938:Differentiation [Clinical Attribute]
   861   C2945687:Differentiation [Functional Concept]
   789 E C0205615:Differentiated [Qualitative Concept]

Phrase: "and"

Phrase: "initiate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1548602:Initiate [Idea or Concept]
  1000   C1704686:Initiate [Functional Concept]

Phrase: "acute leukemia."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0085669:Acute leukaemia [Neoplastic Process]
  1000   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   861   C0023418:Leukaemia [Neoplastic Process]
   861   C0205178:acute [Temporal Concept]
Processing 00000000.tx.310: J Exp Med. 

Phrase: "J Exp Med."
Processing 00000000.tx.311: 2001;193: 531-543.[Abstract/Free FullText] Kelly LM, Kutok JL, Williams IR, et al. 

Phrase: "2001"

Phrase: ";193"

Phrase: ":"

Phrase: "531-543."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kelly LM,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1261082:LM [Body Part, Organ, or Organ Component]
   861   C1551056:lm [Quantitative Concept]
   861   C2981682:LM [Quantitative Concept]

Phrase: "Kutok JL,"

Phrase: "Williams IR,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0022065:IR [Geographic Area]
   861   C0022071:Ir [Element, Ion, or Isotope]
   861   C0034818:IR [Amino Acid, Peptide, or Protein,Enzyme,Receptor]

Phrase: "et al."
Processing 00000000.tx.312: PML/RAR and FLT3-ITD induce an APL-like disease in a mouse model. 

Phrase: "PML/RAR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C3538821:RAR [Gene or Genome]
   734   C0023487:Promyelocytic Leukemia [Neoplastic Process]
   734   C1366903:promyelocytic leukemia [Gene or Genome]
   734   C2745900:Promyelocytic leukemia [Neoplastic Process]

Phrase: "and"

Phrase: "FLT3-ITD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0929370:ITD [Body Part, Organ, or Organ Component]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "an APL-"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0023487:Acute Promyelocytic Leukemia [Neoplastic Process]
           Promyelocytic Leukemia
   913   C0085669:Acute leukaemia [Neoplastic Process]
   913   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   901   C1366903:promyelocytic leukemia [Gene or Genome]
   901   C2745900:Promyelocytic leukemia [Neoplastic Process]
   827   C0023418:Leukaemia [Neoplastic Process]
   827   C0205178:acute [Temporal Concept]

Phrase: "like disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "in a mouse model."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2986594:Mouse Model [Experimental Model of Disease]
   861   C3161035:Model [Intellectual Product]
Processing 00000000.tx.313: Proc Natl Acad Sci U S A. 

Phrase: "Proc Natl Acad Sci U S A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   845   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.314: 2002;99: 8283-8288.[Abstract/Free FullText] Melnick A, Licht JD. 

Phrase: "2002"

Phrase: ";99"

Phrase: ":"

Phrase: "8283-8288."

Phrase: "[Abstract/Free FullText"

Phrase: "] Melnick A,"

Phrase: "Licht JD."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1549972:JD [Intellectual Product]
Processing 00000000.tx.315: Deconstructing a disease: RAR, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. 

Phrase: "Deconstructing"

Phrase: "a disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "RAR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538821:RAR [Gene or Genome]

Phrase: "its fusion partners,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0682323:partners [Family Group]

Phrase: "and"

Phrase: "their roles in the pathogenesis of acute promyelocytic leukemia."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0035820:Roles [Social Behavior]
   708 E C1705810:Role [Conceptual Entity]
Processing 00000000.tx.316: Blood. 

Phrase: "Blood."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.317: 1999;93: 3167-3215.[Free FullText] Pandolfi PP. 

Phrase: "1999"

Phrase: ";93"

Phrase: ":"

Phrase: "3167-3215."

Phrase: "[Free FullText"

Phrase: "] Pandolfi PP."
Processing 00000000.tx.318: Oncogenes and tumor suppressors in the molecular pathogenesis of acute promyelocytic leukemia. 

Phrase: "Oncogenes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029016:Oncogenes [Gene or Genome]

Phrase: "and"

Phrase: "tumor suppressors in the molecular pathogenesis of acute promyelocytic leukemia."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0079427:Tumor Suppressors [Gene or Genome]
   739   C0027651:Tumor [Neoplastic Process]
   739   C1578706:Tumor [Intellectual Product]
   739   C3273930:Tumor [Finding]
   726 E C1325410:tumor suppressor [Cell Function]
   706   C1710252:Suppressor [Manufactured Object]
   706   C2954564:Suppressor [Pharmacologic Substance]
Processing 00000000.tx.319: Hum Mol Genet. 

Phrase: "Hum Mol Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0325074:Genet [Mammal]
Processing 00000000.tx.320: 2001;10: 769-775.[Abstract/Free FullText] Merghoub T, Gurrieri C, Pizaaz F, Pandolfi PP. 

Phrase: "2001"

Phrase: ";10"

Phrase: ":"

Phrase: "769-775."

Phrase: "[Abstract/Free FullText"

Phrase: "] Merghoub T,"

Phrase: "Gurrieri C,"

Phrase: "Pizaaz F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Pandolfi PP."
Processing 00000000.tx.321: Modeling acute promyelocytic leukemia in the mouse: new insights in the pathogenesis of human leukemias. 

Phrase: "Modeling"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870071:Modeling [Intellectual Product,Research Activity]
   966 E C3161035:Model [Intellectual Product]

Phrase: "acute promyelocytic leukemia in the mouse"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0023487:Acute Promyelocytic Leukemia [Neoplastic Process]
           Promyelocytic Leukemia
   790   C1366903:promyelocytic leukemia [Gene or Genome]
   790   C2745900:Promyelocytic leukemia [Neoplastic Process]
   783   C0085669:Acute leukaemia [Neoplastic Process]
   783   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   783   C0596978:Mouse Leukemia [Neoplastic Process]
   753   C0023418:Leukaemia [Neoplastic Process]
   753   C0205178:acute [Temporal Concept]

Phrase: ":"

Phrase: "new insights in the pathogenesis of human leukemias."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0233820:insights [Mental Process]
Processing 00000000.tx.322: Blood Cells Mol Dis. 

Phrase: "Blood Cells Mol Dis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0451119:DIS [Intellectual Product]
   812   C1444662:DIS [Finding]
Processing 00000000.tx.323: 2001;27: 231-248.[CrossRef][Medline] [OrderarticleviaInfotrieve] Dyck JA, Maul GG, Miller WH Jr, Chen JD, Kakizuka A, Evans RM. 

Phrase: "2001"

Phrase: ";27"

Phrase: ":"

Phrase: "231-248."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Dyck JA,"

Phrase: "Maul"

Phrase: "GG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018370:GG [Geographic Area]

Phrase: "Miller WH Jr,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1708595:Jr [Idea or Concept]
   827   C3280986:JR [Disease or Syndrome]

Phrase: "Chen JD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1549972:JD [Intellectual Product]

Phrase: "Kakizuka A,"

Phrase: "Evans RM."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]
Processing 00000000.tx.324: A novel macromolecular structure is a target of the promyelocytic-retinoic acid receptor. 

Phrase: "A novel macromolecular structure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0026383:Macromolecular Structure [Molecular Sequence]
   827   C0678594:Structure [Spatial Concept]

Phrase: "is"

Phrase: "a target of the promyelocytic-retinoic acid receptor."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1521840:Target [Functional Concept]
   744   C2986546:TARGET [Diagnostic Procedure]
Processing 00000000.tx.325: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.326: 1994;76: 333-343.[Medline] [OrderarticleviaInfotrieve] Weis K, Rambaud S, Lavau C, et al. 

Phrase: "1994"

Phrase: ";76"

Phrase: ":"

Phrase: "333-343."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Weis K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Rambaud S,"

Phrase: "Lavau C,"

Phrase: "et al."
Processing 00000000.tx.327: Retinoic acid regulates aberrant nuclear localization of PML-RAR in acute promyelocytic leukemia cells. 

Phrase: "Retinoic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040845:Retinoic Acid [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "regulates"

Phrase: "aberrant nuclear localization of PML-RAR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0475264:Localisation [Functional Concept]
   748   C1744691:localisation [Biologic Function]

Phrase: "in acute promyelocytic leukemia cells."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   808   C1517806:Leukemic Cell [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756   C0023487:Acute Promyelocytic Leukemia [Neoplastic Process]
   708   C0085669:Acute leukaemia [Neoplastic Process]
   708   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
Processing 00000000.tx.328: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.329: 1994;76: 345-356.[Medline] [OrderarticleviaInfotrieve] Jansen JH, Mahfoudi A, Rambaud S, Lavau C, Wahli W, Dejean A. 

Phrase: "1994"

Phrase: ";76"

Phrase: ":"

Phrase: "345-356."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Jansen JH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268060:JH [Disease or Syndrome]
   861   C1415529:JH [Gene or Genome]

Phrase: "Mahfoudi A,"

Phrase: "Rambaud S,"

Phrase: "Lavau C,"

Phrase: "Wahli W,"

Phrase: "Dejean A."
Processing 00000000.tx.330: Multimeric complexes of the PML-retinoic acid receptor fusion protein in acute promyelocytic leukemia cells and interference with retinoid and peroxisome-proliferator signaling pathways. 

Phrase: "Multimeric complexes of the PML-retinoic acid receptor fusion protein"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   738   C1704241:Complexes [Chemical Viewed Structurally]
   737   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   737   C1523872:protein complex [Cell Component]
   737   C1523873:receptor complex [Cell Component]
   704 E C0439855:Complex [Qualitative Concept]

Phrase: "in acute promyelocytic leukemia cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   808   C1517806:Leukemic Cell [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756   C0023487:Acute Promyelocytic Leukemia [Neoplastic Process]
   708   C0085669:Acute leukaemia [Neoplastic Process]
   708   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]

Phrase: "and"

Phrase: "interference with retinoid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0521102:Interference [Qualitative Concept]

Phrase: "and"

Phrase: "peroxisome-proliferator signaling pathways."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   844   C0037080:Signal Pathways [Molecular Function]
   844   C0037083:signaling pathway [Cell Function]
   844   C0086982:Signaling Pathway [Molecular Function]
   812   C1704259:Pathways [Molecular Function]
   812   C1705987:Pathways [Conceptual Entity]
Processing 00000000.tx.331: Proc Natl Acad Sci U S A. 

Phrase: "Proc Natl Acad Sci U S A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   845   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.332: 1995;92: 7401-7405.[Abstract] Rego EM, Wang Z-G, Peruzzi D, He L-Z, CordonCardo C, Pandolfi PP. 

Phrase: "1995"

Phrase: ";92"

Phrase: ":"

Phrase: "7401-7405."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Rego EM,"

Phrase: "Wang Z-G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "Peruzzi D,"

Phrase: "He L-Z,"

Phrase: "CordonCardo C,"

Phrase: "Pandolfi PP."
Processing 00000000.tx.333: Role of promyelocytic leukemia (PML) protein in tumor suppression. 

Phrase: "Role of promyelocytic leukemia (PML) protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in tumor suppression."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1519692:Tumor Suppression [Molecular Function]
   861   C0221103:Suppression [Pathologic Function]
   861   C0301625:Suppression [Organism Function]
   861   C0439181:% suppression [Quantitative Concept]
   861   C0728721:suppression [Mental Process]
Processing 00000000.tx.334: J Exp Med. 

Phrase: "J Exp Med."
Processing 00000000.tx.335: 2001;193: 521-529.[Abstract/Free FullText] Heusel JW, Scarpati EM, Jenkins NA, et al. 

Phrase: "2001"

Phrase: ";193"

Phrase: ":"

Phrase: "521-529."

Phrase: "[Abstract/Free FullText"

Phrase: "] Heusel JW,"

Phrase: "Scarpati EM,"

Phrase: "Jenkins NA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597484:Na+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1272460:{NA} [Qualitative Concept]

Phrase: "et al."
Processing 00000000.tx.336: Molecular cloning, chromosomal location, and tissue-specific expression of the murine cathepsin G gene. 

Phrase: "Molecular cloning,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009017:Cloning, Molecular [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0009015:Cloning [Research Activity]

Phrase: "chromosomal location,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450429:Location [Spatial Concept]
   861   C1515974:Location [Body Location or Region]

Phrase: "and"

Phrase: "tissue-specific expression of the murine cathepsin G gene."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1519516:Tissue-Specific Gene Expression [Genetic Function]
   762   C0017262:Gene Expression [Genetic Function]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.337: Blood. 

Phrase: "Blood."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.338: 1993;81: 1614-1623.[Abstract] Hug BA, Wesselschmidt RL, Fiering S, et al. 

Phrase: "1993"

Phrase: ";81"

Phrase: ":"

Phrase: "1614-1623."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Hug BA,"

Phrase: "Wesselschmidt RL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419337:RL [Gene or Genome]
   861   C3539667:RL [Gene or Genome]

Phrase: "Fiering S,"

Phrase: "et al."
Processing 00000000.tx.339: Analysis of mice containing a targeted deletion of the -globin locus control region 5'HS-3. 

Phrase: "Analysis of mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "a targeted deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1442161:Deletion [Cell or Molecular Dysfunction]
   861   C1511760:Deletion [Genetic Function]
   861   C1880274:Deletion [Activity]

Phrase: "of the -globin locus control region 5'HS-3."
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   845   C0525013:Locus Control Region [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   818   C0023953:locus control [Idea or Concept]
   818   C0062990:HS 3 [Organic Chemical,Pharmacologic Substance]
   795   C0017446:Region [Geographic Area]
   795   C0017645:Globin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0205147:Region [Spatial Concept]
   795   C0243148:control [Qualitative Concept]
   795   C1149093:globin [Molecular Function]
   795   C1550141:Control [Substance]
   795   C1708726:Locus [Gene or Genome]
   795   C1882979:Control [Conceptual Entity]
   795   C2587213:Control [Functional Concept]
   795   C3274648:Control [Qualitative Concept]
   724 E C0205276:Regional [Spatial Concept]
   724 E C1947913:Regional [Spatial Concept]
Processing 00000000.tx.340: Mol Cell Biol. 

Phrase: "Mol Cell Biol."
Processing 00000000.tx.341: 1996;16: 2906-2912.[Abstract] MacIvor DM, Shapiro SD, Pham CTN, Belaaouaj A, Abraham S, Ley TJ. 

Phrase: "1996"

Phrase: ";16"

Phrase: ":"

Phrase: "2906-2912."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] MacIvor DM,"

Phrase: "Shapiro SD,"

Phrase: "Pham CTN,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0917591:CTN [Organic Chemical,Pharmacologic Substance]

Phrase: "Belaaouaj A,"

Phrase: "Abraham S,"

Phrase: "Ley TJ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039247:TJ [Geographic Area]
Processing 00000000.tx.342: Normal neutrophil function in cathepsin G deficient mice. 

Phrase: "Normal neutrophil function in cathepsin G deficient mice."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0031843:function [Physiologic Function]
   744   C0542341:Function [Functional Concept]
   744   C0700205:FUNCTION [Classification]
   744   C1705273:Function [Intellectual Product]
Processing 00000000.tx.343: Blood. 

Phrase: "Blood."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.344: 1999;94: 4282-4293.[Abstract/Free FullText] Zimonjic DB, Rezanka L, DiPaolo JA, Popescu NC. 

Phrase: "1999"

Phrase: ";94"

Phrase: ":"

Phrase: "4282-4293."

Phrase: "[Abstract/Free FullText"

Phrase: "] Zimonjic DB,"

Phrase: "Rezanka L,"

Phrase: "DiPaolo JA,"

Phrase: "Popescu NC."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0027964:NC [Geographic Area]
   861   C0028407:NC [Geographic Area]
   861   C0067895:NC [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.345: Refined localization of the erbB-3 protooncogene by direct visualization of FISH signals on LUT-inverted and contrast-enhanced digital images of DAPI-banded chromosomes. 

Phrase: "Refined localization of the erbB-3 protooncogene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0475264:Localisation [Functional Concept]
   748   C1744691:localisation [Biologic Function]

Phrase: "by direct visualization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0175631:Visualization [Mental Process]
   861   C2827662:Visualization [Occupation or Discipline]

Phrase: "of FISH"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0162789:Fluorescence in situ hybridisation [Molecular Biology Research Technique]
   923   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   861   C0444498:In situ [Spatial Concept]
   812   C0016315:Fluorescence [Natural Phenomenon or Process]
   812   C0020202:Hybridisation [Genetic Function]
   812   C1300517:Hybridization [Laboratory Procedure]
   741 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "signals on LUT-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0043328:LUT [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   790   C1710082:Signal [Phenomenon or Process]

Phrase: "inverted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443241:Inverted [Qualitative Concept]

Phrase: "and"

Phrase: "contrast-enhanced digital images of DAPI-banded chromosomes."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   714   C0020909:Image Enhancement [Machine Activity]
   711   C1704254:Image [Intellectual Product]
   711   C1704922:Image [Entity]
   711   C3542466:Image [Intellectual Product]
Processing 00000000.tx.346: Cancer Genet Cytogenet. 

Phrase: "Cancer Genet Cytogenet."
Processing 00000000.tx.347: 1995;80: 100-102.[CrossRef][Medline] [OrderarticleviaInfotrieve] Sigurdsson F, Khanna-Gupta A, Lawson N, Berliner N. 

Phrase: "1995"

Phrase: ";80"

Phrase: ":"

Phrase: "100-102."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Sigurdsson F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Khanna-Gupta A,"

Phrase: "Lawson N,"

Phrase: "Berliner N."
Processing 00000000.tx.348: Control of late neutrophil-specific gene expression: insights into regulation of myeloid differentiation. 

Phrase: "Control of late neutrophil-specific gene expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0243148:control [Qualitative Concept]
   748   C1550141:Control [Substance]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]

Phrase: ":"

Phrase: "insights into regulation of myeloid differentiation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0233820:insights [Mental Process]
Processing 00000000.tx.349: Semin Hematol. 

Phrase: "Semin Hematol."
Processing 00000000.tx.350: 1997;34: 303-310.[Medline] [OrderarticleviaInfotrieve] Hanson RD, Connolly NL, Burnett D, Campbell EJ, Senior RM, Ley TJ. 

Phrase: "1997"

Phrase: ";34"

Phrase: ":"

Phrase: "303-310."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Hanson RD,"

Phrase: "Connolly NL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027778:NL [Geographic Area]
   861   C0560008:nL [Quantitative Concept]

Phrase: "Burnett D,"

Phrase: "Campbell EJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1718783:Ej [Immunologic Factor]

Phrase: "Senior RM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]

Phrase: "Ley TJ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039247:TJ [Geographic Area]
Processing 00000000.tx.351: Developmental regulation of the human cathepsin G gene in myelomonocytic cells. 

Phrase: "Developmental regulation of the human cathepsin G gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0017263:Gene Regulation [Genetic Function]
   744   C0851285:Regulation [Governmental or Regulatory Activity]
   744   C1327622:Regulation [Biologic Function]

Phrase: "in myelomonocytic cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.352: J Biol Chem. 

Phrase: "J Biol Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.353: 1990;265: 1524-1530.[Abstract/Free FullText] Zimmer M, Medcalf RL, Fink TM, Mattmann C, Lichter P, Jenne DE. 

Phrase: "1990"

Phrase: ";265"

Phrase: ":"

Phrase: "1524-1530."

Phrase: "[Abstract/Free FullText"

Phrase: "] Zimmer M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Medcalf RL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419337:RL [Gene or Genome]
   861   C3539667:RL [Gene or Genome]

Phrase: "Fink TM,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0145779:TM [Amino Acid, Peptide, or Protein,Receptor]
   861   C3540468:TM [Gene or Genome]

Phrase: "Mattmann C,"

Phrase: "Lichter P,"

Phrase: "Jenne DE."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011198:DE [Geographic Area]
   861   C0017480:DE [Geographic Area]
   861   C3541240:DE [Idea or Concept]
Processing 00000000.tx.354: Three human elastase-like genes coordinately expressed in the myelomonocytic lineage are organized as a single genetic locus on 19pter. 

Phrase: "Three human elastase-like genes coordinately"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   841   C0314604:Human gene [Gene or Genome]
   799   C0017337:Genes [Gene or Genome]

Phrase: "expressed in the myelomonocytic lineage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1881379:Lineage [Conceptual Entity]

Phrase: "are"

Phrase: "organized as a single genetic locus"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0678933:Genetic Locus [Gene or Genome]
   762   C2235729:Single birth NOS [Finding]
   753   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   753   C0037179:Single [Population Group]
   753   C0087136:single [Finding]
   753   C0205171:Single [Quantitative Concept]
   753   C0314603:Genetic [Functional Concept]
   753   C1300196:Organized [Functional Concept]
   753   C1708726:Locus [Gene or Genome]

Phrase: "on 19pter."
Processing 00000000.tx.355: Proc Natl Acad Sci U S A. 

Phrase: "Proc Natl Acad Sci U S A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   845   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.356: 1992;89: 8215-8219.[Abstract] Grisolano JL, Sclar GM, Ley TJ. 

Phrase: "1992"

Phrase: ";89"

Phrase: ":"

Phrase: "8215-8219."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Grisolano JL,"

Phrase: "Sclar GM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0546866:GM [Antibiotic,Carbohydrate]

Phrase: "Ley TJ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039247:TJ [Geographic Area]
Processing 00000000.tx.357: Early myeloid-specific expression of the human cathepsin G gene in transgenic mice. 

Phrase: "Early myeloid-specific expression of the human cathepsin G gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0017262:Gene Expression [Genetic Function]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in transgenic mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
Processing 00000000.tx.358: Proc Natl Acad Sci U S A. 

Phrase: "Proc Natl Acad Sci U S A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   845   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.359: 1994;91: 8989-8993.[Abstract] Lane AA, Westervelt P, Ley TJ. 

Phrase: "1994"

Phrase: ";91"

Phrase: ":"

Phrase: "8989-8993."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Lane AA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1235746:Aa [Plant]
   861   C1882141:aa [Qualitative Concept]

Phrase: "Westervelt P,"

Phrase: "Ley TJ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039247:TJ [Geographic Area]
Processing 00000000.tx.360: PML-RAR kills U937 cells: a novel activity of PML-RAR that may contribute to APL pathogenesis [abstract]. 

Phrase: "PML-RAR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C3538821:RAR [Gene or Genome]
   734   C0023487:Promyelocytic Leukemia [Neoplastic Process]
   734   C1366903:promyelocytic leukemia [Gene or Genome]
   734   C2745900:Promyelocytic leukemia [Neoplastic Process]

Phrase: "kills"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0162388:kill [Social Behavior]
  1000   C0681205:Kill [Idea or Concept]
  1000   C1550555:kill [Functional Concept]

Phrase: "U937 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0600531:U937 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "a novel activity of PML-RAR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "that"

Phrase: "may"

Phrase: "contribute to APL pathogenesis"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   833   C0023487:Acute Promyelocytic Leukemia [Neoplastic Process]
           Promyelocytic Leukemia
   790   C1366903:promyelocytic leukemia [Gene or Genome]
   790   C2745900:Promyelocytic leukemia [Neoplastic Process]
   783   C0085669:Acute leukaemia [Neoplastic Process]
   783   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   753   C0023418:Leukaemia [Neoplastic Process]
   753   C0205178:acute [Temporal Concept]
   753   C0543483:pathogenesis [Functional Concept]
   753   C0699748:Pathogenesis [Pathologic Function]
   753   C1880177:Contribute [Activity]

Phrase: "[abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.361: Blood. 

Phrase: "Blood."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.362: 2002;100: 538a. 

Phrase: "2002"

Phrase: ";100"

Phrase: ":"

Phrase: "538a."
Processing 00000000.tx.363: Grosveld F, van Assendelft GM, Greaves DR, Kollias G. 

Phrase: "Grosveld F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "van Assendelft GM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0546866:GM [Antibiotic,Carbohydrate]

Phrase: "Greaves"

Phrase: "DR,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]

Phrase: "Kollias G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.364: Position-independent, high-level expression of the human -globin gene in transgenic mice. 

Phrase: "Position-independent, high-level expression of the human -globin gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0017262:Gene Expression [Genetic Function]
   757   C3244092:expression level [Idea or Concept]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in transgenic mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
Processing 00000000.tx.365: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.366: 1987;51: 975-985.[Medline] [OrderarticleviaInfotrieve] Hanscombe O, Vidal M, Kaeda J, Luzzatto L, Greaves DR, Grosveld F. 

Phrase: "1987"

Phrase: ";51"

Phrase: ":"

Phrase: "975-985."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Hanscombe O,"

Phrase: "Vidal M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kaeda J,"

Phrase: "Luzzatto L,"

Phrase: "Greaves"

Phrase: "DR,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]

Phrase: "Grosveld F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.367: High-level, erythroid-specific expression of the human -globin gene in transgenic mice and the production of human hemoglobin in murine erythrocytes. 

Phrase: "High-level, erythroid-specific expression of the human -globin gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0017262:Gene Expression [Genetic Function]
   757   C3244092:expression level [Idea or Concept]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "the production of human hemoglobin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033268:production [Occupational Activity]

Phrase: "in murine erythrocytes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014772:Erythrocytes [Laboratory Procedure]
   861   C0014792:Erythrocytes [Cell]
Processing 00000000.tx.368: Genes Dev. 

Phrase: "Genes Dev."
Processing 00000000.tx.369: 1989;3: 1572-1581.[Abstract] Greaves DR, Fraser P, Vidal MA, et al. 

Phrase: "1989"

Phrase: ";3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ":"

Phrase: "1572-1581."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]"

Phrase: "Greaves"

Phrase: "DR,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]

Phrase: "Fraser P,"

Phrase: "Vidal MA,"

Phrase: "et al."
Processing 00000000.tx.370: A transgenic mouse model of sickle cell disorder. 

Phrase: "A transgenic mouse model of sickle cell disorder."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C2986594:Mouse Model [Experimental Model of Disease]
   767   C0684309:disorder model [Experimental Model of Disease]
   767   C1519606:Transgenic Model [Experimental Model of Disease]
   744   C3161035:Model [Intellectual Product]
Processing 00000000.tx.371: Nature. 

Phrase: "Nature."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]
Processing 00000000.tx.372: 1990;343: 183-185.[CrossRef][Medline] [OrderarticleviaInfotrieve] Grignani F, Ferrucci PF, Testa U, et al. 

Phrase: "1990"

Phrase: ";343"

Phrase: ":"

Phrase: "183-185."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Grignani F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Ferrucci PF,"

Phrase: "Testa U,"

Phrase: "et al."
Processing 00000000.tx.373: The acute promyelocytic leukemia-specific PML-RAR fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. 

Phrase: "The acute promyelocytic leukemia-specific PML-RAR fusion protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   883   C0146495:Promyelocytic Leukemia Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   883   C3476424:Promyelocytic leukemia protein [Amino Acid, Peptide, or Protein]
   807   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   791   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   791   C0332466:Fusion [Functional Concept]
   791   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "differentiation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "and"

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "survival of myeloid precursor cells."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C0007620:Cell Survival [Cell Function]
   760   C0038952:Survival [Activity]
   760   C0220921:survival [Functional Concept]
Processing 00000000.tx.374: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.375: 1993;74: 423-431.[Medline] [OrderarticleviaInfotrieve] Ferrucci PR, Grignani F, Pearson M, Fagioli M, Nicoletti I, Pelicci PG. 

Phrase: "1993"

Phrase: ";74"

Phrase: ":"

Phrase: "423-431."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Ferrucci PR,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0279759:PR+ [Laboratory or Test Result]
   861   C0279766:PR- [Laboratory or Test Result]
   861   C1418864:PR@ [Gene or Genome]
   861   C3538934:PR [Intellectual Product]
   861   C3538935:PR [Idea or Concept]

Phrase: "Grignani F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Pearson M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Fagioli M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Nicoletti I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Pelicci PG."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1266240:PG [Laboratory Procedure]
Processing 00000000.tx.376: Cell death induction by the acute promyelocytic leukemia-specific PML/RAR fusion protein. 

Phrase: "Cell death induction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1516338:Cell Death Induction [Cell Function]
   827   C0205263:Induction [Functional Concept]
   827   C0857127:induction [Therapeutic or Preventive Procedure]
   734   C0007587:Cell Death [Cell Function]

Phrase: "by the acute promyelocytic leukemia-specific PML/RAR fusion protein."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   883   C0146495:Promyelocytic Leukemia Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   883   C3476424:Promyelocytic leukemia protein [Amino Acid, Peptide, or Protein]
   807   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   791   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   791   C0332466:Fusion [Functional Concept]
   791   C1293131:Fusion [Therapeutic or Preventive Procedure]
Processing 00000000.tx.377: Proc Natl Acad Sci U S A. 

Phrase: "Proc Natl Acad Sci U S A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   845   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.378: 1997;94: 10901-10906.[Abstract/Free FullText] Minucci S, Monestiroli S, Giavara S, et al. 

Phrase: "1997"

Phrase: ";94"

Phrase: ":"

Phrase: "10901-10906."

Phrase: "[Abstract/Free FullText"

Phrase: "] Minucci S,"

Phrase: "Monestiroli S,"

Phrase: "Giavara S,"

Phrase: "et al."
Processing 00000000.tx.379: PML-RAR induces promyelocytic leukemias with high efficiency following retroviral gene transfer into purified murine hematopoietic progenitors. 

Phrase: "PML-RAR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C3538821:RAR [Gene or Genome]
   734   C0023487:Promyelocytic Leukemia [Neoplastic Process]
   734   C1366903:promyelocytic leukemia [Gene or Genome]
   734   C2745900:Promyelocytic leukemia [Neoplastic Process]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "promyelocytic leukemias with high efficiency"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   773   C0023487:Promyelocytic Leukemia [Neoplastic Process]
   773   C1366903:promyelocytic leukemia [Gene or Genome]
   773   C2745900:Promyelocytic leukemia [Neoplastic Process]
   760   C0023418:LEUKEMIAS, NOS [Neoplastic Process]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "retroviral gene transfer into purified murine hematopoietic progenitors."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1517499:Gene Transfer [Molecular Biology Research Technique]
   744   C0017337:Gene [Gene or Genome]
   744   C0040671:Transfer [Mental Process]
   744   C1705822:Transfer [Activity]
Processing 00000000.tx.380: Blood. 

Phrase: "Blood."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.381: 2002;100: 2989-2995.[Abstract/Free FullText]

Phrase: "2002"

Phrase: ";100"

Phrase: ":"

Phrase: "2989-2995."

Phrase: "[Abstract/Free FullText"

Phrase: "]"

